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Abstract
Flavonols are polyphenolic plant secondary metabolites found in high concentrations 
in fruits, vegetables and beverages such as tea and red wine. Many possess 
antioxidant and free radical scavenging activity and epidemiological studies indicate 
that consumption of flavonols is associated with a reduced risk of coronary heart 
disease. (+)-Catechin is one such compound found in red wine and green tea. The 
absorption and metabolism of (+)-catechin is poorly understood and radiolabelled 
material is required to determine its bioavailability and role as an in vivo antioxidant.
We envisaged two main approaches in our retrosynthesis of labelled (+)-catechin i 
from aryllithium ii and radiolabelled carbon dioxide. The first involved flavene iii as a 
key intermediate whilst the second relied on the preparation of 1,3-diarylpropene iv.
A number of routes to model flavenes v were attempted. A range of potential 
synthetic intermediates vi-x were prepared, but all failed to give the cyclised product 
v.
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Various routes to synthetic intermediates corresponding to the 1,3-diarylpropene 
synthon iv were then investigated. The most successful approach proved to be cross­
metathesis. Thus, phloroglucinol xi was protected as its tris-THP ether xii, lithiated 
and allylated to give a mixture of diastereomeric compounds xiii. Cross-metathesis 
then gave 1,3-diarylpropene xiv and dihydroxylation provided the racemic syn diol 
xv.
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Other potential substrates for alkenation reactions were prepared including 
phosphonium salt xvi and sulfone xvii and a range of novel benzothiazole chemistry 
is discussed.
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CHAPTER 1 -  Introduction
1.1 What are flavonoids?
Flavonoids are a large family of phenolic plant secondary metabolites. In fact, they 
are the largest subset of naturally occurring phenols.1 Despite over 3000 different 
examples being known,2 flavonoids share a common core structure, a chroman 
system, which makes them very similar in structure. The diversity in structure comes 
from differing hydroxylation patterns in the A-ring of the chroman and substitution at 
either the 2- or 3-position with a hydroxylated aromatic B-ring. The core structure, 
numbering pattern and designation of the A, B and C rings is shown below (Figure
Flavonoids are divided into eight main subsets according to the oxidation of the C-2- 
C-3 bond, the oxidation of the C-4 position and the substitution at the 2- and 3- 
positions. Four other subsets also exist. These are the aurones, coumarins, chalcones 
and dihydrochalcones, which while strictly speaking not flavonoids, are usually 
included due to their physical properties being similar to flavonoids. A summary of 
the subsets is shown below (Table 1.1).
1.1).
3'
o
Figure 1.1
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Table 1.1
Flavonoids occur mainly as glycosides in plants and plant-derived products e.g. rutin 
1 (Figure 1.2). The aglycones are well known too, with 500 different examples 
reported in the literature by 1997.3
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Figure 1.2
1.2 Nomenclature
The nomenclature of flavonoids has changed several times since their discovery in the 
late 19th century.4,5 The various numbering systems that have been used for chromone 
are shown in Figure 1.3 (2-5). Chromone has had a variety of different names over 
the years which include 2,3-benzopyrone-(4), 4-oxochromen, 4//-l-benzopyran-4-one 
and chromen-4-one, of which 4//-l-benzopyran-4-one was adopted by Chemical 
Abstracts in 1972. This name can also be the basis for naming flavones and flavonols.
2 3 4 5
Figure 1.3
The names of flavonoids may also be based on the flavonoid core structure. For 
example, (+)-catechin 6 (Figure 1.4) could be named (2R, 3 S )-3 \  4 ’, 3, 5, 7- 
pentahydroxyflavan. For simplicity, the flavonoids discussed in this thesis will be 
referred to by their “trivial” names e.g. (+)-catechin or by the parent flavonoid 
structure e.g. (2R, 3S)-3\ 4 ’, 3, 5, 7-pentahydroxyflavan.
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Figure 1.4
1.3 Biological activity
Flavonoids are widespread in nature and are continuously synthesised within plants. 
As well as being implicated in the defence of plants from harmful ultraviolet and 
visible light,6 flavonoids are responsible for the colour of a wide variety of plants.
High flavonoid levels in plants have been associated with high boron levels. This is an 
interesting observation when considered with the fact that many hydroxyflavones 
form stable complexes with boric acid, as well as with a wide variety of metals.7 
Indeed, the ability of these compounds to chelate metals, combined with their free- 
radical scavenging ability, has led to the suggestion that flavonoids act as dietary 
antioxidants. It is this property as potential inhibitors of free-radical-mediated 
diseases such as coronary heart disease, stroke and cancers that has received the most 
attention in recent literature.
It has been found that the average dietary intake of quercetin in the Netherlands is 16 
mg/day obtained mainly from tea, onions and apples.8 It has also been estimated that 
the human consumption of flavonoids may exceed 800 mg/day.8 Due to the 
potentially high consumption of these compounds, a vast amount of research has gone 
into studying the in vivo and in vitro properties of flavonoids.
Many flavonoids are known to possess a variety of biological properties in mammals 
including anti-inflammatory, anti-allergenic, anti-hepatotoxic, anti-anginal, anti-ulcer 
and anti-oxidant properties.9 Some flavonoids have also been shown to possess in
15
vitro and in vivo anti-viral properties against several viruses such as the rhinovirus, 
herpes simplex virus, poliovirus and HIV.9
Moderate consumption of red wines, which are a rich source of flavonoids, is 
associated with a reduced risk of coronary heart disease. A high intake of saturated 
fats has been linked to higher levels of coronary heart disease, yet this is not true in 
certain regions of France where red wine is consumed instead of beer (the French 
paradox).9,10 There is a rapid increase in the antioxidant activity of the serum of 
human volunteers after consuming red Bordeaux wine and it is the phenolic 
components of the wine, rather than the alcohol content, which exert the effect.11
Resveratrol 7, a non-flavonoid phenolic also found in red wine, has received a lot of 
attention in the popular press due to its ability to prevent platelet aggregation in 
coronary arteries and reduce the incidence of cancer (Figure 1.5). However, the 
hydroxybenzoate gallic acid 8 and certain flavonoids, in particular the flavan-3-ols 
(+)-catechin 6 and (-)-epicatechin 9, as well as the flavonols quercetin 10 and 
myricetin 11, are present in much higher concentrations and show similar, if not 
greater, antioxidant and anti platelet aggregation activity.11
wn OH
O
7 8
OH OH
OH OH
6 9
OH OH
OH O OH O
10 11
Figure 1.5
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1.4 Antioxidant ability of phenols
Despite the increasing amount of evidence showing flavonoids acting as antioxidants 
in vitro, their efficacy in vivo is still poorly understood. This may be attributed to the 
lack of information regarding the bioavailability of these compounds. It has only 
recently been proved that flavonoids from dietary sources are absorbed at levels that 
could allow them to act as antioxidants. It is widely believed that flavonoid glycosides 
are initially hydrolysed to the aglycones, however it has recently been proved that 
glycosides can be absorbed. The absorption of catechins has also been studied and it 
was found that (-)-epigallocatechin gallate (EGCG) 12 and epicatechin gallate (EGC) 
13 (Figure 1.6) could be detected after the consumption of green tea, decaffeinated 
green tea extracts and dark chocolate and that glucuronide and sulfate conjugates of 
(+)-catechin and 3 ’-0-methyl-(+)-catechin were detected after consumption of red 
wine.12
OH OH
OH OH
HO.HO.
OH
OH OH
OH OH
OH OH
12 13
Figure 1.6
The level of absorption does not normally exceed a few percent of the ingested dose 
and food composition may be an important factor that affects the bioavailability. 
Binding to proteins would reduce the availability, whereas alcohol may increase the 
availability.12 Evidence for the latter suggestion has been observed in the increased 
uptake of red wine phenolics compared to the levels observed after consumption of 
alcohol-free red wine.12 Recent data also suggests that specific flavonoids may have 
improved absorption in the presence of fats. For example, catechins from green tea 
are absorbed to a greater extent when administered as phospholipid complexes 
compared to the free flavonoids.12
17
A variety of mechanisms have been proposed that account for phenols, including 
flavonoids acting as biological anti oxidants. Flavonoids could act as antioxidants by 
inhibiting enzymes such as xanthine oxidase, which is involved in the generation of 
reactive superoxide radicals.13 The chelation of low valent metal ions like Fe2+ and 
Cu+, which can generate the highly reactive hydroxyl radical by the Haber-Weiss and 
Fenton reactions (eq 1 and eq 2) may also contribute to their effect.14
H20 2 + Mn+ + 0 2 
H20 2 + Mn+
-  HO + 0 2 + Mn+ + HO (eq 1) 
HO + M(n+1)+ + HO* (ecl 2)
M = Fe2+ or Cu+
Phenols in general may act as antioxidants by directly quenching free radicals via 
hydrogen atom abstraction from a free phenolic hydroxyl (Scheme l . l ) .8 If the 
resulting phenolic radical is stable, then the generation of harmful radicals will be 
terminated.
Sch em e 1.1
This property of phenols led to the suggestion that flavonoids may combat diseases 
where oxidative damage occurs e.g. cancers and coronary heart disease. This can be 
explained by flavonoids regenerating natural antioxidants such as a-tocopherol 
(vitamin E) 14 (Figure 1.7).15
HO.
Figure 1.7
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1.4.1 Antioxidant ability
Many different methods have been used to determine the ability of phenols to quench 
free radicals so acting as chemical reductants and thus antioxidants. The most widely 
applied method is to react the phenol with a stable radical and simply monitor the 
disappearance of the radical species’ ultraviolet absorbance. A commonly used stable 
radical is diphenylpicrylhydrazyl (DPPH) 15 (Figure 1.8). DPPH has been used to 
quantify the antioxidant ability of many flavonoids by titrating the flavonoid against 
the DPPH.14-16
15
Figure 1.8
Antioxidants are characterised by their stoichiometry, n, which is defined as the 
number of DPPH molecules reduced by one molecule of the antioxidant. The greater 
the value for n, the better the antioxidant. This only applies in vitro. The 
stoichiometry is determined by the structure and the oxidation mechanism of the 
antioxidant. For example, a monophenol (ArOH) could react with DPPH to give 
aryloxy radical (A rO ), which can dimerise giving (ArO)2. If the dimer is unreactive 
towards DPPH n will be one. If, however, the dimer can be further oxidised by DPPH, 
then n will be higher than one. In the case of o- and p-diphenols, which can be 
oxidised twice by DPPH, the corresponding o- and p-quinones are formed. If these 
quinones are unreactive to DPPH, then n will be two. If the quinones can react further 
with DPPH, then n will be higher than two. This is illustrated in Scheme 1.2.
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This method has been used to determine stoichiometries for quercetin 10 and rutin 1, 
two of the most commonly studied and significant dietary-derived flavonoids. The 
values obtained ranged between 3.19 (± 0.02) and 4.53 (± 0.04) for quercetin and 2.1 
(± 0.01) and 2.57 (± 0.01) for rutin. The variation in values arises from solvent 
effects. In this case, the lower values were obtained from studies carried out in DMF 
and the higher values were obtained using MeOH. Stoichiometries for a variety of 
flavonoids including quercetin and rutin have also been measured using another stable 
radical, galvinoxyl 16 (Figure 1.9).17 In this case the values of 3.27 ± 0.04 for 
quercetin and 3.18 ± 0.01 for rutin were obtained using EtOH as solvent. This study 
also showed (+)-catechin to be a good anti oxidant with a value of 2.96 ± 0.01. 
Interestingly, all of these values are greater than that obtained for vitamin E (2.14 ± 
0.12) under the same conditions. Vitamin E is the main lipid-soluble small molecule 
involved in the human antioxidant defence.
•o
f-Bu'
A proposed mechanism for the high reaction stoichiometry of catechin is shown 
below in Scheme 1.3. This mechanism is based on Dangles proposed mechanism for 
the oxidation of quercetin.14 One-electron oxidation (H-atom abstraction) of catechin
f-Bu f-Bu
16
Figure 1.9
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6 gives aryloxy radicals 17 and 18. These are stabilised by H-bonding and by 
conjugation. A further H-atom abstraction from radicals 17 and 18 leads to a 
tautomeric mixture of ortho and para-quinones 19 and 20. Solvent addition to para- 
quinone 20 gives alcohol 21 and regenerates the catechol-moiety of the B-ring. The 
newly reformed catechol system can then be re-oxidised, which will lead to 
degradation products. The regeneration of the catechol-moiety allows further H-atom 
abstractions to occur thus explaining the higher than expected value for catechin’s 
stoichiometry (i.e. >2).
OHOH
HO*
■0H  or HOg HO. HO.HO. OH —
'OH 'OH'OH
OH OHOH
H2 O2  or H2 O
As before or 
disproportionation
HO. HO
OH
'OH 'OH
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20
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Sch em e 1.3
1.4.2 Effect of hvdroxylation pattern
A potentially crucial discovery to understanding the antioxidant ability of flavonoids 
was made by Cos when investigating SAR studies of flavonoids as inhibitors of 
xanthine oxidase, one of the enzymes responsible for the generation of superoxide 
radicals.13 Cos found that the A-ring hydroxylation pattern was important for good 
binding to the enzyme. The most important positions for good enzyme inhibition were 
found to be the 5- and 7-positions, while a free 3-hydroxyl reduced the observed
21
inhibition. It can be concluded from this that any hydroxylation pattern may prove to 
be important depending on the mode of action in vivo.
1.4.3 Prooxidant ability
While investigating the antioxidant and prooxidant potential of a variety of phenolic 
compounds, Fukumoto and Mazza found that almost all phenolics tested exhibited 
some prooxidant behaviour i.e. they have the ability to cause cellular damage.16 The 
ability of flavonoids to chelate metals such as iron and copper may be vital to their 
ability to act as antioxidants, but may also allow them to act as prooxidants. The B- 
ring catechol moiety has been reported to bind metals strongly (Figure 1.10).8 It is 
believed that the redox potential of the chelated metal is reduced, allowing the 
formation of low valent metal ions that can assist the formation of damaging radicals 
via the Fenton reaction.8,18 As stated above, the ability of flavonoids to sequester metal 
ions may allow them to act as antioxidants, however, it may also promote their 
prooxidant potential.19
HO—-M
HO
.OH
'OH
OH
M = Metal 
Figure 1.10
Flavonoids have also been shown to cause strand scission of DNA molecules in the 
presence of copper ions leading to the suggestion that they can act as mutagens and 
carcinogens.20 The damage caused has been attributed to the various radical and 
quinonoid species formed during the oxidation process. However, it has been 
suggested that solvent addition onto the quinones is rapid, resulting in the formation 
of innocuous products and hence preventing potentially harmful side reactions.14
22
1.5 Metabolism
The metabolism of flavonoids in plants, fungi, microorganisms and mammals has 
been extensively studied and reviewed.21"23 The metabolism of flavonoids in mammals 
is discussed below.
1.5.1 Metabolism of Catechins
The two most important areas involved in the metabolism of flavonoids are the liver 
and colon. The liver is responsible for forming soluble conjugates e.g. sugar 
conjugates and sulfates and also for 0-methylation by catechol-Omethyltransferase. 
Bacteria in the colon are responsible for the removal of the sugar moieties, which 
potentially allows the flavonoids to be reabsorbed.24 The colonic bacteria are also 
responsible for the opening of the C-ring to give a variety of phenolic acids, which 
may themselves contribute to the antioxidant activity of the parent flavonoid.25,26
Early studies showed that catechins are extensively metabolized in humans. Oral 
administration of [U-14C]-(+)-catechin to humans results in around 50 % of the 
radioactivity being recovered in urine with only 0.5 -  3 % of this as the catechin 
aglycone.27 Glucuronation and sulfation in body tissues has been shown to occur, with 
rats and humans excreting sulfates and glucuronides of 3-methoxy-(+)-catechin in 
urine, plasm a and bile after intravenous in jec tion .28 Conjugates of (-)- 
epigallocatechin-3-gallate, (-)-EGCG, and (-)-epicatechin from green tea identified in 
plasma were sulfates, whereas (-)-epigallocatechin was detected as the glucuronide 
after oral administration to humans.12 Of the (-)-EGCG administered, 20 % was also 
detected unchanged. In addition to these metabolites, glucuronides of the main 
co lon ic  m etabo lites S-(4-hydroxy-3-methoxyphenyl)-y-valerolactone, 8-(3,4- 
dihydroxyphenyl)-y-valerolactone and 8-(3-hydroxyphenyl)-y-valerolactone and 3- 
hydroxyphenylpropionic acid were detected in the urine of humans.29 Sulfates of S-(3- 
hydroxyphenyl)-y-valerolactone and 3-hydroxyphenylpropionic acid were also 
detected. In vitro incubation of (+)-catechin in liver homogenates resulted in the 
formation of 3’-methoxy-(+)-catechin, proving that O-methylation does occur.30
23
It has been concluded from this data that liver enzymes metabolise catechins giving 
sulfates and glucuronides and that O-methylation by catechol-Omethyl transferase 
also occurs. The basic metabolic processes proposed for catechins are summarised 
below (Scheme 1.4). However, these early studies give at best a patchy and 
qualitative picture since very many metabolites could not be identified and quantified.
OH
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HO.
'OH
OH
(+)-catechin
Tissues
OMe
OH
HO.
'OH
OH
3’-methoxy-(+)-catechin
OMe
0
OH
O
5-(4-hydroxy-3-methoxyphenyl)-Y-valerolactone 
Tissues
OH
Colon O-
OH
O
5-(3,4-dihydroxyphenyl)-Y-valerolactone 
Colon
OH
O
O
5-(3-hydroxyphenyl)-Y-valerolactone 
Colon
3-hydroxyphenylpropionic acid 
Tissues
3-hydroxybenzoic acid
S chem e 1.4
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1.5.3.1 Recent work on M-EGCG
The metabolic fate of (-)-EGCG in rats has been investigated using (-)-[4-3H]- 
epigallocatechin gallate administered intravenously and orally.31 This oral feeding 
study is one of the key modem investigations into the metabolic fate of this 
compound. The study revealed that very little intact (-)-EGCG is absorbed from oral 
dosing. Although 32 % of the radioactivity had appeared in the urine after 72h, 
showing that absorption of material derived from (-)-EGCG does take place, 68 % of 
the 30 % excreted by 48h was 3’-glucuronidated 5 -(3 \ 5’-dihydroxyphenyl)-y- 
valerolactone. The compound was convincingly identified by NMR spectroscopy and 
mass spectrometry. 35 % of the total radioactivity appeared in the feces and 41 % of 
this was (-)-epigallocatechin and 17 % 5-(3’, 5’-dihydroxyphenyl)-y-valerolactone. 
Thus, a third of the total radioactivity was not recovered and only about 45 % of the 
radioactivity was found in compounds that could be identified by the researchers e.g. 
the identified (3’, 5 ’-dihydroxyphenyl)-y-valerolactone and its glucuronide only 
accounted for 28 % of the total radioactivity. Similar results were obtained when 
feeding beagles the same radiolabelled material.32 The results obtained allowed the 
authors to propose a metabolic route for (-)-EGCG, which is shown below (Scheme 
1.5).
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Schem e 1.5
The first transformation is the hydrolysis of the galloyl group giving (-)- 
epigallocatechin (EGC) 22 and gallic acid 8, which occurs in the intestine. Reductive 
cleavage of the C-ring of EGC leads to propan-2-ol derivative 23. This compound 
then undergoes dehydroxylation at the 4 ’-position of the B-ring giving alcohol 24, the
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phloroglucinol unit (A-ring) is decomposed and subsequent lactonisation of the C2- 
OH with the residual carbonyl group leads to formation of lactone 25 (detected in the 
feces). An alternative pathway is degradation of the A-ring of propan-2-ol derivative 
23 to form lactone 26 after which dehydroxylation at the 4 ’-position of the B-ring 
gives lactone 25. Glucuronidation of lactone 25 gives the major urinary metabolite, 
glucuronide 27. Other examples of ring fission on (+)-catechin,29 (-)-epicatechin33 and 
(-)-EGC33 by intestinal bacteria have been reported.
This paper is the leading metabolic study in the metabolism of flavan-3-ol derivatives 
despite the low recovery of radioactivity and the lack of conclusive evidence for the 
assignment of some metabolites. However, in the last few years a new method that 
overcomes the problems of quantification and identification of metabolites has been 
introduced, but not yet applied to flavan-3-ols.
1.5.3.2 The technique of HPLC-radiocounting and tandem mass spectrometry
In 2002, a feeding study carried out in rats was published that revolutionised the 
field.34 The study used reversed-phase HPLC with on-line radioactivity detection and 
ion-trap mass spectrometry capable of performing data dependent MS-MS studies.35 
This technique allows structural information to be obtained using low-nanogram 
quantities of material. The use of tandem mass spectrometry provides structural 
information on HPLC peaks and allows the conclusive identification of each peak. 
The ion-trap mass spectrometer “traps” the parent ion of the compound and excludes 
all other ions. The “trapped” ion is then fragmented and a specific fragment ion 
produced. This method has been applied to [2-14C]-quercetin-4’-glucoside where its 
radioactivity allowed the location and quantification of [2-14C]-quercetin-4’-glucoside 
derived material in different tissues. The HPLC separates the metabolites, the 
radioactivity identifies and quantifies those derived from [2-14C]-quercetin-4’- 
glucoside and the tandem MS allows structural determination of the metabolites so 
that the HPLC peak assignment is unambiguous. The ion trap method allows all 
contributors to HPLC peaks to be identified. The results of this study were that 93.6 
% of ingested radioactivity was recovered and 18 metabolites were detected. The use 
of this technique allowed 17 of these metabolites to be identified.
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CHAPTER 2 -  Synthesis and labelling of Flavan-3-ols
2.1 Introduction
The aim of my research was to investigate new potential routes for the carbon-14 
radioisotopic labelling of (+)-catechin. In this chapter, I will survey the various 
methods that have been used to make catechin and epicatechin, including methods by 
which they have been isotopically labelled. I will then discuss routes to a related 
flavan-3-ol of dietary importance, (-)-epigallocatechin gallate and methods of 
accessing labelled dimers of catechin (found in many beverages) from labelled 
catechin-derived monomers. The use of biosynthesis for 14C-labelling of flavan-3-ols 
and the synthesis of catechin and EGCG labelled with isotopes of hydrogen will then 
be discussed briefly. Most of the work reviewed here was published during the course 
of my PhD research, which began in October 2000.
2.2 Ferreira’s approach: Asymmetric dihvdroxvlation of 1.3-diarylpropenes and 
acid-induced cvclisation
Ferreira has reported the synthesis of a number of flavan-3-ol acetates 28a-e from 
simple 1,3-diarylpropenes (one enantiomeric series shown in Scheme 2.1).36,37 To 
accomplish this, chalcones 29a-e were synthesised. Hydrogenation, followed by 
borohydride reduction to alcohols 30a-e proceeded in almost quantitative yield. 
Treatment with thionyl chloride followed by elimination of the chloride gave the 
required 1,3-diarylpropenes 31a-e in moderate to good yield. Sharpless asymmetric 
dihydroxylation with AD-mix-a gave (+)-(lS , 2S) diols 32a-e in good yield and 
excellent enantiomeric excess. The authors noted that the (-)-(l/?, 2R)-syn-dio\s were 
formed on treatment with AD-mix-p only after prolonged reaction times (12 - 48 h). 
The absolute configuration for the diols was tentatively assigned according to the 
Sharpless model for AD-mix.
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Scheme 2.1
Ferreira's work on the synthesis of dihydroflavonols38 by Lewis acid catalysed 
phenylmethanethiol ring-opening and cyclisation of chalcone epoxides led to the 
investigation of this method for the cyclisation of diols 32b (Scheme 2.2). Selective 
substitution of the benzylic hydroxyl using tin tetrachloride and phenylmethanethiol 
at -20 °C and subsequent removal of the methoxymethyl group at 0 °C gave 
benzylthio derivative 33 in 70 % yield as a mixture of s y n  and a n ti isomers. 
Treatment of ether 33 with silver tetrafluoroborate in DCM at 0 °C resulted in slow 
and low conversion (24 h, 10 - 20 %) to the flavan-3-ols, which were then converted 
into the corresponding acetates anti and syn 28b.
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28b
1 0 - 2 0 %  
anti: syn  77:23
Scheme 2.2
Exploration of methods aimed at selective removal of the methoxymethyl group and 
subsequent ring-closure under mild acidic conditions was more successful. It was 
found that simultaneous deprotection and cyclisation of diols 32a-e in the presence of 
3 M hydrochloric acid in methanol, followed by acetylation, gave 2,3-awfz-28a-e (48 - 
68 %) and for the first time 2,3-5yn-flavan-3-ol methyl ether acetate derivatives 28a-e 
(17 - 22 %) in excellent enantiomeric excesses (>99 %). The optical purity was 
measured using a chiral shift reagent [Eu(hfc)3], which consistently showed only one 
enantiomer to be present.
Attempted cyclisation of oxygen-rich diol 32e led to the formation of two separable 
intermediate products 34 and 35 (Scheme 2.3). Formation of 34 can be rationalised by 
methanol initially acting as a nucleophile in an SNl-type acid-catalysed solvolysis of 
the benzylic hydroxyl group, giving a mixture of syn and anti isomers. It was found 
that prolonged exposure (2 h) of the mixture led to the deprotection of the MOM 
group to give phenol derivative 35. This is surprising as phenolic MOM ethers are 
acid-labile, yet in this case exposure to 3 M hydrochloric acid in refluxing methanol 
for two hours was required for complete removal. The authors report that this 
surprising stability was also observed in the synthesis of isoflavans.39 Phenol 
derivative 35 is then susceptible to cyclisation to give both the 2,3-anti- and 2,3-syn- 
flavan-3-ols 28e. Formation of a mixture of isomers can be explained by formation of
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a benzylic carbocation by protonation of the benzylic methoxy group, followed by an 
SN1 cyclisation leading to the predominant formation of the thermodynamically more 
stable antiarrangement.
.OMOM
OH
OMOM
OHHCI, MeOH
MeO a  OMe ,OMe
OAc
OMe
anti-2Be
Scheme 2.3
MeO
OMe
syn- 28e
Thus, the authors had reported the development of the first and highly efficient 
synthesis of essentially enantiopure flavan-3-ols of both the 2,3-anti and 2,3-syn  
configurations. They had successfully demonstrated the use of polyoxygenated 
diarylpropane-l,2-diols as intermediates in the synthesis of flavan-3-ols, however, all 
of the flavan-3-ols synthesised had the phenolic hydroxyls protected as methyl ethers. 
The synthesis of flavan-3-ols with free phenolic hydroxyls would have been more 
biologically relevant. The potential of this route in the chemistry of proanthocyanidins 
and condensed tannins in general was evident. However, there is evidence in the 
literature that removal of methyl ethers from such compounds would be problematic.40 
Indeed, a search of the literature reveals several syntheses of related compounds in 
which the synthesis ends one step from the natural product, with the methyl ethers
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still attached.36,37,40'42 There is no comment made as to why having made the flavan-3- 
ols, the authors then decided to acetylate them. This is presumably carried out to aid 
the purification of the final compounds, which was achieved by preparative thin-layer 
chromatography. This last point indicates that the route may be unsuitable for the 
synthesis of large quantities of these compounds.
In 1999, Ferreira and co-workers published the asymmetric synthesis of both 
enantiomers of catechin and epicatechin in their free phenolic forms.43 The synthetic 
route is effectively the same as previously reported with only a change in protecting 
groups from methyl ethers to methoxymethyl ethers (one enantiomeric series shown 
in Scheme 2.4). The authors again reported the slow conversion to the enantiomer of 
diol 36 with AD-mix-(3_The authors also reported that the dihydroxylation procedure 
worked when applied to 4-O-benzyl-2'-0-methoxymethylchalcone providing that 
acetone was used as co-solvent. However since the two-phase system could not be 
maintained above 20 % acetone, the limited solubility of benzyl ethers excludes their 
use in this synthesis. This synthesis was reported as the first asymmetric synthetic 
route providing access to both enantiomers of the two diastereoisomers of free 
phenolic flavan-3-ols in essentially enantiopure form (>99 % ee). It was suggested 
that the route would be extended to the synthesis of radiolabelled compounds required 
for biosynthetic studies. Its applicability to radiolabelling is not yet clear. The 
proposed position of the label was not disclosed and any label incorporated in the 
synthesis will be split between catechin and epicatechin, which is not ideal. No 
information was provided as to how the compounds were purified, so it is difficult to 
assess whether this would pose a difficulty in a radiochemical synthesis or affect 
scale-up.
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In summary, the key steps in Ferreira’s approach are access to 1,3-diarylpropenes by 
reduction of chalcones, asymmetric dihydroxylation of these and acid-induced 
cyclisation. Using this approach, both enantiomers of catechin and epicatechin were 
prepared with >99 %ee.
2.3 Gesson’s and Grubbs’ cross-metathesis routes to make 1.3-diarvlpropenes
The first example of the synthesis of flavan-3-ols using cross-metathesis was reported 
in 2001 by Gesson.44 Starting from three readily prepared protected 2-allylphenols 37 
- 39 , which were prepared by Claisen rearrangem ent of l-allyloxy-3,5- 
dimethoxybenzene, a variety of 1,3-diarylpropenes 40a-f, 41a, 42a were synthesised 
in moderate to good yield by reaction with styrenes derivatives 43a-f in the presence 
of Grubbs' first generation catalyst (Scheme 2.5).
The authors report that the optimum yields were obtained on reaction with two 
equivalents of styrene and 18 mol% catalyst in DCM for 48 hours. In the case of 40a, 
a 75 % yield was obtained using these conditions. This dropped to 55 % with one
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equivalent of styrene and dropped further still to 28 % with 10 mol% catalyst. 
Reducing the reaction time gave a yield of 51 % and conducting the reaction in 
refluxing DCM also lowered the yield. Changing the protecting group was found to 
make no significant difference to the results. Two other noteworthy points made by 
the author are that no significant amounts of symmetrical cross-metathesis products 
were observed and that only the ^-isomers were observed. The authors concluded that 
the cross-metathesis of protected 2-allylphenols with styrenes would provide a 
general route to 1,3-diarylpropenes, useful for the synthesis of flavan-3-ols, but that 
further experiments with more efficient catalysts were needed to lower the amount of 
catalyst to more attractive levels. This is a very attractive procedure for the synthesis 
of 1,3-diarylpropenes.
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Grubbs has also reported the synthesis of two flavan-3-ols as part of an investigation 
into the cross-metathesis of styrenes (Scheme 2.6).42 Treatment of silyl ether 44 with 
either 45 or 46 in refluxing DCM in the presence of Grubbs' second generation 
catalyst 47 gave the £-diarylpropenes 48 and 49 in high yield. Asymmetric 
dihydroxylation of both alkenes proceeded again in high yield to give diols 50 and 51. 
Deprotection and cyclisation of the diols gave the permethyl flavan-3-ols 52 and 53 in 
good yields and moderate to good selectivities. Grubbs' route appears to combine 
ideas from three other syntheses already discussed with his own modification, the use 
of his second-generation catalyst, to good effect. The commercial availability of a 
wide variety of variously substituted styrenes would allow the efficient and rapid 
synthesis of a large number of flavan-3-ols and derivatives although, in most cases,
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the protecting group would need to be changed in order to obtain the natural free 
phenolic flavanols. The route also appears to be suitable for labelled syntheses. This 
last point will be discussed in more detail later.
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Schem e 2.6
In summary, cross-metathesis is a potentially useful approach to 1,3-diarylpropenes, 
but neither the group of Gesson nor that of Grubbs prepared an intermediate that was 
appropriately protected to allow access to catechin itself.
2.4 V ercauteren’s use of dibenzvloxycinnam yl alcohol to prepare 1.3- 
diarvlpropenes
Vercauteren has also achieved the synthesis of 1,3-diarylpropenes e.g. 54 and 55 by 
coupling phloroglucinol and cinnamyl alcohol moieties in the presence of a 
molybdenum (IV) catalyst.45 Two examples are shown below (Scheme 2.7). Benzyl 
ether 56 and alcohol 57 coupled in moderate yield to give propene 54. The best 
example was achieved with TBS protected phloroglucinol 58. Unfortunately the
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product could not be obtained in a pure form due to the difficulty in removing the 
starting TBS ether. Employing the chemistry developed by Ferreira could then lead to 
the synthesis of a variety of flavanols.
R1
56 R = R1 = OBn 
58 R = R1 = OTBS
r 2 Mo(acac)2Cl2 
AgSbF6
R2 '
57 R2 = OBn
DCM, rt
54 R = R1 = R2 = OBn, 52 %
55 R = R1 = OTBS, R2 = OBn, 70-80 %
S chem e 2.7
2.5 .Tew and Park’s approach: Asymmetric dihvdroxylation prior to assembly of 
carbon framework
3-Hydroxyflavanone natural products also have interesting biological properties.46 
Two examples of these compounds are taxifolin 59 and silybin 60 (Figure 2.1), which 
have strong hepatoprotective effects due to their strong antioxidant effect.47
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Figure 2.1
In 2000, Jew and Park reported a new method for the enantioselective synthesis of the 
parent structure (2R, 3R)-3-hydroxyflavanone 61 and its application to the synthesis 
of (2R, 3R)-3',4 '-0-dim ethyltaxifolin 62 from which they later developed an 
asymm etric synthesis of catechin (Scheme 2.8).48 Sharpless asymmetric 
dihydroxylation of methyl cinnamates 63 and 64 gave optically active diols 65 and 66 
in high yield and excellent enantiomeric excess. The enantiomeric excesses were 
determined by analysis of the ]H NMR spectra of the Mosher's esters of 65 and 66. 
Protection of the diols with MOMC1 using Htinigs base gave 67 and 68 in excellent
36
yield. DIBAL reduction gave aldehyde 69 in good yield and 70 in high yield. 
Addition of aryllithium 71 to aldehyde 69 and 72 to aldehyde 70 proceeded to give 
alcohols 73 and 74 in moderate yield. Oxidation with A-methylmorpholine-A-oxide 
(NMO) using catalytic tetrapropylammonium perruthenate gave ketones 75 and 76. 
Deprotection of the MOM groups was accomplished with dilute acid giving phenols 
77 and 78 in excellent yield. The formation of the C-ring was achieved by an 
intramolecular Mitsunobu reaction giving 61 and 62 in moderate yields and moderate 
to excellent enantiomeric excesses. No comment about the removal of the methyl 
ethers was made. It is possible that as previously mentioned, the deprotection of the 
methyl ethers was not trivial and proved inconvenient. In this paper the authors have 
reported a general and relatively efficient enantioselective synthesis of 3- 
hydroxyflavanones.
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Scheme 2.8
In 2002, Jew and Park published a relatively short asymmetric synthesis of (+)- 
catechin 6 to allow SAR studies as part of an ongoing program to find new candidates 
for anticancer and psychoactive drugs.49 The synthesis was achieved using a similar 
approach to their preparation of the flavanones and avoids the epimerisation problem 
encountered by Ferreira during the acid-catalysed cyclisation by using an
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intramolecular Mitsunobu reaction for the cyclisation. The synthesis starts from 
commercially available methyl 3,4-dihydroxy-cinnam ate 79 (Schem e 2.9). 
Methoxymethyl protection of the phenols gave ester 80 in essentially quantitative 
yield. Asymmetric dihydroxylation of ester 80 gave diol 81 in quantitative yield and 
>99 % ee. The enantiomeric excess was determined by analysis of the !H NMR 
spectrum of the corresponding Mosher's esters. Protection of the diol, again using 
methoxymethyl ethers, gave ester 82 in excellent yield. Reduction of ester 82 with 
DIBAL gave aldehyde 83 in excellent yield. Addition of organolithium 72 proceeded 
in moderate yield to give alcohol 84. Subsequent Barton-McCombie deoxygenation 
gave 1,3-diarylpropane derivative 8 5  in 90 % yield over two steps. Global 
deprotection of the methoxymethyl ethers was achieved by treatment with dilute acid 
in methanol to give polyphenol 86 in moderate yield. An intramolecular Mitsunobu 
reaction then gave (+)-catechin 6 in moderate yield and good enantioselectivity (50 
%, >99 % ee). The absolute configuration of the new chiral centre was assigned as R 
on the basis of the coupling constant between C(2)H and C(3)H (J = 7.3 Hz). This 
asymmetric synthesis was achieved in nine steps with an overall yield of 9 % and >99 
% ee. The synthetic route devised by Jew and Park is good for several reasons. The 
starting materials are both cheap and commercially available, the synthesis is 
relatively short, all diastereoisomers can be synthesised and the route, although not 
ideal, could be applied to the radiolabelled synthesis of these compounds. The use of 
MOM protection is fully exploited to the authors’ advantage. The ability of MOM 
groups to allow ortho-metallation is well known, as is their acid lability. These factors 
combined make MOM ethers the ideal choice for this synthesis. Indeed, this synthesis 
relies on these properties of the MOM group. For this reason, it is all the more 
frustrating that no experimental details are given for the synthesis of MOM protected 
phloroglucinol from which organolithium 72 is synthesised. This omission raises 
questions as to the ease of synthesis of MOM protected phloroglucinol and casts 
doubt on the use of the route for the large-scale synthesis of the catechin flavonoids.
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In summary, Jew and Park’s synthesis of (+)-catechin involved asymmetric 
dihydroxylation of a caffeic acid derivative, followed by construction of the carbon 
framework by alkylating an aldehyde intermediate with lithiated, fully MOM- 
protected phloroglucinol. Barton-McCombie deoxygenation was used to remove the
4-OH, only MOM protection was used to allow global deprotection and cyclisation 
was carried out under Mitsunobu conditions to ensure complete inversion of 
configuration at C-2.
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2.6 Vercauteren’s carbon-13 labelling of (+)-catechin and M-epicatechin
In 2000, Vercauteren reported the first total synthesis of racemic catechin containing a 
carbon-13 label.50 The key C-C forming step in the synthesis involved the coupling of 
dibenzyloxycaffeic acid 87-13C and benzyl protected phloroglucinol 56 (Scheme 
2.10). Commercially available potassium [13C]-cyanide 88-13C was methylated with 
dimethylsulfate in moderated yield to give l- [13C]-acetonitrile 89-13C. Deprotonation 
with LDA and quenching with benzaldehyde derivative 90 gave the P-hydroxynitrile 
91-13C in good yield, which was dehydrated to give a 3:1 mixture of E- and Z- 
cinnamonitrile derivatives 92-13C and 9 3 -13C. The mixture was hydrolysed to 
dibenzyloxycaffeic acid 87-13C in 64 % yield. At this stage the Z-isomer could not be 
recovered which was attributed to complete isomerisation to the E-isomer during the 
hydrolysis. Activation of carboxylic acid 87-13C with trifluoroacetic anhydride 
allowed acylation of 1,3,5-tribenzyloxybenzene to proceed in moderate yield to give 
pentabenzyloxychalcone derivative 94-13C. The 2'-hydroxychalcone derivative 95-13C 
was prepared by selective deprotection with titanium tetrachloride, however this 
procedure also led to a small amount of chalcone 96-13C being formed. Employing the 
Clark-Lewis method the synthesis of flavan-3,4-diol 97-13C was accomplished in 
three steps and in 58 % yield from chalcone derivative 95-13C. Borohydride reduction 
of 95-13C followed by Lewis acid catalysed cyclisation gave racemic flavene 98-13C, 
which is very labile and was subjected to osmium catalysed dihydroxylation without 
purification. Dihydroxylation of flavene 98-13C proceeded in moderate yield and high 
diastereoselectivity (the all ds-isomer was not observed). Diol 97-13C is an interesting 
compound in its own right, since it can be used as a precursor for the synthesis of 
several flavonoid classes. In this case, reduction of 9 7 -13C with sodium 
cyanoborohydride in acetic acid gave the protected flavonol 99-13C. Subsequent 
hydrogenolysis gave the racemic catechin 6 in quantitative yield. The synthesis was 
completed in ten steps and 4 % overall yield from a readily available, easy to 
incorporate, relatively cheap source of carbon-13. Contrary to Vercauteren's belief, 
this synthesis would not be easily extended to carbon-14. The main problems 
associated with the synthesis are the use of labelled compounds from the start, the 
length, the overall yield and the fact that the product is racemic.
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Vercauteren later published the first synthesis of optically pure 4-[13C]-(+)-catechin 
(Scheme 2.11).51 The synthesis is very similar to his previous synthesis described 
above, however alterations were made to allow Vercauteren to synthesise multi-gram 
quantities of labelled (+)-catechin for biological testing. His previous route yielded 40 
mg of racemic catechin. The synthesis of benzyl ether 56 using standard conditions is 
problematic due to the C-benzylation that occurs with highly electron-rich phenols 
e.g. phloroglucinol 100.51 This problem was avoided by using Kawamoto's52 
procedure allowing the synthesis of ether 56 on a large scale. The use of three 
equivalents of l- [13C]-acetic acid allowed the straightforward introduction of the label 
via  cheaper and substantially less toxic materials (avoiding potassium cyanide). 
Treatment of ether 56 with the labelled acetic acid in the presence of trifluoroacetic 
anhydride gave labelled acetophenone derivative 101-13C in moderate yield. 
Conversion of fully protected acetophenone derivative 101-13C into phenol derivative 
102-13C was achieved using titanium tetrachloride. Monodebenzylation of the 
hydroxyl group that forms an intramolecular hydrogen bond with the ketone is a key 
step in both of Vercauteren’s syntheses. Monodebenzylation of acetophenone 
derivative 101-13C was more efficient than the corresponding reaction on chalcone 
derivative 94-13C in the previous synthesis. However, a similar amount of C- 
benzylation occurred in both. Standard benzylation of 3,4-dihydroxybenzaldehyde 
103 gave benzyl protected aldehyde 90 in high yield. Condensation of aldehyde 90 
with phenol derivative 102-13C gave chalcone derivative 95-13C also in high yield. 
Chalcone derivative 95-13C was converted into diol 97-13C in moderate yield as 
described earlier. Reduction of the 4-hydroxyl gave racemic catechin 99-13C in good 
yield as before.
43
HO
OH
100
OH BnO
1) Ac20 ,  AcONa
2) NaH, BnCI 
H20 , DMF
87%
^ ^ J D H  BnBr, K2C 0 3 
O H C ^ ^ T D H  DMF’ 83 %
103
OHC
90
OBn
OBn
56
- a :
c h 313c o 2h
TFAA, 58 %
BnO OBn
OBn O 
101-13C
TiCI4
OBn 
OBn
NaH, DMF, 0 °C, 86 %
OH O
102-13C
80%
•  = 13C
BnO. OBn BnO. OBn
Bn
OH O
7%
BnO
OH O
95-'°C
1) NaBH4, DME,
85 °C BnO
2) BF3.OEt2
OBn
98-13C
41 % yield 
from 95-13C
O s0 4
THF
NMO
OBn
OBn , NaCNBH3, AcOH BnQ-
OBn
BnO.
OBn
81 %rOH rOH
OBn 
rac. 99-13C
OBn OH 
97-13C
Scheme 2.11
At this point, the enantiomers were resolved using a procedure developed by 
Vercauteren (Scheme 2.12).53 Esterification of the racemic mixture with dibenzoyl-L- 
tartaric acid monomethyl ester L-104 in refluxing DCM in the presence of DCC and 
DMAP gave a mixture of esterified diastereomers (-)-105-13C and (-)-106-13C. It was 
discovered that ester (-)-105-13C crystallised selectively from a hexane/DCM mixture 
(3:1). When subjected to a single recrystallisation from the same solvent mixture, 
ester (-)-105-13C was obtained (de > 99% based on HPLC).
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Hydrolysis of the ester followed by hydrogenolysis gave the optically pure (+)- 
catechin 6-13C in excellent yield (Scheme 2.13). The other diastereoisomer (-)-106- 
13C (de 88 %) did not crystallise. It has been reported that (+)-catechin can epimerise 
at C-2 through reversible opening of the C-ring in basic media to form (-)- 
epicatechin.54-56 To this end, ester (-)-106-13C was hydrolysed to give protected (-)- 
catechin 99-13C and esterified with D-104 to give optically pure (+)-105 (de > 99 %) 
after chromatography and crystallisation. Hydrolysis of the ester followed by 
hydrogenolysis gave the unnatural (-)-catechin 6-13C in excellent yield. Treatment of 
(-)-6-13C with 1 % (w/v) sodium phosphate at pH 11.4 gave a mixture of (-)-catechin 
6-13C and (-)-4-[13C]-epicatechin 9-13C in a 3:1 ratio after 20 h at room temperature.
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The desired epicatechin 9-13C was purified and the recovered starting material was 
recycled four times to obtain a gram quantity of 9-13C (50 %, ee > 99 % based on 
HPLC). Some starting material was also recovered.
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The authors51 report the total synthesis of gram amounts of 13C-labelled natural (+)- 
catechin 6-13C and (-)-epicatechin 9-13C in 6.2 % overall yield from phloroglucinol 
100. They believe that they have significantly improved the yields in comparison to 
their previous strategy and that their new route gives enantiomerically pure material. 
Although access to the catechins in an optically pure form has been achieved, the new 
synthesis has not significantly improved the yield over the previous synthesis (6.2 % 
vs 4 %). It is not a truly asymmetric route since obtaining enantiomerically pure 
material relies on the resolution of a racemic mixture of protected (±)-catechin. The
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quoted overall yield is ambiguous as there are several different yields quoted for some 
reactions and it appears to be a combined yield for catechin and epicatechin. 
Furthermore, the yield reported for the epimerisation to give (-)-epicatechin is the 
combined yield for four cycles of the epimerisation reaction, which is not ideal.
In summary, Vercauteren’s group prepared racemic [4-13C]-catechin, (+)-[4-13C]- 
catechin, (-)-[4-13C]-catechin and (-)-[4-13C]-epicatechin using potassium [13C]- 
cyanide or [ l -13C]-acetic acid as the source of the label. Like the syntheses of 
Ferreira’s group and Jew and Park, chalcones were key intermediates, but these were 
converted into 3-flavenes before dihydroxylation. A weakness in the approach is that 
enantiomeric enrichment was achieved late in the sequence by resolution and this 
deficiency was accentuated in the preparation of (-)-[4-13C]-epicatechin by the 
necessity of repeated equilibration of (-)-[4-13C]-catechin and separation of 
enantiomers. None-the-less, these are the only published routes for labelling simple 
flavan-3-ols with a carbon isotope and gram quantities of the enantiomerically 
enriched materials were obtained.
2.7 Chan and co-worker’s preparation of (-)-epigallocatechin gallate
In 2001, Chan published a synthesis of the main constituent of green tea extract, (-)- 
epigallocatechin gallate 12.40 Since (-)-EGCG is closely related to catechin and 
epicatechin, synthetic approaches to EGCG should be applicable to these other flavan- 
3-ols. The main challenges of the synthesis lie in the selective formation of the 
thermodynamically less stable cfs-disubstituted benzopyran and maintaining the 
stereochemical integrity at the benzylic C-2 position, which is activated by the 
electron-donating groups on the B-ring. Coupling of 3,4,5-tribenzyloxycinnamyl 
alcohol 107 with 3,5-dibenzyloxyphenol 108 gave coupled product 109, which when 
dihydroxylated gave 110 (Scheme 2.14). Formation of the orthoester 111, followed 
by cyclisation gave 112, which was deprotected to give 113. Dess-Martin oxidation of 
113 gave 114 and reduction with L-selectride gave 115. Treatment of 115 with 3,4,5- 
tri-O-benzylgalloyl chloride and DMAP in DCM gave protected EGCG 116. 
Deprotection of 116 by catalytic hydrogenation gave racemic EGCG 12. No yields 
were reported for any of the transformations.
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The previous attempts to asymmetrically dihydroxylate 109 had proved unsuccessful, 
but it was found that protection of the phenol as the TBS ether allowed AD-mix to be 
successfully used, thus allowing access to both enantiomers of EGCG 12 (Scheme 
2.15). TBS protection of 109 gave silyl ether 117. Asymmetric dihydroxylation with 
AD-mix-p gave diol 118, which when deprotected with TBAF gave optically active 
110. This sequence of reactions was repeated using A D -m ix-a to complete the 
synthesis of (+)-EGCG 12.
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The synthesis achieved the diastereo- and enantioselective synthesis of (-)-EGCG. 
The overall yield of (-)-12, based on cinnamyl alcohol derivative 107, was 19 %. This 
is a viable route for the synthesis of analogues with varying substituted aromatic 
rings.
In summary, Chan and co-worker’s synthesis of (-)-EGCG involved constructing a 
1,3-diarylpropene by a Friedel-Crafts reaction. Following the approach of Ferreira and 
co-workers, this was subjected to asymmetric dihydroxylation. Inversion at C-2 was 
maximised by converting the diol to an orthoformate before cyclisation to the 
gallocatechin derivative. Rather than relying on equilibration as Vercauteren and co­
workers did in their synthesis of (-)-epicatechin, oxidation of the 3-OH and reduction
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of the ketone with a bulky hydride source ensured clean conversion to the 
epigallocatechin derivative.
2.8 Zaveri’s synthesis of partially methylated gallocatechin and epigallocatechin 
gallates
At the same time as Chan was developing his route to EGCG, Zaveri was also 
developing a route to EGCG which is a combination of chemistry similar to 
Vercauteren and Chan.41 The route is shown below (Scheme 2.16). The protected 
benzaldehyde 119 was synthesised by a published procedure in 87 % over three steps 
from methyl gallate 120. Condensation with the acetophenone 102, formed by 
benzylation of tri hydroxy acetophenone 121 gave the chalcone 122 in moderate to 
good yield. Cyclisation to the flavene 123 was achieved using sodium borohydride in 
a mixture of THF and ethanol. Hydroboration of the flavene 123 gave the anti-flavan- 
3-ol 124 with less than 5 % of the sy«-compound. The stereochemistry was assigned 
based on coupling constants obtained from the !H NMR and from nOe experiments. 
The synthesis was completed using the same chemistry as Chan. The anti-flavonol 
was converted to the syn-isomer by Dess-Martin oxidation to give ketone 125, which 
was selectively reduced to the racemic syn-flavanol 115 using L-selectride. 
Esterification with trimethoxygalloyl chloride, followed by global deprotection of the 
benzyl ethers by hydrogenation gave trimethoxy EGCG derivative 126. The anti- 
isomer 127 was synthesised using the same esterification and deprotection procedure.
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In summary, Z averi’s syntheses of racemic m ethylated gallocatechin and 
epigallocatechin gallates resemble Vercauteren’s method for the construction of 
catechin and epicatechin, except that the 3-flavene derivative undergoes 
hydroboration-oxidation rather than dihydroxylation-reduction and the oxidation- 
reduction sequence employed by Chan and co-workers is employed to access the syn 
stereochemistry of epigallocatechin.
2.9 Labelling catechin dimers found in the diet
The condensation of racemic 9 7 -13C, derived from 56 in six steps, with 
tetrabenzyloxycatechin 99 produced the dimer diastereoisomers 128-13C, 129-13C, 
130-13C and 131-13C (Scheme 2.17).57 The major dimers 130-13C and 131-13C were 
formed as an inseparable 1:1 mixture in moderate yield. The other two dimers contain 
unnatural stereochemistry at the C-ring centres and were formed in small amounts (6 
% and 13 %). The mixture of 130-13C and 131-13C was deprotected by hydrogenation 
to give a separable mixture of dimers 132-13C and 133-13C. A small amount of 
catechin (8 %) was also isolated which was attributed to the reduction of the 
interflavanolic linkage. The authors report the synthesis of procyanidin B3 133-13C in 
eight steps and 6 % overall yield from 1,3,5-tribenzyloxybenzene 56 and 1-[13C]- 
acetic acid.57 Considering the availability of both 2-[13C]- and l,2 -[13C]2-acetic acid, 
the authors have devised a flexible route to the isotopic labelling of procyanidins. The 
drawbacks to the route are the use of three equivalents of the labelled acetic acid and 
the low yields associated with the dimerisation and the hydrogenation. The reduction 
of the interflavanolic linkage is also undesirable as this wastes 8 % of the label. These 
problems would be accentuated in a radiochemical synthesis as radiolabelled acetic 
acid is expensive and use in excess would not be good.
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Having previously synthesised procyanidin B3 via a route unsuitable for large-scale 
syntheses, Vercauteren developed a route applicable to the synthesis of large 
quantities of procyanidin B3 (Scheme 2.18).58 The previous route was mildy altered, 
but the changes simplified the purification of the crude dimers and eliminated the 
undesired reduction of the interflavanolic linkage. Their synthesis of large quantities 
of (+)-catechin provided them with the desired starting material. They found that the 
best conditions for the re-oxidation of the C-4 position of protected labelled (+)- 
catechin 99-13C were those described by Ferreira.59 These conditions led to a moderate 
yield of diastereomerically pure ether 134-13C. Coupling of ether 134-13C with (2R, 
3S')-tetrabenzyloxcatechin 99 using the same conditions as before gave a mixture of 
only two diastereomeric dimers 129-13C and 130-13C in a 1:2 ratio and in 82 % yield. 
This compares favourably to the mixture of four dimers obtained previously. 
Separation of the mixture gave the desired dimer 130-13C in 55 % yield, which was 
then deprotected to give procyanidin B3 133-13C in 71 % yield after purification. The 
authors found that the use of non-acidic Pd(OH)2/C in a mixture of THF and water at 
room temperature instead of Pd/C (which often contains traces of acid) in dioxane at 
90 °C, eliminated the problem of reduction of the sensitive linkage. At first glance, 
this procedure looks essentially identical to the previous synthetic route. However, the 
relatively minor changes had a major beneficial effect on the useability of the route. 
Although there are still problems with the route, it is now much more feasible as a 
useful route to radiolabelled procyanidins.
54
.OBn
OBnBnO
'OH
OBn
(+)-99-13C
DDO, ^  
56 %  DCM/MeOH (3:1)
OBn
BnO
OBn OMe
(+)-134-13C
8 2 %
.OBn
BnO
OBnBnO
'OH ,OBn
OBn
OBnBnO
'OH
OBn
OBn
OBn
'OH OBn
OBn
OBnBnO
'OH
OBn
130-13C
2
I H 2, Pd(OH)2/C  
71 %  T H F /H 20  (20:1)
cr0-,
o j X ,
129-13C
1
Scheme 2.18
55
2.10 Biosynthesis for labelling flavan-3-ols
The [U-14C]-(+)-catechin and A-ring labelled (+)-catechin used in early studies of 
catechin metabolism were prepared by feeding radioactive materials to plants or plant 
cell cultures. Recently, cell-suspension cultures of ohelo and grape provided with 
uniformly labelled [14C]-sucrose were used to prepare 14C-enriched flavonoid fractions 
containing (+)-catechin.60 Unfortunately, such methods lead to complex mixtures of 
compounds that have to be extracted from the plant cells and separated to obtain the 
radiolabelled catechin required for feeding studies.
2.11 Labelling of flavan-3-ols with isotopes of hydrogen
The synthesis of [4-2H]-procyanidin B3 133-2H has also been reported by Vercauteren 
and is shown in Scheme 2.19.61 Benzylation of (+)-taxifoliol 135 gave a 3:7 mixture 
of compounds 136 and 137. The positive optical rotation obtained from the mixture 
after hydrogenation suggests that (2R, 3S)-alcohol 137 is the major product. The 
mixture was reduced with NaBD4 to give a 1:1 mixture of deuterium labelled alcohols 
138-2H, 139 -2H and 1 4 0 -2H, 141-2H. Using the same procedure as described 
previously (Section 2.9), [4-2H]-procyanidin B3 and its diastereom er were 
synthesised in a 7:3 ratio and separated by preparative HPLC. The structure was 
corroborated by 2H NMR and by comparison of the *13 NMR spectrum with the 
unlabelled compound.
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In summary, the synthesis of [4-2H]-procyanidin B3 was achieved in 4 steps from (+)- 
taxifoliol. However, there are two main drawbacks associated with the synthesis. The 
use of isotopes of hydrogen may lead to inconclusive metabolic results due to the
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possibility of the label being exchanged in the body. The position of the label is also 
potentially problematic as this position can be cleaved during metabolism, potentially 
leading to the loss of the label.
2.12 Summary
Since our aim was to synthesise 14C-labelled (+)-catechin, some of the chemistry 
discussed in this chapter was a useful starting point for our studies. Vercauteren has 
synthesised racemic catechin via  a 3-flavene intermediate. He has successfully 
applied his strategy to the synthesis of [4-13C]-labelled catechin. The synthesis of [4- 
13C]-labelled (+)-catechin was also achieved, however, this relied on the resolution of 
the racemic catechin. This is not ideal an ideal process for labelling (50 % of the label 
is lost) or synthesis in general as the maximum recovery of material is 50 %.
Ferreira, Jew and Park and Chan have successfully applied asymm etric 
dihydroxylation as the key step in the synthesis of flavan-3-ols. Grubbs used cross­
m etathesis followed by asymm etric dihydroxylation in his synthesis of 
tetramethylcatechin. This strategy has the advantage over Vercauteren’s approach that 
asymmetric dihydroxylation allows high enantioselectivities to be more readily 
achieved in fewer steps than resolution.
Our initial goal was to synthesise 14C-labelled (+)-catechin using a novel asymmetric 
hydroboration route. However, as will become clear in chapter 3, this proved difficult. 
As a result of the difficulties encountered, we devised a route based on a combination 
of Grubbs’ cross-metathesis and Ferreira’s dihydroxylation strategies already 
discussed in this chapter. Our studies based on this revised route are discussed in 
chapter 4.
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CHAPTER 3 -  First approach; Asymmetric hvdroboration of 2-
flavenes
3.1 Introduction
The inconclusive evidence in the literature on the bioavailability of flavonoids makes 
the synthesis of these compounds in a labelled form appropriate for biological studies 
vitally important. The aim of this project was to investigate novel approaches to the 
radiochemical synthesis of the flavan-3-ol, (+)-catechin to allow its absorption, 
metabolism and excretion to be investigated. By labelling (+)-catechin in a position 
that is stable under normal physiological conditions, its potential as a dietary 
antioxidant could be assessed. The 14C-labelled material would be used for feeding 
studies in rats to determine the metabolites of this compound and where they arise in 
the body. The synthesis of the 14C-labelled material should be as short as possible 
from the introduction of the label. Each step should be as high yielding as possible 
and also allow easy purification of the compounds. It is also highly desirable to avoid 
column chromatography as this can generate large quantities of contaminated material 
that is very expensive to dispose of.
Two routes for the synthesis of (+)-catechin were investigated. Asymmetric 
hydroboration of flavene 142 (Scheme 3.1) should allow access to (+)-catechin. Thus, 
the first route involved the syntheses of model flavene intermediates, which could 
then be used to test the asymmetric hydroboration step. The chemistry involved in 
these studies will be discussed in this chapter. An alternative synthesis of catechin 
was also envisaged employing a dihydroxylation-cyclisation strategy of 1,3- 
diarylpropene 143, which will be discussed in more detail in chapter 4.
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The main approach to the model flavene system focused on titanium alkylidenation 
chemistry. Literature precedence for titanium alkylidenation of similar systems will 
be discussed later in this chapter. Some time was also devoted to the investigation of 
intramolecular Wittig and Grignard reactions to give model flavene systems. Our 
initial retrosynthesis and proposed synthetic route to (+)-catechin will now be 
discussed in more detail.
3.2 General synthetic strategy
Our retrosynthesis of (+)-catechin 6-14C is shown below (Scheme 3.2). (+)-Catechin 
could be synthesised from flavene 142-14C by asymmetric hydroboration. Flavene 
142-14C could in turn be synthesised from ester 144-14C, which could be synthesised 
from phenol derivative 145a and benzoic acid derivative 146-14C. Benzoic acid 
derivative 146-14C should be easy to prepare in a single step from radiolabelled 
carbon dioxide.
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This retrosynthesis led to our first proposed synthetic route (Scheme 3.3), 
Benzylation of phloroglucinol62 100 should give tribenzyl ether 56, which could be 
deprotected with sodium ethanethiolate62 to give phenol derivative 108. Allylation of 
108 to give 147 followed by a Claisen rearrangement should give phenol derivative 
145a. Esterification of 145a with benzoic acid derivative 146-14C should give ester 
144a-14C, which could be methylenated to give enol ether 148-14C. Subsequent ring- 
closing metathesis (RCM) should give flavene 142-14C. Asymmetric hydroboration- 
oxidation should lead to the tetrabenzylated (+)-catechin 99-14C. Finally, global 
deprotection of 99-14C should give (-i-)-catechin 6-14C. The key steps in this approach 
are a) Claisen rearrangement to C-allylate phloroglucinol b) alkylidenation-RCM to 
prepare the 2-flavene and c) asymmetric hydroboration. I shall consider the literature 
precedent for each of these key steps before discussing our model studies on the 
formation of 2-flavenes. Our original route employed the synthesis of phenol 
derivative 145a. However, as will become clear later, we were forced into 
investigating both 145b and 145c derivatives as well.
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3.2.1 Claisen rearrangement of aryl allvl ethers
The Claisen rearrangement was the first sigmatropic rearrangement to be discovered. 
An example of the rearrangement occurs when an aryl allyl ether is heated with no 
solvent present to give an o-allyl phenol. The mechanism is shown below (Scheme 
3.4), When heated, allyl ether 149 undergoes a [3,3]sigmatropic rearrangement to give 
intermediate 150, which re-aromatises via a proton transfer to give allyl phenol 151. 
In the ortho  migration the allylic group always undergoes an allylic shift i.e. a 
substituent a  to the oxygen will become y to the ring and vice versa. If both ortho- 
positions are filled, the allylic group migrates to the /?ara-position (para-Claisen
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rearrangement). A double allylic shift occurs in the para migration and no reaction 
takes place if the para and both ortho positions are filled.
heat
H
150
proton transfer
149 151
Scheme 3.4
Claisen rearrangements have been used in the synthesis of a wide variety of 
compounds. Some examples on systems similar to our own (147 —»145, Scheme 3.3) 
are discussed below.
Psorospermin 152 (Figure 3.1) is a plant-derived natural product possessing 
significant activity in several animal tumour models.63
In developing an enantioselective route to 152, Cassady and co-workers chose the 
dim ethyl ether 153  as a model target to establish the synthesis of the 
epoxydihydrobenzofuran system.63 A Claisen rearrangement was used early in the 
synthesis to construct the side chain (Scheme 3.5).
O OMe
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Figure 3.1
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A wide variety of biologically and medicinally interesting compounds contain the 
chroman ring system and new examples are continually emerging. Wallace et al used 
(R)-(+)~methyl p-tolyl sufoxide to allow access to chromans in high enantiomeric 
purity.64 A Claisen rearrangement was used to install the necessary side-chain in their 
route to the methyl ether derivative 154 of the antibiotic LL-D253a 155 (Scheme 
3.6).
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Grigg et al employed a Claisen rearrangement to synthesise C-dienyl phenols to 
investigate their acid-catalysed cyclisation products.65 A range of mixtures of exo- 
methylene chromans e.g. 156 and dihydrobenzofurans e.g. 157 were synthesised. 
These ring systems are found in many natural products and this procedure provides a 
short, convenient approach to these systems with no need for protecting groups to be 
used. An example is shown below (Scheme 3.7).
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Scheme 3.7
In the recent literature, Moody and Davis devised a novel use for the Claisen 
rearrangement in their synthesis of macrocyclic lactams related to the ansamycin 
antibiotics (Scheme 3.8).66 Mitsunobu coupling of dienol 158 with 2-nitrophenol 
followed by reduction of the nitro group and amide formation with 4-pentenoic acid 
gave amide 159 in 78 % over three steps. Claisen rearrangement gave phenol 
derivative 160 in moderate yield, which underwent RCM with Grubbs catalyst 
[(PCy3)2Cl2Ru=CHPh] to give the 19-membered macrocycle 161 as a 1:1 mixture of 
E\Z  isomers in good yield. Oxidation with Fremy’s salt gave the final benzoquinone 
derivative 162 in good yield. Alternatively, RCM of amide 159 gave the 17- 
membered macrocycle 163 in good yield as a mixture of E- and Z-isomers. Claisen 
rearrangement of 163 gave the ring-expanded 19-membered macrocycle 161 in 
moderate yield. Oxidation as before gave the final macrocycle 162. The expansion of 
an 72-membered 1,2-bridged macrocycle to an «+2-membered ring represents a novel 
use of the Claisen rearrangement.
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3.2.2 Synthesis of cyclic olefins using alkvlidenation and ring-closing metathesis
Throughout the 1990’s, ring-closing metathesis (RCM) reactions have developed into 
one of the most powerful ways of synthesising cyclic olefins. A number of catalysts 
have been developed for RCM reactions including Schrock’s molybdenum based 
catalyst67 164 and several ruthenium based catalysts 165,68 16669 and 4770 developed 
by Grubbs (Figure 3.2).
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In 1994, a two step procedure for the synthesis of simple five and six membered 
cyclic enol ethers by intramolecular metathesis of alkenes with enol ethers was 
reported by Grubbs.71 The procedure involved Tebbe methylenation or Takai 
alkylidenation of esters followed by RCM using Schrock’s catalyst 164. Grubbs 
found that his own catalyst 165 did not give the desired enol ethers. This procedure 
has been successfully employed in the synthesis of phytoalexine 167, an antifungal 
agent (Scheme 3.9).72 Esterification of phenol derivative 168 with acid chloride 169 
under phase-transfer conditions gave ester 170 in good yield. Takai ethylidenation 
gave enol ether 171, which when treated with catalyst 164 in refluxing benzene, gave 
benzofuran derivative 172 in high yield. Removal of the benzyl ethers by 
hydrogenation proceeded to give phytoalexine 167 in almost quantitative yield.
68
BnO
168
BnO.
p - frrv
c r
167
EtOAc
nBu4 NHS04
NaOH
Dioxane
70%
BnO .OBn
0
<O
170
CH3 CHBr2, TiCI4  
Zn, TMEDA, PbCI2  
THF, 25 °C
BnO OBn
12 mol% 164 0
PhH ,60 °C 
85%
171
Scheme 3.9
The procedure was expanded to the synthesis of fused bicyclic enol ethers containing 
six and seven membered rings during the synthesis of polycyclic ether structures 
found in marine neurotoxins such as brevetoxin B 173 and gambierol 174 (Figure
3.3).73
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A variety of enol ether precursors 175-177 were constructed to investigate the 
alkylidenation-RCM reaction (Scheme 3.10). The results are summarised below 
(Table 3.1).
164 (9 - 14 mol%)
pentane, RT 
a n = 1 
b n = 2
175 R1 = R2  = H
176 R1 = H, R2  = Me
177 R1 = Et, R2  = H
cfxH n
177 R1 = R2  = H
178 R1 = H, R2  = Me
179 R1 = Et, R2  = H
S ch em e 3.10
Substrate Enol ether
Yield
(%)
175a 178a 64
175b 178b 65
176a 179a 93
176b 179b 94
177a 180a 72
177b 180b 40
Table 3.1
From the table it can be seen that treatment of enol ethers 175-177 with a sub- 
stoichiometric amount of catalyst gave the desired cyclic enol ethers in good to 
excellent yield, the best results being obtained with the trisubstituted enol ethers 176a 
and 176b. The authors attributed this to the metal alkylidene reacting with 176 at the 
less hindered enol ether in the initial step of the metathesis sequence and that ring- 
closure then occurs by rapid reaction of the resulting alkylidene with the
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electronically more reactive 1,1-disubstituted alkene. For substrates 175 and 177 the 
opposite would apply thus extending the lifetime of the intermediate olefin alkylidene 
and allowing potential side-reactions to take place.
The concept of a tandem alkylidenation-RCM procedure using the Tebbe reagent was 
reported by Nicolaou in the synthesis of polycyclic ether marine neurotoxin 
skeletons74 e.g. the conversion of bicyclic acetate 181 into tricyclic enol ether 182 via 
enol ether 183 (Scheme 3.11). Enol ether 183 was proven to be the intermediate by 
isolation and full spectral characterisation.
BnO
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77%
H H H
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X then reflux, 5h, 71 %
—  181 X = O
Tebbe (2 eq) , BnO
H ^  H H _
183 X = CH2  THF, reflux, 3h 
65% BnO O H
182
Schem e 3.11
The proposed mechanism is shown below (Scheme 3.12). Initial methylenation of 
ester 181 gives enol ether 183, which could then react with another equivalent of 
Tebbe reagent to give titanacyclobutane derivative 184. Fragmentation of 184 would 
lead to the generation of titanium alkylidene 185. Intramolecular reaction of 
alkylidene 185 would lead to titanacyclobutane derivative 186, which could undergo a 
regioselective fragmentation to form the desired enol ether 182.
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Nicolaou et al investigated the generality and scope of the reaction and found that the 
reaction successfully formed six- and seven-membered cyclic enol ethers in good 
yields e.g. acetate 187 to enol ether 188 and acetate 189 to enol ether 190 (Scheme 
3.13).74
BnO
Me Me
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BnOTebbe
64% BnO
Me Me
188
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BnO
189
Tebbe BnO
45% BnO
190
Scheme 3.13
It was found that dimethyltitanocene can be used instead of the Tebbe reagent and 
allows the isolation of labile cyclic enol ethers (Scheme 3.14).74 For example, acetate 
191 gives alkene 192 when treated with the Tebbe reagent, but the desired cyclic enol 
ether 193 on treatment with dimethyltitanocene.
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The applicability of this procedure to the synthesis of complex polyether frameworks 
has already been shown (Schemes 3.11 and 3.13), however an important example of 
its use is illustrated in the synthesis of hexacycle 194 from ester 195 (Scheme 3.15).74
OBnITBSO'
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THF, RT, 20 min 
then reflux 5h
OBn
194
Scheme 3.15
This example shows that the reaction will tolerate trisubstituted alkenes elsewhere in 
the molecule. Another example of the power of this procedure is demonstrated in the 
synthesis of the complex hexacycle 196 (Scheme 3.16).74 The strategy employed in 
this synthesis was made possible by this reaction.
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3.2.3 Hvdroboration and asymmetric hvdroboration
Hydroboration reactions provide a convenient procedure for the conversion of alkenes 
into alcohols. The first examples were reported in 1956 and since then hydroboration 
has found many important applications in organic synthesis.75 Unhindered alkenes 
react rapidly with borane to give in the first instance monoalkylboranes, followed by 
di- and tri alky lboranes. The second and third hydroborations become increasingly 
difficult with increasing steric hindrance around the double bond. Borane, BH3, is the 
simplest borane hydride, which exists in equilibrium with diborane, B2H 6 (Scheme 
3.17). The equilibrium lies greatly in favour of diborane under normal temperature 
and pressure.
2 BH3 h z: B2H6 Scheme 3.17
Several stable sources of borane are available e.g. BH3.THF, BH3.SMe2. The empty p- 
orbital on boron can accept a lone pair of electrons from a Lewis base to give a 
neutral species or can combine with a nucleophile to form a negatively charged anion.
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Hydroboration reactions exhibit three main characteristics:
a) The boron atom adds preferentially to the less hindered end of an unsymmetrical 
double bond i.e. anti-Markovnikov (Scheme 3.18).
BHo.THF /  ^  \ R
^ ( R X ^ / 3  Scheme 3.18
b) Stereospecific syrc-addition occurs (Scheme 3.19).
H
BH3 .THF
Scheme 3.19
2 'BH
c) Stereoselective addition takes place on the less hindered face of the molecule 
(Scheme 3.20).
These characteristic features of hydroborations are consistent with a concerted four- 
centre transition state (Figure 3.4).
R\8 ©
H BH2
5©
Figure 3.4
Borane can transform a wide range of alkenes into trialkylboranes under mild 
conditions, however the trifunctional nature of borane and its trialkylborane products 
causes some limitations in their use. Many synthetically useful reactions of 
trialkylboranes use all three alkyl substituents, however some reactions use only two 
or even one of the substituents. This imposes a limit on the maximum yield based on 
the alkene for these reactions. This is clearly undesirable particularly if the alkene
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requires a multi-step synthesis. Another problem associated with borane is the 
formation of intractable polymers on addition to dienes and alkynes. To solve these 
problems mono- and dialkylborane reagents were developed.
The commonly employed borane reagents thexylborane (ThBH2), disiamylborane 
(Sia2BH), 9-borabicyclo[3.3.1]nonane (9-BBN) and dicyclohexylborane (Cy2BH) are 
shown below (Figure 3.5).
ThBH2  Sia2BH
Cy2BH 9-BBN
Figure 3.5
Thexylborane is prepared by hydroboration of 2,3-dimethylbut-2-ene with BH3.THF 
(Scheme 3.21).
Sch em e 3.21
It is ideal for the hydroboration of dienes due to the presence of two boron-hydrogen 
bonds. The hydroboration is more reliable than the corresponding borane reaction, 
which generally forms polymeric organoboranes. Thexylborane is normally prepared 
and used immediately as the tert-alkyl group slowly isomerises to a primary alkyl 
group on standing at room temperature.
The preparation of 9-BBN is also relatively straightforward. Addition of BH3.THF to 
1,5-cyclooctadiene gives a mixture of 9-borabicyclo[4.2.1]nonane and 9-
76
borabicyclo[3.3.1]nonane. The [4.2.1] system isomerises to the thermodynamically 
favoured [3.3.1] system on heating (Scheme 3.22).
9-BBN 
| heat \
S chem e 3.22
9-BBN is a very popular hydroborating reagent since it is a crystalline, relatively air 
and heat stable commercially available compound. The greater steric bulk of 9-BBN 
makes it far more regioselective in hydroboration reactions compared to borane. 
Clean hydroboration of internal alkynes can also be achieved with 9-BBN whereas 
the corresponding reaction with borane generally gives polymeric material. It is, 
however, less useful for the hydroboration of terminal alkynes as monohydroboration 
can only be achieved with an excess of alkyne.
Our synthesis of 2-flavenes requires the hydroboration of an enol ether. Clark and 
Kettle employed such a hydroboration step in their synthesis of polyether 
fram ew orks.73 They found that hydroboration-oxidation of enol ether 197 with 
thexylborane gave a 90:10 mixture of diastereomeric alcohols 198 (Scheme 3.23).
H n
1) ThBH2, THF, - 2 0  °C* 0 -
2) NaOH (aq.), 30% hW  +
H 
197
=—OH
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S chem e 3.23
The hydroborating reagents discussed above are generated from achiral alkenes. 
Addition of borane to enantiopure alkenes from the chiral pool produces enantiopure 
alky lboranes that can be used for asymmetric hydroborations. Some examples are 
discussed below.
Two of the most commonly used borane reagents in asymmetric hydroboration are 
diisopinocampheylborane (Ipc2BH) and monoisopinocampheylborane (IpcBH2). The
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reagents are prepared by hydroboration of a-pinene (Scheme 3.24). Both enantiomers 
of a-pinene are readily available thereby allowing easy access to both enantiomers of 
Ipc2BH and IpcBH2.
(-)-lpc2BH
2 \  ^  /  
(+)-lpc2BH
(+)-a-pinene (-)-a-pinene
...BH2 h 2 b.(/
(+)-lpcBH2 (-)-lpcBH2
Sch em e 3.24
In the mid 1960’s, Brown et al proposed a model for the asymmetric hydroboration of 
ds-alkenes (Scheme 3.25).76 Borane 199 is the most stable rotameric conformation 
for (-)-Ipc2BH. This can be simplified further as shown in 200 where S = H, M = C-4 
methyl, and L = C-2 methyl group. Hydroboration leads to borane 201, which after 
oxidation gives the (/?)-alcohol 202.
H
199
IV, ,
M. B H
S°' L
200 201 202
Scheme 3.25
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The lack of reports on asymmetric hydroboration of heterocyclic olefins prompted 
Brown et al to investigate several five- and six-membered heterocyclic enol ethers.77 
The furan and pyran results are shown in Schem e 3.26. This is the only literature 
precedent for our transformation.
1)(-)-lpc2BH
-25 °C, 6  h .OH
2) MeCHO /— (
O 3) NaOH, H2 0 2" S d
92%  100 % ee
1) (-)-lpc2BH
° ° C ’ 1 2 h  OH
2) MeCHO
3) NaOH, H2 0 2
81 % 83 % ee  
Sch em e 3.26
In summary, the synthetic use of the Claisen rearrangement in similar systems to our 
own has been shown. Also discussed is the applicability of an alkylidenation-RCM 
type strategy in the synthesis of cyclic enol ethers. An overview of hydroborations 
and asymmetric hydroborations was given, describing the reagents used in both cases. 
The origin of the stereoselectivity observed in asymmetric hydroborations was also 
discussed.
3.3 Proposed routes to 2-flavenes
Model systems are often used in organic synthesis to allow the latter, potentially vital 
stages of a synthesis to be evaluated more readily. One potential route to flavene 142 
from ester 144 using an alkylidenation-RCM strategy has been described (Scheme
3.3). A variety of other routes to a model 2-flavene system 203 from structurally 
similar systems to ester 144 are shown in Scheme 3.27.
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Flavene 203-14C could be synthesised using Nicolaou’s one-pot methylenation and 
RCM of ester 204-14C.74 Alternatively, Takai alkylidenation followed by RCM could 
also give flavene 203-14C. Intramolecular Barbier reaction of iodide 205-14C could 
also be envisaged. Methodology developed within the Hartley group suggests that 
alkylidenation of a suitable resin-bound ester with titanium alkylidene 206 followed 
by cyclisation of enol ether 207-14C could provide a viable route to the flavene.78 
Intramolecular cyclisation of thioacetals 208-14C and 209-14C using Takeda’s 
methodology may allow flavene 203-14C to be synthesised, although there are only a 
few examples of successful intramolecular Takeda reactions in the literature.79,80 
Phosphonium salts similar to 210-14C have been cyclised under Wittig conditions to 
give chromenes81 and benzofurans.82,83 Alkylidenation and cyclisation of dibromide 
211-14C could also be employed, however only one example on a similar system 
exists in the literature and this proceeded in poor yield.84
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3.4 Titanium alkvlidenes in 2-flavene synthesis
Some background to the titanium chemistry needed for some of the proposed routes in 
Scheme 3.27 will now be given.
3.4.1 Titanium alkvlidene reagents
The discovery of titanium alkylidenes by Tebbe has had a huge impact in the field of 
synthetic organic chemistry.85 Tebbe found that the reaction of trimethylaluminium 
with titanocene dichloride gave the bridged titanium-aluminium metallacycle 212, 
which can be used for the effective methylenation of ketones and amides. Esters, 
including lactones, can also be methylenated. When 212 is treated with a Lewis base 
such as pyridine or THF, the highly reactive methylidene 213 is formed, which can be 
used to methylenate carboxylic and carbonic acid derivatives to give alkenes 214  
(Scheme 3.28).72 Methylenation of aldehydes and ketones in the presence of amides 
or esters can be easily achieved. The Tebbe reagent has also been shown to catalyse 
RCM reactions (Section 3.2.2),
Cp2 TiCI2  A|Me3.
,CI
CpaTi^'AIMe-
212
pyridine
or THF
Cp2Ti=CH2
213
O
X  2R1 R2 AR1 R2  
214
R2  = alkyl, OR, NR2
S chem e 3.28
In 1987, Takai reported a general procedure for the stereoselective alkylidenation of 
esters 215 to give Z-enol ethers 216 (Scheme 3.29).86
R3 CHBr2, Zn H R3  
°  TiCI4, TMEDA ||
R1 OR2  THF R1 OR2
215 216
S chem e 3.29
The titanium alkylidene is generated from a 1,1-dibromoalkane, activated zinc, 
TMEDA and titanium (IV) chloride. Takai alkylidenations are Z-selective and usually
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give high stereoselectivities. A noteworthy point is that the reaction is not very 
sensitive to the bulk of R3 however, bulky R2 substituents reduce the 
stereoselectivities and branching a  to the carbonyl group in R1 gives only Z-isomers.72
In 1990, Petasis reported the synthesis of dimethyl titanocene from titanocene 
dichloride and m ethyllithium .87 Petasis has shown that this compound will 
methylenate carbonyl compounds, including esters and lactones (e.g. 217 and 218 
respectively), when heated in THF or toluene (Scheme 3.30 and 3.31).87,88
J? Cp2 TiMe2  II
0TBS PhMe, 70 °C 0TBS  
217 70%
Sch em e 3.30
V  VO O Cp2TiM e2  ^ 0  0
A A q  THF, 60 °C . A A ,  
80%
218
Sch em e 3.31
The advantage of the Petasis reagent over the previously mentioned alkylidenes is that 
it is relatively air and water stable and it is not pyrophoric.72 As with the Tebbe 
reagent, aldehydes and ketones can be methylenated in the presence of less reactive 
carbonyl groups e.g. amides, carbamates and esters.72 Dimethyltitanocene has also 
been shown to catalyse RCM reactions (Section 3.2.2). It has also been shown that it 
is possible to selectively methylenate the less hindered of two esters by careful 
consideration of the conditions used.89,90
Takeda has shown that titanium alkylidenes can be formed by the reduction of 
thioacetals with the low valent titanium species Cp2Ti[P(OEt)3]2219 (Scheme 3.32). 
The complex is formed by the reduction of titanocene dichloride with magnesium in 
the presence of triethylphosphite.91 Molecular sieves are used to aid the rapid 
reduction of the titanocene dichloride. Complex 219 is then added to thioacetals to 
generate titanium alkylidenes 220. Both 1,3-dithianes and diphenyldithioacetals can
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be used,91 but the diphenyldithioacetals are more reactive.92 Takeda has published 
many examples and the procedure has also been applied to solid-phase synthesis.
C p2TiCI2 Mg- (EtO)3P C p2Ti[P(OEt)3]2
2194A MS, THF R1 R2 
220
Sch em e 3.32
Alkylidenations using titanium reagents has recently been reviewed.72
3.4.2 Intramolecular alkylidenation
In 1988, Mortimore and Kocienski reported an early example of an intramolecular 
alkylidenation using a Takai-type procedure (Scheme 3.33).84 Exposure of dibromide 
221 to titanium(IV) chloride gave cyclic enol ether 222 in poor yield.
In 2001, Rainier et al. reported the first example of metathesis-type products formed 
by the Takai procedure (Scheme 3.34).93
TMEDA, THF 
15 %
221 222
S ch em e 3.33
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When exposed to Takai conditions, acetate 223 gave a mixture of bicyclic and 
monocyclic enol ethers 224 and 225 respectively in good yield. Treating the mixture 
with Schrock catalyst 164 converts enol ether 225 to 224 allowing cyclic enol ether 
224 to be isolated in 93 % yield. A similar monocyclic enol ether to 225 did not 
cyclise under Takai conditions which led to the proposal that a titanium alkylidene is 
generated from the allyl group on acetate 223, which then intram olecularly 
alkylidenates the ester. Further investigation revealed that the cyclised product is 
favoured by increasing the amount of lead(II) chloride and using mainly DCM as 
solvent under high dilution conditions.94 Using these modified conditions, bicyclic 
enol ether 226 was formed preferentially over monocyclic enol ether 227 from acetate 
228 (Scheme 3.35).
OBn
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BnO
BnO
228 30%
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50%
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Schem e 3.35
It was noted that resubjecting monocyclic enol ether 227 to the reaction conditions did 
not give bicyclic enol ether 226 confirming that intramolecular alkylidenation rather 
than metathesis is involved. It was found that the intramolecular alkylidenation was
84
substrate dependent, as the homoallylic analogue of acetate 228 gave no cyclised 
products.
Our first attempt at the synthesis of flavene 203 using a Takai alkylidenation is shown 
below (Scheme 3.36). Benzoylation of 2-allylphenol 157 proceeded in high yield to 
give benzoate 229. Unfortunately, when benzoate 229 was treated under modified 
Takai alkylidenation conditions, a violent reaction occurred giving a complex mixture 
of products that contained very little, if any desired enol ether 230.
TiCI4f Zn.OH .OBzBzCI, pyridine
97% TMEDA, Br2 CHCH3
151
230
Sch em e 3.36
The route based on this strategy was unsuccessful and no further optimisation was 
carried out. Therefore, we decided to investigate intram olecular Takeda 
alkylidenations to allow acces to flavene 201.
Intramolecular alkylidenations are also possible using the low valent titanium species 
developed by Takeda. Takeda has used the methodology to synthesise a number of 
interesting compounds. When S-[3,3-bis(phenylthio)propyl]thioalkanoates were 
treated with 4 equivalents of Cp2Ti[P(OEt3)]2 in THF the products obtained were 5- 
substituted 2,3-dihydrothiophenes.95 The best example obtained contained only 3 % of 
the isomerised material (Scheme 3.37). It was found that the products isomerised to 
the corresponding exocyclic compounds on exposure to light. Consequently, reactions 
and work-ups were performed in the dark.
O
Cp2Ti[P(OEt)3]2 
P h S ^ S P h  7 2  °/c
97 % endo  isomer
Schem e 3.37
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Takeda has employed this methodology to synthesise a variety of co-hydroxy 
ketones.96 An example is shown below (Scheme 3.38). However, the route was not 
effective for the preparation of cyclic enol ethers due to competitive polymer 
formation. Although this route is not appropriate for the synthesis of cyclic enol 
ethers, it is effective for the synthesis of co-hydroxy ketones as the polymeric material 
formed also forms the desired ketones on treatment with acid.
Cp2 Ti[P(OEt) 3 ]2  (4 eq) + polymers
h 3 o +
45%
O
OH
S chem e 3.38
When the oxygen atom of the enol ether is exo to the formed ring intramolecular 
alkylidenation is more successful. The synthesis of 5-, 6-, 7- and 9-membered rings 
has also been accomplished using this procedure.79 An example of a 9-membered 
system is shown below (Scheme 3.39).
Cp2 Ti[P(OEt) 3 ] 2
Sch em e 3.39
However, there was some hope for our cyclisation, which would put the oxygen atom 
within the formed ring. Recently, Oishi et al. used an intramolecular Takeda 
cyclisation in the synthesis of the HIJKLM ring segment of ciguatoxin CTX3C to 
overcome the unreliability of a related RCM reaction when carried out using the 
Tebbe reagent.80 The transformation is illustrated below (Scheme 3.40).
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OBn
BnO
BnO PhS SPh
Cp2 Ti[P(OEt) 3 ]2  (3 or 4 eq) 
THF, reflux, 1 h, 52 - 67 %
Scheme 3.40
Our proposed retrosynthesis of flavene 203 based on Takeda’s methodology is shown 
below (Scheme 3.41).
o x
^TiCp2
231
203
^ Y O T M S
233 Ar
/ V 0™S
206
208 R = Ph
209 R = (CH2 ) 3
232
OTMS
RS SR
234 R = Ph
235 R = (CH2 ) 3
Scheme 3.41
Disconnection by route a gives titanium alkylidene 231, which can be made from 
thioacetals 208 and 209 or gem-dibromide 232. We decided to use thioacetals 208 and 
209 because thioacetals have been successfully used within our group and a search of 
the literature gave only one example of an intramolecular cyclisation of a gem- 
dibromide to a pyran system, which proceeded in poor yield.84 Alternatively, 
disconnection by route b, gives enol ether 233, which can be made from the 
alternative titanium alkylidene 206. This alkylidene can in turn be made from 
thioacetals 234 and 235. Route b is derived from work in the Hartley group on 
benzofurans and indoles, which will be explained in section 3.4.4.78,97,98 Both routes 
were investigated at the same time and the routes used are described below.
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Looking first at route a, the synthesis of the thioacetals proved to be quite difficult. 
Initially, we attempted to synthesise aldehyde 236 (Scheme 3.42) but despite several 
attempts, never managed to isolate it.
Sch em e 3.42
This led us to attempt the thioacetalisation in situ. Following the procedure of 
Overman," ozonolysis of 2-allylphenol 151 , reduction of the ozonide and 
thioacetalisation gave thioacetals 237 and 238 in poor yields (Scheme 3.43). 
Thioacetal 237 was then esterfied with benzoic acid derivative 146 to give ester 208 
in moderate yield.
0H  1 ) 0 3, EtOH,-78°C
151
2) Ph3 P, 0 °C
3) RSH, MgBr2 .OEt2
ArC02H 146, 
EDCI 
DMAP, DCM 
46%
237 R = Ph, 28 %
238 R = (CH2)3, 6  %
Ar = XXOBnX  "OBn 
Sch em e 3.43
PhS SPh 
208
Cp2 Ti[P(OEt) 3 ] 2
t
CX ^Ar
203
An alternative synthesis of thioacetals 237 and 238 was attempted (Scheme 3.44). A 
search of the literature found an example of the synthesis of thioacetals from 
benzofuran 239.100 Treatment of benzofuran 239 with the appropriate thiol in the 
presence of a Lewis acid was carried out several times with varying conditions (Table
3.2) but with no success. In all cases a complex mixture was obtained with the best 
example for this route being 2 % (entry 3). Purification of the reactions containing 
product (as shown by the ]H NMR spectrum) was attempted but no appropriate 
method was found.
a ° y  HS(CH2)3SH or PhSH y  Lewis acid239
237 R = Ph(CH2 ) 3
238 R = (CH2 ) 3
Scheme 3.44
Run
Number
Reagents Result
1 AcOH, BF3.OEt2, PhMe, 
propanedithiol, RT
Complex mixture of starting material, 
product and unidentified material
2 TFA, propanedithiol, RT Complex mixture of starting material, 
product and unidentified material
3 TFA, BF3.OEt2, propanedithiol, RT Unidentified material and trace of 
product (2 %)
4 p-TsOH, TMSC1, propanedithiol, RT Unidentified material and trace of 
product
5 TFA, hexane, propanedithiol, RT Starting material recovered
6 TFA, BF3.OEt2, thiophenol, RT Unidentified material
Table 3.2
At this point three factors prompted us to move away from this route. The first 
problem was the low yield. The esterification to give 208 in particular was 
unacceptably low. This step would ultimately be used to introduce the label and was 
not efficient enough. The second factor was the difficulty forming enol ethers. The 
third problem was precedent within the group that solution phase Takeda reactions are 
very difficult to purify. For these reasons this route was stopped after the synthesis of 
ester 208 (Scheme 3.43).
3.4.3 Intermolecular alkylidenation on solid-phase
We then concentrated our efforts on route b (Scheme 3.41). Although this route still 
depends on a Takeda reaction, the purification problem is avoided by loading the acid 
onto resin and using the resin-bound ester for the cyclisation. Takeda’s methodology
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for the generation of titanium alkylidenes has successfully been applied to the 
synthesis of benzofurans and indoles within the Hartley group.78,97,98 The general 
strategy is shown in Scheme 3.45.
Merrifield resin
S ch em e 3.45
This approach was used for the synthesis of a library of benzofurans and indoles 
(Schemes 3.46 and 3.47 respectively).
T'Cp2 
R2^ " T )T M S
° y r 3  ^ _____ - RT r V " 3 * = h h;n °b ;f
O 2 ) TFA, DCM R2A^ ^ 0  R3  = (CH2 )2 Ph, CH=CMe2,
240 242 p-OMeC6H4
Sch em e 3.46
The benzofurans78,97 were synthesised from resin-bound esters 240 made by reaction 
of Merrifield resin with the corresponding cesium carboxylate. Reaction with titanium 
alkylidene 241 followed by treatment with TFA gave benzofurans 242 in moderate to 
excellent yields (33 -  91 %).
90
llUDo
1) R2TT
TMS
241Y
o 2) TFA, DCM
243
FT 20 % TFA in DCM R2 i i
245
R1 = (CH2 )2 Ph, Ph, Me 
R2  = OMe, Cl, OH,-0CH 2 0 -
Schem e 3.47
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In a similar manner, resin-bound esters 243 were reacted with titanium alkylidene 244 
followed by TFA to give Boc-protected indoles 245 in moderate to good yields (58 -  
72 %).78,98 In the case where R2 = 7-OMe, significant spontaneous deprotection of the 
A-Boc indoles was observed, hence these compounds were fully deprotected by 
treatment with 20 % TFA in DCM to give 7-methoxyindoles 246.
In order to adopt this procedure to the synthesis of flavene 203 a longer but more 
convenient and reliable synthesis of thioacetal 238 was devised (Scheme 3.48).
n
2  eq. S .  .S
,OH
247
c c 2 eq. BuLi
O
248
O ^A r
203
1)Cp 2Ti[P(OEt) 3 ] 2
2) a.K / O y A r  
O
3) 1% TFA-DCM
249
Elimination
OTMS
Schem e 3.48
TMSCI
Py
238
Lithiation of two equivalents of commercially available 1,3-dithiane 247 and 
quenching with salicylaldehyde 248 would give thioacetal 249. We then envisaged
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elimination of the benzylic hydroxyl would give thioacetal 250, which could be 
reduced with lithium aluminium hydride to give thioacetal 238. Protection of the 
phenol with TMSC1 would give silyl ether 235, the required precursor for the Takeda 
reaction. In practice, lithiated dithiane gave alcohol 249 in 65 % yield, but thioacetal 
250 was never made. Several different conditions were tried for the elimination but all 
were unsuccessful (Table 3.3). The majority of attempts resulted in recovered starting 
material whilst others gave a complex mixture of unidentified materials, presumably 
from decomposition of the starting material. In one case (entry 4) tosylation of the 
phenol was observed.
249
C C
250
Run Number Reagents Result
1 MsCl, Et3N, DCM, RT Complex mixture of 
unidentified material
2 LiAlH4, THF, RT Unidentified material
3 NaBH(OAc)3, AcOH, THF, RT Starting material recovered
4 TsCl, Et3N, DCM, RT Tosylation of phenol
5 NaBH4, THF, RT Starting material recovered
6 NaBH4, EtOH, RT Starting material recovered
7 p-TsOH, PhMe, reflux Unidentified material
8 NaBH4, THF, RT (10 x conc. of 5) Starting material recovered
9 NaBH4, EtOH, RT (10 x conc. of 6) Starting material recovered
Table 3.3
We eventually found reductive conditions that allowed the synthesis of thioacetal 238 
directly, albeit in low yield (Scheme 3.49).
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o
248
S ^ S
247
BuLi 
THF 
0°C
OH 2 e q ' C s  
Li
0 °C - RT, THF
Et3 SiH, TFA
TMSCI
CL M
203a Ar = Ph
203b Ar = Ph(CH2 ) 2
1) Cp2 Ti[P(OEt) 3 ] 2 .OTMS
ArY
251a Ar = Ph 
251b Ar = Ph(CH2 ) 2
235
3) 1% TFA-DCM 
Scheme 3.49
Protection of phenol 238 with TMSCI in pyridine gave silyl ether 235 in excellent 
yield. The Takeda reaction was tested using two resin-bound esters 151a and 151b. 
Unfortunately, an intractable mixture was obtained.
CL .Ph Ph
252 253
Figure 3.6
The mechanism for the reduction of alcohol 249 is shown below in Scheme 3.50.
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249
Schem e 3.50
3.5 Routes to 2-flavenes via an iodide intermediate
Due to the unsuccessful alkylidenation routes discussed in the previous sections, we 
turned our attention to a route based on ester 144b (Scheme 3.2) and iodide 205 
(Scheme 3.27) using an intramolecular Wittig procedure and an intramolecular 
Grignard procedure respectively.
3.5.1 Intramolecular Wittig reaction
Hercouet and Le Corre used an intramolecular Wittig reaction to synthesise a variety 
of chromenes 254 using stabilised ylids (Scheme 3.51).81
Br Ph3 P=CHR"
OCOR'
© © 
.PP h3Br
Ph3 P=CHR" R"
'OCOR'
-PPh3
OCOR'
R
254
Scheme 3.51
Some of the chromenes synthesised are shown in Table 3.4.
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IR R' R"
%
yield
H Et Ph 6 6
H Me Ac 87
H Et Ac 87
H Me C 0 2Me 98
H Ph C 0 2Me 98
OBz Ph C 02Me 95
Table 3.4
This procedure was also applied to the synthesis of several dihydropyrans 255 where 
R was tt-heptyl, furyl, phenyl and styryl (Scheme 3.52).101
R f-AmONa
255
76 - 8 6  %
Schem e 3.52
A related procedure has also been used in the synthesis of benzofurans 256 (Scheme 
3.53).82,83
0 >
256 
S ch em e 3.53
The proposed mechanism for the reaction is illustrated in Scheme 3.54.
a  (3 0
PPh3Br RCOCI or (RC0)20  
OH ^  '
95
OCOR
OCOR
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Using this method a variety of benzofurans where R ranged from alkyl, alkenyl, 
styryl, phenyl and furyl were synthesised in moderate to good yields (50 -  93 %). 
Indeed, the total synthesis of Moracin C 257 (Scheme 3.54), a powerful antifungal 
natural product, has been achieved within the Hartley group using this procedure.102
AcO
NaCNBH3
THF-H20
pH 3, RT, 8 8  %
OAc AcO
OAc Ph3 P.HBr
MeCN
0 ©
Br PPh3
reflux, 98 % . _  
OH AcO. c c
AcO
76%
a) 3,5-dimethoxybenzoic acid 
DCC, DMAP, DCM
b) remove solvent
c) Et3 N, dioxane, reflux
OMe
OMe
Moracin C 
257
S chem e 3.55
We applied this methodology to the synthesis of flavene 203. The synthetic route is 
shown in Scheme 3.56.
96
c c
151
1 ) 0 3, EtOH,-78 °C
2) NaBH4, EtOH, 95 %
OH
Ar
PhMe
203
258
PPh-
210
OH
Ph3 P, l2. 
imidazole
DCM, 77 %
143, EDCI, 
DMAP
DCM, 78 %
OH
95%
259
Ph3P
PhMe
reflux
.OH
PPh-
262
260
S ch em e 3.56
Ozonolysis of 2-allylphenol 151 gave alcohol 258 in almost quantitative yield with no 
purification required. Iodination of alcohol 258 gave iodide 259 in good yield. A 
quantity of 2,3-dihydrobenzofuran 260 was also isolated from the reaction. This 
suggests that 2,3-dihydrobenzofuran 2 6 0  is form ed from  the com peting 
intramolecular cyclisation of phenol intermediate 261 (Scheme 3.57) and not from 
cyclisation of the iodide itself.
+ Ph3PO
S ch em e 3.57
More evidence supporting this suggestion comes from the lack of dihydrobenzofuran 
260 observed on treatment of iodide 259 with triphenylphosphine in refluxing 
toluene, to give phosphonium salt 262 in excellent yield. Subsequent esterification 
with benzoic acid derivative 146 gave ester 210 in moderate yield although there were 
some impurities that proved difficult to remove. We decided to use the crude ester and 
purify after the cyclisation. This would be more convenient as the impurities would be 
of vastly differing polarities, which would aid in its purification. A more appropriate 
alternative for the labelled synthesis would be to use polymer supported 
triphenylphosphine, which would remove the problem of the impurities. Indeed, this 
procedure has been used for the traceless solid-phase synthesis of a variety of 
different compounds including indoles.103 Unfortunately, when ester 210 was treated
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with the literature conditions only starting material was recovered. Several variations 
were attempted (sodium r-amylate and LiHMDS in PhMe and THF at room 
temperature and reflux), but starting material was recovered in every case.
3.5.2 Cyclisation of a Grignard reagent
An alternative route to flavene 203 is shown below (Scheme 3.58). Esterification of 
iodide 259 with benzoic acid derivative 146 gave ester 205 in poor yield. Formation 
of the Grignard reagent should allow cyclisation to flavene 203. The magnesium was 
activated by warming with a crystal of iodine and also by stirring under an 
atmosphere of nitrogen overnight. Unfortunately, treatment of iodide 205 with 
activated magnesium in THF consistently failed to give the flavene.
ArC0 2H 146, P „ T1 ir_
EDCI, DMAP M9>THF / y O y A r\A/\« 26%  / ^ \
259 205 203
S ch em e 3.58
3.5.3 Cyclisation of ketones derived from nitriles
Swapping the source of the label from 14C 0 2 (from Ba14C 0 3) to ,4CN— (from K14CN) 
would allow a different approach to be considered (Scheme 3.59). 2-Allylphenol 151 
was protected as the TBS, TBDPS and TIPS104 silyl ethers 263-265 in good to 
excellent yield. Ozonolysis of 263 and 264 proceeded uneventfully in quantitative 
yield to give alcohols 266 and 267, which were iodinated in moderate to good yield to 
give 268 and 269 respectively. Unfortunately, when iodides 268 and 269 were treated 
with potassium cyanide, nitrile 270 was not formed. The products isolated from the 
reaction were dihydrobenzofuran 260 and nitrile 271 (3:1, 75 % from 268 and 1:0, 44 
% from 269).
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OH
151
R3 SiCI, DMAP 0R  1) 0 3> EtOH, -78 °C
2) NaBH4, EtOH
263 R = TBS, 8 6  %
264 R = TBDPS, 74 %
265 R = TIPS, 90 %
*C = proposed 
position of label CC CN
270
K*CN, DMSO
OR
OH
266 R = TBS, 100%
267 R = TIPS, 98 %
■ CC,
268 R = TBS, 50 %
269 R = TIPS, 74 %
KCN
DMSO
0  * 0 C „
260 271
Schem e 3.59
A second route using iodide 268 as a key intermediate was also investigated (Scheme 
3.60). Reacting the Grignard reagent generated from iodide 268 with an appropriate 
nitrile should give ketone 272, which could be cyclised to give flavene 203. Several 
attempts at forming the Grignard reagent were attempted (Mg/I2 and potassium 
napthalenide), however the reaction was unsuccessful.
^ ^ .O T B S  1 ) Mg, THF or Et20  / ^ . O T B S
" O C - ~ Y - Ar
268 2 >Ar*CN 2 7 2  O
*C = position of label
Sch em e 3.60
At this stage we abandoned the routes based on 2-flavenes and turned our attention to 
an alternative based on Ferreira’s 1,3-diarylpropene intermediates.
203
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CHAPTER 4 - Second Approach: Alkene dihvdroxvlation-cvclisation
4.1 Introduction
The unsuccessful routes to 2-flavenes (for asymmetric hydroboration reactions) 
discussed in Chapter 3, led us to consider an alternative approach to (+)-catechin. We 
chose to study the dihydroxylation-cyclisation of 1,3-diarylpropenes such as alkene 
143 (Scheme 4,1). The two approaches to alkene 143 we chose to study were the Julia 
olefination and cross-metathesis.
OBn
BnO-
OBn
142
HO-
OH
'OH
OH
OH
THPO- OTHP
OTHP
•  = 14C 
Schem e 4.1
4.2 General synthetic strategy
As discussed in Chapter 2, Ferreira has reported the asymmetric synthesis of both 
enantiomers of (+)-catechin and (-)-epicatechin from 1,3-diarylpropenes by 
asymmetric dihydroxylation and acid-induced cyclisation (Scheme 4.2). Jew and Park 
and Chan and co-workers have improved on the acid-induced cyclisation by using 
Mitsunobu conditions or preparing an ortho-ester intermediate to encourage inversion 
of configuration to set the C-2 stereochemistry of the flavan-3-ols.
100
MOMO AD-mix-a,M eS0 2 NH2.OMOM MOMO OMOMOH
OMOM
OMOM
OMOM f-BuOH:H20  (1:1), 
0°C OMOM OH
OMOM
3 M HCI, 
MeOH:H20  (3:1)
OH
HO.
OH
OH
Schem e 4.2
The key intermediate in the alkene dihydroxylation-cyclisation strategy is 1,3- 
diarylpropene 273-14C. We envisaged a variety of new routes to E-alkene 273-14C 
based on the stereocontrolled formation of the alkene C=C bond from a fragment 
derived from a radiolabelled protected 3,4-dihydroxybenzoic acid, which would be 
easy to prepare and a phloroglucinol-derived C6-C2 fragment (Scheme 4.3). These 
routes included coupling of aldehyde 274 with a Wittig reagent 275-14C (route a) or a 
lithiated sulfone 273-14C (route b), or reversing the nucleophilic and electrophilic 
fragments and using aldehyde 277-14C with lithiated sulfone 278 (route c). The recent 
reports from Grubbs and others, also encouraged us to investigate the cross­
metathesis of allyl phloroglucinol-derivative 279 and styrene derivative 280-14C 
(route d), but with protecting groups R and R ’ that could easily be removed (i.e. not 
methyl). The protecting group issue proved very significant in all routes as will 
become apparent later.
Essential to these strategies is preparation of the radiolabelled compounds 275-14C- 
277-14C and 280-14C, which would be derived from 3,4-dihydroxybenzoic acid and 
the C6-C2 compounds 2 7 4 ,  2 7 8  and 279 by C-alkylation or C-allylation of 
phloroglucinol.
101
RO OR
OR
274
Pn3R*s
275- Croute a
.OR'
BT-S 'OR'
route b
O
OR
274
route c
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4.3 B-ring and label
We aimed to introduce the label by trapping 14C-enriched carbon dioxide using an 
aryllithium105,106 generated from either bromide 281 or iodide 282 by lithium-halogen 
exchange (Scheme 4.4). It could also be introduced using a Grignard reagent.107
OBn OBn
0B n 1) BuLi, THF, -78 °C r f ^ < 0Bn
2 ) 1 4 C 0 2
3) H3 0 +
281 X = Br
282 X = I
O
146-14C
S chem e 4.4
14C-labelled barium carbonate is commercially available and is one of the cheapest 
sources of 14C-enriched carbon compounds. Treating the labelled barium carbonate 
with acid easily generates the 14C-enriched carbon dioxide. Other methods for the 
synthesis of labelled benzoic acid derivatives are available, for example, the oxidation 
of labelled toluene derivatives.108 We chose to use the barium carbonate method due 
to the low cost and the simple chemistry involved.
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Our proposed synthesis of benzoic acid derivative 146-14C is shown in Scheme 4.5. 
Benzylation of catechol 283 gave dibenzyl ether 284 in moderate yield. Iodination of 
284 with iodine monochloride109 was expected to give iodide 282 which would then 
be carboxylated to give benzoic acid derivative 146-14C. Unfortunately, when the 
iodination was attempted essentially no product was formed. The evidence for this 
was the unchanged multiplet of the aromatic protons from the starting material in the 
NMR spectrum between 6.83 -  6.94 ppm. Several different conditions for the 
iodination (IC1/THF, RT; ICl/Et20 , RT; ICl/Et20 , reflux) were attempted but gave 
recovered starting material.
This led to the minor modification in the synthesis shown below (Scheme 4.6). 
Iodination of 2-benzyloxyphenol 285 with iodine monochloride110 gave iodide 286 in 
low yield. Benzylation of 286 gave iodide 282 in good yield. Subsequent 
carboxylation should then give benzoic acid derivative 146-14C. The carboxylation 
was only attempted once with Ba13C 0 3 due to time constraints but gave a complex 
mixture of products. Subsequent investigation within the group has found this 
reaction to be problematic.
\ /  ICI 
/ \  Et20
O
146-14C
S ch em e 4.5
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a 0H  ICI, Et20OBn 285 36%
OBn
OBn 1) BuLi, THF, -78 °C r p V
( T J  H)'c622) o u
3) H3 0 +
OH
OBn 
286
BnBr, K2 C 0 3  
DMF, 80 °C 
83%
OBn
146-14C
S ch em e 4.6
The labelled benzoic acid derivative could then be manipulated to give phosphonium 
salt 287, benzaldehyde derivative 90 or styrene derivative 288. All three of these 
compounds were synthesised to test the feasibility of each route. Reduction of non­
labelled benzoic acid derivative 146 gave alcohol 289, which was then converted into 
phosphonium salt 287 in moderate yield or oxidised with O-iodoxybenzoic acid (IBX) 
to give benzaldehyde derivative 90 in good yield (Scheme 4.7).
BnO
LiAIH4, THF 
80%  * I X 0HB n O ^ y ^
OBn
289
Ph3 P.HBr 
60 % MeCN 
reflux
© © 
PPh3Br
IBX, EtOAc 
reflux, 97 % BnO
BnO
OBn
287
Sch em e 4.7
OBn
90
94% Ph3 P=CH2, THF 
-78 °C - RT
OBn
OBn
288
Aldehyde 90 was converted into styrene derivative 288 in high yield. Aldehyde 90 
could also be prepared from commercially available 3,4-dihydroxybenzaldehyde 103 
(Scheme 4.8).
104
S chem e 4.8
Importantly, all three compounds 90, 287 and 288 could be easily purified. Simple 
filtrations through silica were employed for aldehyde 90 and styrene derivative 288, 
whereas phosphonium salt 287 precipitated from the reaction mixture.
4.4 Protected C-Alkvlated and C-Allvlated Phloroglucinol derivatives
4.4.1 Route to 3.5-dibenzyloxvphenol 108 for C-allvlation via Claisen 
rearrangement
Phenol 145a previously discussed in Chapter 3 (Scheme 3.3) is still an important 
intermediate, which we intended to synthesise via a Claisen rearrangement of allyl 
ether 147. The successful synthesis of styrene derivative 288 necessitated the 
synthesis of phenol 145a. An updated synthetic overview is shown in Scheme 4.9.
105
HO OH „ „ „  ^  BnO 
BnBr, K2 CQ3
DMF "
OBn
EtSNa, DMF 
reflux
BnO OH
OH
100
OBn
56
OBn
108
Allyl bromide
K0 CO3
DMF
BnO OH
O
OBn
290
BnO. OH
OBn
145a
heat BnOY T
■OHBnO.
S 0 2BT
BnO. OHOBn
291 PPh.
OBn
292
Schem e 4.9
Three new alternative routes can be added. Phenol derivative 145a should allow 
access to aldehyde 290, BT-sulfone (BT = Benzothiazol-2-yl) 291 and phosphonium 
salt 292. Clearly, the synthesis of phenol derivative 145a is vitally important and it is 
the key intermediate in all of the three routes shown. The syntheses of simpler 
structures related to aldehyde 290 and phosphonium salt 292 have already been 
discussed (Section 3.4.3 and 3.5.1 respectively). Sulfones similar to 291 will be 
discussed later (Section 4.5.2).
The synthesis of the required phenol 145a was expected to proceed smoothly. Both 
the benzylation of phloroglucinol62 100 and the monodeprotection of 56 with sodium 
ethanethiolate62 to give phenol derivative 108 had been reported in the literature. 
Allylation of 108 should give ether 147. Claisen rearrangement of 147 should then 
give the desired phenol derivative 145a.
Following the method of Chow, benzylation of phloroglucinol 100 proceeded in low 
yield to give the desired tribenzyl ether 56 and C-benzylated derivative 293 also in 
low yield (Scheme 4.10).
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HO OH
BnBr, K2 CQ3  
DMF
OH
100
BnO. / ^ . O B n  EtSNa, DMF
I reflux
OBn
56 R = H, 17%
293 R = Bn, 11 %
BnO OH
OBn
108
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The literature procedure reports a 59 % yield after recrystallisation. Despite several 
attempts we could not obtain tribenzyl ether 56 in reasonable yield. This can partly be 
attributed to using column chromatography to separate the close running products, as 
the literature recrystallisation did not work in our hands. Although not mentioned by 
Chow, C-benzylation of phloroglucinol has been reported as a major problem.51 A 
slightly modified version of Chow’s procedure was used for the monodeprotection of 
tribenzyl ether 56 to give phenol derivative 108, i.e. in order to avoid stench we 
decided to use commercially available sodium ethanethiolate rather than generating 
the salt in situ from fresh reagents. Unfortunately, the reaction failed. At this point an 
alternative procedure for synthesising 56 was sought.
Kawamoto has reported the synthesis of tribenzyl ether 56 via acetate 294.52 Our 
attempted synthesis via the same intermediate is shown below (Scheme 4.11).
H O ^ ^ .O HV
OH
100
Ac2 Q, DCM/py 
95%
BnCI, NaH,
DMF, H20
- o '
OAc
294
BnBr, NaOMe, 
DMF
OBn
56
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Acetylation of phloroglucinol 100 proceeded smoothly to give acetate 294 essentially 
in quantitative yield. Following Kawamoto’s procedure, water was added to a mixture 
of acetate 294, benzyl chloride and sodium hydride in DMF at 0 °C. Unfortunately, 
the addition of water caused a dangerous exotherm that could not be controlled.
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Consequently we adopted an alternative approach to 56, also shown in Scheme 4.11, 
where the acetate 294 was treated with sodium methoxide and benzyl bromide. 
Unfortunately, tribenzyl ether 56 was not formed.
A second alternative route to ether 56 is shown in Scheme 4.12. Benzylation of 
benzoic acid derivative111 295 proceeded in good yield to give benzyl ester 296, which 
was reduced with LiAlH4m to give benzyl alcohol derivative 297 in quantitative 
yield. The oxidation of alcohol 297 was performed with both manganese dioxide and 
IBX. Both proceeded in high yield however, IBX was found to give superior yields of 
aldehyde 298 (96 % vs 81 % respectively). Unfortunately, when aldehyde 298 was 
treated with mCPBA no useful product was isolated..
OH K2 C 0 3> BnBr
295 296 297
IBX
EtOAc
96%
mCPBA, DCM
OBn OBn
108 298
Schem e 4.12
A table summarising the variety of different methods used for the benzylation of 
phloroglucinal 100 is shown below (Table 4.1).
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Run
Number
Conditions Result
1 100 (1 eq.), BnBr (4 eq.), K2C 0 3 (3 eq.), 
DMF, 70 °C, 3 d
Mainly 293 formed
2 100 (1 eq.), BnBr (4 eq.), K2C 0 3 (4.3 eq.), 
DMF, RT, 2 d
17%  56 and 11%  293
3 100 (1 eq.), BnCl (3 eq.), NaH (3 eq.), 
DMSO, RT, 1 h
Starting material recovered
4 100 (1 eq.), trichlorobenzyl imidate (6 eq.), 
BF3.OEt2 (0.3 eq.), MeCN, -30 °C -  RT, 1 d
Recovered imidate
5 294 (1 eq.), BnCl (3.6 eq.), NaH (3.6 eq.), 
H20 , DMF, 0 °C, 2 h
Dangerous exotherm
6 294 (1 eq.), BnCl (3 eq.), 1.43 M NaOH (3 
eq.), DMF, RT, 2 h
Starting material recovered
7 294 (1 eq.), BnCl (3 eq.), 10 M KOH (3 eq.), 
DMF, RT, 6 h
Starting material recovered
8 294 (1 eq.), NaOMe (0.5 M in MeOH, 2 eq.), 
BnBr (2 eq.), DCM, 2 d
Complex mixture obtained 
(7 compounds by tic)
Table 4.1
4.4.2 Alternative approach to 2-r(3\5 ,-dibenzyloxyM*-hydroxyphenyHethanal 
290
After the unsuccessful attempts to synthesise C-allylated phloroglucinol derivative 
145a, we needed an alternative synthesis of aldehyde 274.
Aldehyde 274 is an important intermediate in routes a and b (Scheme 4.3). It could be 
reacted with either a labelled phosphonium salt 275-14C or a labelled sulfone 276-14C 
to give the diarylpropene 273-14C required for the dihydroxylation-cyclisation 
strategy (Scheme 4.13).
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An alternative synthesis of aldehyde 274 is shown below (Scheme 4.14). Benzylation 
of phloroglucinal 299 gave aldehyde 300 in poor yield. Unfortunately, treatment of 
aldehyde 300 with Corey’s ylid followed by BF3.OEt2112 did not give the desired 
phenylacetaldehyde 290. Only starting material was recovered with no evidence of 
epoxide formation. No further investigation of this reaction was attempted.
OH
299
O
K2 CO3 , BnBr 
DMF, 22 %
BnO OH
II
OBn O 
300
1) NaH
Me3 SOI, DMF
— X -
2 ) BF3 .OEt2
THF
BnO \^^v.O H
T ^ C c
OBn
290
Sch em e 4.14
The mechanism for the proposed transformation of 300 into 290 is shown in Scheme 
4.15. Addition of the sulfoxonium ylid 301 to an aldehyde gives intermediate 302. 
Elimination of DMSO gives epoxide 303, which when treated with BF3.OEt2 gives the 
chain-extended aldehyde 304.
0  0  
R ^ / ^ V ° 0  .  T ^ l  -DMSO, / O  BF3 .OEt2  n
&  ^  R^  R
301 0° ^  303 304
302 
Sch em e 4.15
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4.4.3 Substrates for lithiation
We also looked at alternative ways to the Claisen rearrangement of introducing the 
allyl group to obtain substrate 279, which could be used for cross-metathesis reactions 
(Scheme 4.3, route d). Lithiation of iodide 305 followed by quenching with allyl 
bromide should give ether 306 (Scheme 4.16).
BnO^ ^OBn BnO. X)Bn
1)BuLi, THF j|
•I 2) Allyl bromide
OBn OBn
305 306
S ch em e 4.16
The synthesis of iodide 305 again involved the benzylation of a phloroglucinol core 
(Scheme 4.17).
H O ^ ^ /O H  HO. .OH BnO. OBn
HNO3 /H2 SO4   ^ j f  K2 C03, BnBr jT
H2 S 0 4i 45 % " Y ^ N 0 2  Kl, DMF, 79 % Y ^ ° 2
OH OH OBn
100 307 308
Fe
NH4 CI
EtOH/H20
95%
B n O ^ ^ J D B n  1) N a N ° 2 - H2S ° 4  B n O . / ^ O B n
OBn 2 >Kl OBn
305 309
S ch em e 4.17
Nitrating the ring should make the aromatic ring sufficiently electron-poor to prevent 
the C-benzylation side-reaction from occurring. Nitration of phloroglucinol 100 gave 
2-nitrophloroglucinol 307 in moderate yield. Benzylation of 2-nitrophloroglucinol 
307 then proceeded to give benzyl ether 308 in good yield, with no C-benzylation 
observed. Reduction of nitro compound 308 gave aniline derivative 309 in excellent 
yield. However, the diazotisation-iodination returned only starting material. This was 
attributed to the insolubility of the aniline in the dilute sulfuric acid used as the 
reaction solvent.
I l l
We also considered an orr/io-lithiation approach. Protection of phloroglucinol as the 
tris(methoxymethyl)ether 310 would have allowed us to ortfto-lithiate and quench 
with allyl bromide. Our attempted syntheses of ether 310 are shown in Scheme 4.18. 
Unfortunately, we could not synthesise ether 310.
H ° ^ _ 0H  MOMCI, NaH M O M O ^ ^ J D M O M  MOMCI, NaOMe A c O ^ ^ ^ O A c
v  V V
OH DMF, 0 °C - RT OMOM OAc
100 310 294
Sch em e 4.18
Switching to tetrahydropyranyl (THP) ethers instead of MOM ethers led to the 
successful protection of phloroglucinol in moderate yield (Scheme 4.19). Acetal 311 
was isolated as a 2:1 mixture of diastereoisomers as indicated by the presence of two 
singlets in the NMR spectrum at 5 6.43 and 6.44 corresponding to the aromatic 
protons. Allylation of 311 proceeded uneventfully to give ether 312 as a 10:1 ratio of 
product: starting material indicated from the integrations of the aromatic signals in the 
starting material and the multiplet at 6 6.48-6.52 corresponding to the mixture of 
diastereomeric products.
HO OH THPO
OH
100
DHP, H+ 
DCM, 0 °C 
45%
OTHP
OTHP
311
1) f-BuLi, THF, -78-0 °C
2) Allyl bromide, 0 °C-RT
85%
THPO^ ^ O T H P
v e x
OTHP 
312
Schem e 4.19
4.5 Cross-metathesis-Dihydroxvlation route 
4.5.1 Cross-metathesis
With allyl compound 312 and styrene derivative 288 in hand, we considered the 
cross-metathesis reaction to give alkene 143 (Scheme 4.20).
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The intermolecular coupling of two different alkenes via cross metathesis potentially 
forms three new alkenes; the desired cross-coupled product and the undesired 
products of self-metathesis (Scheme 4.21).113
R1^  + r 2 ^ .  M=CH2  (cat.) r 1^ R 2  + r 1/ ^ R 1 + r 2 ^ ^ r 2
desired undesired
Sch em e 4.21
Minimising the formation of unproductive self-metathesis products (homodimers) and 
hence maximising the desired cross-metathesis process is of crucial importance. In 
addition to this, stereocontrol of the newly formed double bond is also an important 
factor. Although the production of homodimers is undesirable, they may be isolable 
and can be resubjected to the reaction conditions in place of the corresponding 
monomer to produce the desired cross-metathesis product.114
In recent years, well-defined single component metal carbene complexes have been 
synthesised and applied to olefin metathesis.113 A number of titanium and tungsten 
catalysts have been developed. However, Schrock’s molybdenum complex67 164, and 
the ruthenium-based catalysts 165,68 16669 and 4770 (Figure 3.2) developed by Grubbs 
are the most widely used catalysts.
A major advantage of Schrock’s catalyst 164 is its high reactivity towards a wide 
range of substrates with a number of steric or electronic variations.113 The alkoxy 
groups can be readily altered to adjust the catalyst’s activity.113 There are however, 
some important drawbacks to this system. It possesses only moderate to poor 
functional group tolerance, is highly sensitive to air, moisture and even to trace
113
impurities in solvents.113 Thermal instability on storage and the high cost of 
preparation are also problematic.113
In contrast to this, ruthenium complexes 165 and 166 can be easily prepared by 
reaction of RuCl2(PPh3)3 with 3,3-diphenylcyclopropene and phenyldiazomethane 
respectively followed by ligand exchange with tricyclohexylphosphine (Schem e
4.22).113
Ph Ph
Phv Ph C I,'lP^ y = <  2PCy3  C I,JCJ y = <
RuCI2 (PPh3 ) 3  + X  ---------- '  J r  ph - 5 = ^ -  Ph
Cl PPh3  -2PPh3  Cl pCy3
165
RuCI2 (PPh3 ) 3  + /=N2 ---------   Cl/Ru^x 2P° y3 ► Cl/f ! u = \
Ph Cf^ph V h  -ZPPhg Cl pcygPh
166
Sch em e 4.22
The ruthenium-based catalyst have gained a lot of attention because they exhibit high 
reactivity in a variety of cross-metathesis, RCM and ring-opening metathesis 
polymerisation (ROMP) processes and possess a remarkable tolerance towards a wide 
range of organic functional groups.113 Their catalytic activity is not significantly 
reduced in the presence of air, moisture or trace impurities in solvents.113 They can be 
conveniently stored, even under air without appreciable decomposition for several 
weeks.113 They often exhibit lower propagation rates, particularly with bulky 
substrates compared to Schrock’s catalyst, but their availability and ease of use make 
these the catalysts of choice with the exception of the most difficult metathesis 
substrates.113
The generally accepted mechanism for both cyclic and acyclic olefin metatheses 
proceeds through a series of metallacyclobutanes and carbene complexes (Scheme
4.23).115
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Scheme 4.23
Interestingly, although the stability of the carbenes and metallacyclobutanes can 
change with reaction conditions, catalyst composition and alkene substituents, the 
mechanism appears to be the same for all catalysts. As discussed earlier, Gesson has 
reported the synthesis of a variety of 1,3-diarylpropenes from substituted allylphenols 
and styrenes using cross-metathesis (Section 2.3).44 More recently Grubbs reported 
the synthesis of two flavan-3-ols using a cross-metathesis strategy (Section 2.3).42
Following the procedure used by Grubbs for the synthesis of tetramethylcatechin we 
attempted the cross-metathesis of ether 312 with styrene derivative 288 and obtained 
Zs-alkene 143 as a mixture of diastereomers in moderate yield (Scheme 4.24).
Analysis of the crude ‘H NMR spectrum shows the presence of only the £-alkene 
determined by the large coupling constant (15.8 Hz) of the doublet at 5 6.23 
corresponding to the benzylic methine proton of the alkene system. The multiplet at 8 
6.48-6.53 indicates the presence of a mixture of diastereomers. The low yield can be 
partly attributed to the dimerisation of styrene derivative 288 to stilbene derivative 
313 (Figure 4.1), which precipitates from the reaction mixture during the work-up
Grubbs' 2nd
generation
catalystTHPO- .OTHP THPO.
OTHP
DCM, reflux 
44%OTHP
312
OTHP
Scheme 4.24
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procedure. Another by-product was isolated during purification, which was expected 
to be dimerised alkene 314 (Figure 4.1). However, analysis of the ]H NMR spectrum 
did not agree with this and the compound remains unidentified.
.OTHPTHPO
OTHP
OTHP
'OTHPTHPO
314
Figure 4.1
4.5.2 Dihvdroxvlation
With alkene 143 in hand we turned our attention to the dihydroxylation. Initial 
attempts at the asymmetric dihydroxylation of alkene 143 with AD-m ix-a proved 
unsuccessful. This was attributed to the limited solubility of the alkene in the reaction 
solvent mixture. We repeated the dihydroxylation using osmium tetroxide and NMO. 
The reaction proceeded smoothly and diol 315 was obtained in moderate yield after 
purification (Scheme 4.25).
THPO> OBn
0 s 0 4, NMO 
OBn THF/H2 0 , 46 %
THPO OTHP 
OH
OTHP
143
OTHP OH 
315
Scheme 4.25
The diol was obtained as a racemic mixture of six diastereomers, the evidence for 
which can be readily obtained from the NMR spectrum and is easily rationalised. 
The stereospecificity of dihydroxylations is well understood and addition to the 
double bond occurs in a syn manner. The two newly formed chiral centres can either 
be R,R- or 5,5-configuration. If we consider the new chiral centres in the desired 5,5- 
configuration and label the THP groups in a clockwise fashion as A, B and C (Figure
4.2) then the possible combinations of diastereomers are shown in Table 4.2. The 
same situation applies for the /^-configuration giving the enantiomeric series.
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Figure 4.2
Diol
configuration ® © ©
S .S R R R
S ,S S S S
S ,S R R S
S ,S R S R
S ,S S S R
S ,S S R S
Table 4.2
Cyclisation of 315 to give 316 was attempted, using 3 M HC1 in methanol/water (3:1) 
at 60 °C (Scheme 4.26).
THPO OTHP
OH HCI, MeOH/H20
OTHP OH
Scheme 4.26
These conditions were tried twice but no product was obtained. A third attempt using 
10 % HCI in methanol/water (3:1) at 60 °C was also attempted but again no product 
was formed. In each case a complex mixture was isolated making interpretation of the 
NMR spectra very difficult. Due to time constraints no further attempt was made 
to cyclise the diol 315.
4.6 Modified Julia alkenation in ^-alkene synthesis
A potentially successful approach to catechin was found employing the cross­
metathesis strategy. While investigating the synthesis of alkene 143 via cross­
metathesis (Scheme 4.24), studies on the synthesis of alkene 143 using the Julia
117
alkenation were also being carried out in parallel. The background of the Julia 
alkenation is briefly discussed below.
4.6.1 Choice of Julia alkenation explained
In 1973, the process now known as the classical Julia alkenation was reported.116 The 
process was a novel method of synthesising alkenes from phenyl sulfones. The 
general method is outlined in Scheme 4.27. Lithiation of sulfone 317, followed by 
addition of an aldehyde gives (J-alkoxysulfone 318. Acetylation of sulfone 318 gives 
P-acyloxysulfone 319, which is reduced with sodium-mercury amalgam to give 
alkene 320. Although useful, the classical Julia alkenation is quite a long process. All 
four steps can be carried out in one pot but yields are higher if the (3-hydroxy sulfones 
are isolated and purified.
M
Ph'SA Ri
02
317
M = H —
M = Li
R2CHO
BuLi
LiO^R2
P h .s A Rl AcCI 
02 
318
A c(X  ,R 2
Ph. XS '  ~'R1 
02
319
Na(Hg) 
EtOH R1
320
Scheme 4.27
In 1991, Julia and co-workers published a novel one-pot synthesis of alkenes 
employing the reaction of lithiated benzothiazol-2-yl sulfones (BT sulfones) with 
carbonyl compounds (Scheme 4.28).117 The reaction proceeds by the addition of the 
lithiated sulfone 321 to the carbonyl compound to give alkoxide 322, which 
undergoes a series of rearrangements resulting in the loss of sulfur dioxide, lithium 
benzothiazolone and the formation of the new olefin 320.
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Schem e 4. 28
Julia found that some lithiated benzothiazolyl sulfones are unstable, undergoing self­
condensation even at low temperatures (Scheme 4.29).118
This problem was avoided by adding the base to a mixture of the sulfone and 
aldehyde i.e. Barbier-type protocol. Using this procedure, the sulfone is lithiated in 
situ and addition of the lithiated sulfone to the aldehyde occurs faster than self­
condensation. Using the Barbier method, Julia found that enolisable aldehydes or 
ketones and allylic or benzylic BT-sulfones could be used.118
Julia progressed from the early work to carry out a detailed study of the 
stereochemistry of the alkenes formed from lithiated heterocyclic sulfones.118 Using 
the Barbier conditions and saturated carbonyl compounds, several simple alkenes 
were synthesised albeit in low to moderate yield and essentially as a 50:50 mixture of 
E  - and Z - isomers.
The stereochemical outcome of the BT-modified Julia alkenation is substrate 
controlled but can be affected by the reaction conditions.119 An investigation into the 
base-mediated elimination of stereodefined P-hydroxy-BT-sulfones showed that 
simple P-oxy-BT-sulfones (i.e. 3 2 1 , 324 with R 1 and R2 = alkyl) breakdown
Scheme 4.29
stereospecifically with the arcfz-diastereoisomer 323 giving is-olefins and the syn- 
diasteroisomer 326 giving Z-olefins (Scheme 4.30).120
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The disappointing selectivities observed by Julia can therefore be attributed to poor 
diasterocontrol in the nucleophilic addition to the carbonyl compound.
The most synthetically useful reaction of BT-sulfones is the synthesis of conjugated
1,2-disubstituted is-alkenes.119 Most structural varieties of BT-sulfones will react with 
a,P-unsaturated aldehydes, including aromatic aldehydes, to give Zs-alkenes with high 
stereoselectivity.119 The reactions of simple alkyl BT-sulfones with electron-rich 
conjugated aldehydes are particularly successful.119 An example is shown in Scheme 
4.31.
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328 R = OMe, 95 %, 99:1 E:Z
329 R = H, 6 8  %, 94:6 E:Z
330 R = Cl, 51 %, 77:23 E:Z
Sch em e 4.31
Reaction of lithiated 2-(butylsulfonyl)benzothiazole 327 with para-substituted 
benzaldehydes gave the expected products 328-330  with moderate to high 
stereoselectivity. This example also shows the beneficial effect an electron donating 
para-substituent on the ring to stereoselectivity of the reaction.119
Lithiated oxy-BT-sulfones, 322 and 325 with R2 = vinyl or aryl do not breakdown 
stereospecifically to give alkene products.119 It has also been shown that some 
lithiated syn-P-hydroxy-BT-sulfones with R2 = vinyl or aryl collapse giving mainly E- 
alkene products.120 A direct pathway for this transformation must therefore exist. 
Julia’s proposed pathway is shown below (Scheme 4.32).118
sxN_Li
° 2i o
R ^ H
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Loss of benzothiazolone from intermediates 322 and 325 may lead to zwitterionic 
conformers 331 and 332 respectively. Equilibration of the betaine intermediates 
favours 332 , which gives an E-alkene on loss of sulfur dioxide. Unsaturated
121
substituents at R2 will provide stabilisation for the carbocation ion in 331 and 332 and 
therefore, could promote this pathway.119 This proposed route also accounts for the 
influence of para-substituents on the stereochemical outcome of aromatic aldehyde 
alkenations discussed previously.119
Julia et al investigated the alkenation of a vast array of BT-sulfones and aldehydes.118 
They found that alkenations with saturated aldehydes and allylic or benzylic 
heterocyclic sulfones are generally not very stereoselective although there were some 
exceptions (Scheme 4.33).
O
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BT ^  LDA, THF H
333 -78 °C - RT 334 R = /7-C8H17i 81 %, 37:63 E:Z
335 R = APr, 51 %, 90:10 E:Z
336 R = fiu , 63 %, >99:<1 E:Z
337 R = oHx, 78 %, 50:50 E.Z
Sch em e 4.33
These results were obtained by adding the aldehyde to the lithiated sulfone. 
Interestingly, using Barbier conditions, alkenes 334 and 335 were formed in 80 % 
yield and as a 23:77 mixture of Z^Z-isomers and in 69 % yield as a 45:55 mixture of 
Z^Z-isomers respectively. The high selectivities obtained in alkenes 335 and 336 were 
attributed to the branched alkyl groups forcing the reaction through the alternative 
pathway previously discussed (Scheme 4.32).
Also of interest is the switch in selectivity observed between olefinations with 
saturated alkyl BT-sulfones compared to saturated alkyl phosphonium salts (Scheme 
4.34).
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Scheme 4.34
In summary, the modified Julia alkenation is a powerful synthetic tool for the 
synthesis of ^-alkenes. High selectivities are obtained with saturated BT-sulfones and 
aromatic aldehydes and also from benzylic BT-sulfones and branched saturated, a ,p - 
ethylenic or aromatic aldehydes.
4.6.2 Synthesis and use of sulfones
After the unsuccessful solid-phase route (Scheme 3.49), we devised another route 
employing the ozonolysis chemistry previously discussed (Scheme 3.59) and 
investigated Julia alkenations using iodide 269. The route is shown in Scheme 4.35. 
Sulfide 338 was readily prepared using Julia’s methodology118 in moderate yield from 
iodide 269 and the commercially available 2-mercaptobenzothiazole 339. Oxidation118 
of sulfide 338 proceeded smoothly to give sulfone 340 in moderate yield. To test the 
alkenation procedure we used veratraldehyde 341 to compare our results to those 
obtained by Julia.118 Our results were very encouraging (83 %, E\Z  100:0). However, 
despite several attempts, the reaction did not go to completion. Purification of alkene 
342 was attempted but a pure sample was not obtained. Dihydroxylation of olefin 342 
should give diol 343 which should cyclise under acidic condi tions36,37,43 to give 
alcohol 344.
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We decided at this stage that the Julia alkenation was a good method to use on model 
compounds and two new routes were developed for the real system. Our routes are 
shown in Schemes 4.36 and 4,37. Our attention was first devoted to protecting 2,4,6- 
trihydroxy benzaldehyde 299 which proceeded in poor yield to give the 2,4- 
bis(methoxymethyl)ether121 345. Methylation122 of 2-mercaptobenzothiazole 339 gave 
methyl sulfide derivative 346 in excellent yield, which when lithiated reacted with 
aldehyde 345 to give sulfide 347 in moderate yield. Elimination of water would give 
vinyl sulfide 348, which could then be oxidised to sulfone 349 and hydrogenated to 
give the desired precursor 350. However, all attempts to synthesise 348 were 
unsuccessful.
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Alternatively, lithiating sulfide 346 and quenching with chlorotrimethylsilane gave 
sulfide123 351 in poor yield but the reaction was easily scaled up. Lithiation of sulfide 
351 followed by quenching with aldehyde 345 gave vinyl sulfide 348 in good yield as 
a 10:1 ratio of EZZ isomers. Subsequent oxidation would potentially give sulfone 349 
which might undergo hydrogenation to give sulfone 350. The alkenation with 
aldehyde 90 should then give olefin 352, which could be dihydroxylated and cyclised 
to the secondary alcohol 316. Finally, deprotection would give (+)-catechin 6.
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The first step in the above synthesis was im proved by alkylating 2- 
mercaptobenzothioazole 339 with (chloromethyl)trimethylsilane to give sulfide 351 in 
excellent yield. This is shown below in Scheme 4.38.
f Y V s n  K2 CQ3 ,CICH2 SiMe3  _ f V V g  TMS 
Acetone, reflux, 90 %
339 351
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Since the yield of diprotected phenol 345 was poor and manipulation of vinyl sulfide 
348 was expected to be convoluted, we considered that an alternative route to sulfone 
278 should be attempted.
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Using the idea of using a protecting group to direct lithiation on the ring and 
modifying our benzothiazole chemistry, we proposed the route shown below in 
Scheme 4.39. Tetrahydropyranyl ether 311 was lithiated and quenched with ethylene 
sulfide in the hope of producing thiol 353 but this failed. Reacting 353 with 
commercially available 2-chlorobenzothiazole 354, should then have given sulfide 
355. Oxidation to sulfone 356, followed by olefination with aldehyde 90 should give 
olefin 143. Dihydroxylation of 143, followed by cyclisation should give protected (+)- 
catechin 316. Cleavage of the protecting groups should give (+)-catechin 6.
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We then decided to investigate whether reaction between a lithiated derivative of THP 
ether 311 and a vinyl sulfone would give the desired sulfone 356 (Scheme 4.40). 
Alkylation of 2-mercaptobenzothiazole 339 proceeded smoothly to give hydroxy 
sulfide 357 in excellent yield.124 Oxidation with ammonium molybdate gave hydroxy 
sulfone 358 also in excellent yield. Elimination with mesyl chloride and triethylamine 
gave vinyl sulfone 359 in moderate yield. Coupling of vinyl sulfone 359 with acetal 
311 to give sulfone 355 was initially problematic. After the reaction we isolated acetal 
311 in almost quantitative yield but the vinyl sulfone was consumed.
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To confirm that acetal 311 was being deprotonated, we treated it with n-butyllithium 
and terr-butyllithium and quenched with deuterated methanol to form 360 (Scheme 
4.41). The experiments showed we got complete incorporation of deuterium onto the 
ring when we used either «-butyllithium or teTt-butyllithium. Evidence for this comes 
from the change in integration size of the signals at 6.43 and 6.44 ppm from three 
protons to two protons. This led us to believe that conjugate addition of the 
aryllithium was leading to the formation of a sulfone anion that could add to another 
molecule of vinyl sulfone 359 leading to polymerisation.
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At this stage, we decided to try adding «-butyllithium, phenyllithium and the 
corresponding cuprates to sulfone 359 to check whether it would add to the vinyl 
group to give sulfone 361 and 362 (Scheme 4.42).
N 0 2
V s ^  s
359
BuLi/PhLi or
Bu2 CuLi/Ph2CuLi
361 R = Bu
362 R = Ph
Sch em e 4.42
It is not clear what happened on addition of phenyllithium. It did not give sulfone 362 
or polymerise sulfone 359. It is possible that it added directly to the benzothiazole 
ring to give 2-phenylbenzothiazole 363 and vinyl sulfinic acid 364 (Scheme 4.43). 
The lack of the two expected triplets of the product and the disappearance of the vinyl 
protons from the starting material support this suggestion. The phenyllithium-derived 
cuprate gave similar results.
PhLi/Ph2CuLi
.BuLi/Bu2CuLi
S chem e 4.43
Addition of n-butyllithium gave a mixture of products that were difficult to separate. 
It is clear from the !H NMR spectrum that a small amount of the desired sulfone 361 
was present. The triplet at 3.12 ppm, coupling constant 7.7 Hz is evidence of this 
compound. A synthesis of sulfinic acids has been reported where benzothiazole
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sulfones with varying lengths of chain have been synthesised by treating the sulfone 
with alkyllithiums123 and sodium borohydride.125 Katritzky’s group also isolated a 
small percentage of 2-alkylbenzothiazoles as side products. It is therefore probable 
that some 2-butylbenzothiazole 365 was also formed. The evidence for this comes 
from the aromatic protons from 7.26 - 7.39 ppm and 7.42 - 7.48 ppm integrating to 
exactly eight protons instead of the expected four for the product. Addition of the 
butyl cuprate gave similar results (Scheme 4.43).
We decided at this stage to try forming the organocopper species derived from acetal 
311. This initially gave us the same problem as lithiated 311. However, if the copper 
iodide was freshly ground and dried by azeotrope prior to use, the reaction proceeded 
to give the required sulfone 356 in good yield as a 4.5:1 mixture of product to starting 
material (Scheme 4.44). Unfortunately, impurities that proved difficult to remove 
were formed on scaling-up the reaction hence alternative routes were sought. Julia 
alkenation should give alkene 143 which could be dihydroxylated and cyclised in 
acidic methanol to give phenol derivative 316. Subsequent hydrogenation should give 
(+)-catechin 6.
Along with the route described above a new graduate working with me, Lisa Sloan, 
investigated the route shown in Scheme 4.45. Ozonolysis of acetal 312 followed by 
reduction of the ozonide gave alcohol 366 in moderate yield. Iodination of alcohol 
366 gave iodide 367 in moderate yield. We found iodide 367 to be moderately 
unstable and therefore, we used it without purification to give sulfide 355 in good 
yield. Sulfide 355 was also found to be unstable. Attempts to oxidise sulfide 355 to 
the sulfone 356 were unsuccessful and this route was discontinued. Much of this work 
was originally done jointly between Lisa and me, however I later repeated the route.
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S ch em e 4.44
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A brief amount of time was spent investigating Heck couplings onto sulfone 359. To 
this end iodide 368 was synthesised but never used (Scheme 4.46). Three model Heck 
couplings were attempted. The first attempt gave a messy mixture of products, but 
some desired product, alkene 369 was formed. Evidence of this came from the 
presence of two doublets at 7.15 and 7.89 with coupling constants of 15.4 Hz in the 
*H NMR spectrum. After purification it became clear that the reaction had not worked 
to any useful extent. Two attempts were made using microwave irradiation. 
Unfortunately, neither worked to any useful extent either. Interestingly, the product 
obtained from the microwave reactions is not alkene 369, but the reduced form 361. 
The presence of triplet-like peaks at 3.64 and 4.03 in the ’H NMR spectrum suggests 
this compound is present. These results are summarised in Scheme 4,46.
131
THPO OTHP
1) f-BuLi, THF, -78 °C
2) l2, THF, 0 °C, 96 %
THPO
OTHP
311
i p c
OTHP
368
OTHP
Phi, Pd(OAc) 2  
Et3 N, MeCN 
Reflux
N 0 2
7“ s ^
359
N 0 2
N 0 2PhBr, Pd(OAc) 2  
Ph3 P, DIPEA 
H2 0 , DMF, microwave
Sch em e 4.46
This last result suggests that protonation of the 16-electron adduct 370 (Figure 4.3) is 
faster than the P-hydride elimination step and would account for the low yields 
observed with this system.
(MeCNUPd^ 1
" y W
H
370 
Figure 4.3
4.7 Conclusions
Two main routes, covering a wide range of chemistry have been attempted towards 
the synthesis of isotopically labelled (+)-catechin. The two routes involved either 
flavene 203 or 1,3-diarylpropene 273 as the key intermediates (Figure 4.4).
OR
203 273
Figure 4.4
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Our studies have focused on a number of routes with flavene 203 as the common 
intermediate (Schem e 4.47). A variety of intermediates were synthesised but 
unfortunately failed to give the desired flavene. For example, methylenation of ester 
229 to give an enol ether which could then undergo RCM to 203 was unsuccessful. 
Likewise, the intramolecular Wittig reaction of phosphonium salt 210 did not yield 
203. Barbier reaction of iodide 205 also failed to synthesise 203. It was hoped that the 
solid phase methodology developed within the Hartley group for the synthesis of 
benzofurans and indoles could also be extended to the synthesis of benzopyrans. 
However, despite several attempts, the Takeda reaction of thioacetal 235 did not 
produce 203.
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Several different routes to 1,3-diarylpropene 273 (Figure 4.4) were investigated. Of 
the routes investigated, the cross metathesis route was particularly successful. This
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route involved a novel procedure for the protection of phloroglucinol that avoids the 
problem of C-alkylation (Scheme 4.19). The procedure allows the synthesis of 
material that can be rapidly converted into 1,3-diarylpropene 143 (F igure 4.5). 
Dihydroxylation of 143 was successful, however, the subsequent cyclisation failed to 
give (+)-catechin 6.
THPO. OTHP
OTHP
Figure 4.5
A model study of the Julia alkenation using iodide 269 (F igure 4.6) was very 
encouraging and led to the investigation of several other described routes. 
Unfortunately, the same encouraging results were not obtained with the initial routes 
employing aldehyde 345 or acetal 311, which could have led to the synthesis of (+)- 
catechin 6.
THPO •OTHP
OTIPS
OTHPI MOMO OMOM
269 345 311
Figure 4.6
Further development of the Julia chemistry led to the successful coupling of acetal 
311 with vinyl sulfone 359 to give the required sulfone precursor for the synthesis of 
(+)-catechin, however further optimisation of this step is required to allow large-scale 
reactions to be carried out efficiently (Scheme 4.44).
We have described a novel procedure for the protection of phloroglucinol that avoids 
the problem of C-alkylation and allows the rapid synthesis of key 1,3-diarylpropene 
structures used in the synthesis of flavan-3-ols. An exhaustive investigation into the 
synthesis of flavene structures is also described.
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A novel and promising route to alkene 143 has been investigated which would allow 
the use of the Julia alkenation. The synthesis of alkene 143 using this methodology 
could then lead to (+)-catechin using known literature procedures i.e. 
dihydroxylation-cyclisation. We have also applied G rubbs’ cross-m etathesis 
methodology to the synthesis of alkene 143. Although neither of the routes we have 
investigated to (+)-catechin are entirely novel, they would provide a new method for 
the synthesis of radiolabelled (+)-catechin and other flavan-3-ols.
4.8 Future work
There are two routes in particular that are deserving of further investigation.
The successful protection of phloroglucinol and subsequent allylation allowed us to 
synthesise the desired 1,3-diarylpropene for the dihydroxylation-cyclisation 
procedure. At this stage the cross metathesis is not efficient and requires optimisation 
to minimise the formation of homodimer side-products. The dihydroxylation also 
requires optimisation and a way to allow the use of AD-mix needs to be found. The 
cyclisation step requires thorough investigation as preliminary studies were 
unsuccessful and very little time was available to investigate this procedure.
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The conjugate addition to sulfone 359 is potentially the most interesting route 
(Scheme 4.44). If the problems encountered during scale-up could be overcome then 
this would be a novel approach to the 1,3-diarylpropene compounds. There is also the 
potential for the conjugate addition and subsequent olefination to be developed into a 
one-pot procedure. In addition to its application in the synthesis of (+)-catechin this 
chemistry could be applied to the synthesis of a variety of other interesting molecules.
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CHAPTER 5 - Experimental
General Considerations
THF and diethyl ether were freshly distilled from sodium/benzophenone. DCM, 
hexane, toluene, acetonitrile and triethylphosphite were distilled from calcium hydride 
prior to use. Pyridine was distilled from potassium hydroxide. DMF and triethylamine 
were distilled from calcium hydride and stored over 4 A molecular sieves. The solid- 
phase reactions were carried out in normal glassware, but with the resin (particle size 
= 150-300 pm diameter) contained within porous polypropylene reactors that had an 
internal volume of 2.4 mL and a pore size of 74 pm . Reagents obtained from 
commercial suppliers were used without further purification. Purification by column 
chromatography was carried out on silica gel (particle size 70-230 mesh) or 
deactivated neutral alumina (particle size -150 mesh) as stationary phase. TLC was 
carried out using Merck silica gel foil-backed plates (0.25 mm layer thickness) the 
plates were visualised by illumination with UV light, permanganate or DNP stains. !H 
and 13C NMR spectra were recorded using a Bruker DPX/400 spectrometer operating 
at 400 and 100 MHz. Chemical shifts are relative to tetramethylsilane. The 
multiplicities of the 13C nuclei were determined using the DEPT pulse sequence. The 
data reported for compounds 143, 311, 312, 315, 355, 356, 360, 366 and 367 
corresponds to all isomers present. Mass spectra were recorded on a Jeol JMS700 
spectrometer. Microanalysis was carried out using a Carlo-Erba 1106 elemental 
analyser. IR spectra were recorded using a Nicolet Impact 410 FT-IR spectrometer.
1.3.5-tris(BenzyIoxv)benzene 56 and 2-Benzvl-1.3.5-tris(benzyloxy)benzene 293
BnO>v^ v ; .OBn
X p C -
OBn
By the published procedure,62 benzyl bromide (18.9 mL, 158.6 mmol, 4 eq) was 
added to a solution of phloroglucinol 100 (5.00 g, 39.7 mmol, 1 eq) and potassium 
carbonate (23.6 g, 170.5 mmol, 4.3 eq) in DMF (65 mL) and the mixture was stirred 
at room temp, for 48 h. The reaction mixture was poured into ice-water (100 mL), the
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aqueous layer was decanted and the oily residue extracted into EtOAc (100 mL). The 
organics were washed with brine (20 mL) and concentrated under reduced pressure to 
give the title mixture (15.09 g) as a yellow oil that crystallised on standing. 
Purification by column chromatography [silica, eluting petroleum ether (60 -  80 
°C)/toluene (2:3)] gave the pure title compound62 56 (2.69 g, 17.1 %) as a white 
powder. ]H and 13C NMR and melting point for 56 in agreement with published data.
Sp (400 MHz: CDCM
4.98 (s, 6H, 3 x -OCH2), 6.26 (s, 3H, H-2, 4, 6), 7.29-7.41 (m, 15 H, Ar-H).
5.  (TOO MHz: CDCU
70.06 (CH2), 94.87 (CH), 127.54 (CH), 127.97 (CH), 128.55 (CH), 136.78 (C), 
161.09 (C).
MS m/z (EI+) 396.1 (M+ , 25 %), 91.1 (100), 18.0 (12); calculated 396.1725,
observed 396.1729.
Microanalysis requires C 81.79 %, H 6.10 % found C 81.67 %, H 6.15 %.
IR vm  (golden gate) 2931 (CH2), 2868 (CH2), 1610 (aromatics), 1593 (aromatics),
1496 (aromatics), 739 (aromatics).
mp = 95.8 -  96 °C [lit.62 93 -  94 °C (EtOAc/EtOH)].
Rf = 0.28 [silica, petroleum ether (40 -  60 °C):toluene (2:3)].
293126 (2.20 g, 11.4 %) was also isolated as a white powder.
5p 1400 MHz: CDCU
4.04 (s, 2H, ArCH2), 4.96 (s, 2H, -OCH2), 4.99 (s, 4H, 2 x -O CH2), 6.28 (s, 2H, H-4 + 
H-6), 7.10-7.40 (m, 20H, Ar-H).
(TOO MHz: CDCU
28.74 (CH2), 70.19 (CH2), 93.09 (CH), 111.49 (C), 125.22 (CH), 127.22 (CH), 127.54 
(CH), 127.70 (CH), 127.88 (CH), 127.99 (CH), 128.40 (CH), 128.58 (CH), 128.69 
(CH), 136.91 (C), 137.09 (C), 142.23 (C), 157.88 (C), 158.65 (C).
MS m/z (EI+) 486.2 (M+ , 25 %), 91.1 (100); C34H30O3 calculated 486.2195, observed 
486.2192.
Microanalysis C34H30O3 requires C 83.92 %, H 6.21 % found C 83.91 %, H 6.31 %.
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IR vmax (golden gate) 2922 (CH2), 2866 (CH2), 1601 (aromatics), 1496 (aromatics),
754 (aromatics), 729 (aromatics).
mp = 100.3 -  100.5 °C [lit.126 101 -  103 °C (EtOH)].
Rf = 0.34 [silica, petroleum ether (40 -  60 °C):toluene (2:3)].
3.4-bis(Benzyloxy)benzaldehyde 90
Benzyl bromide (69.6 mL, 586.4 mmol, 3 eq) was added to a stirring solution of 3,4- 
dihydroxybenzaldehyde 103 (27.0 g, 195.5 mmol, 1 eq), potassium carbonate (81.1 g,
586.4 mmol, 3 eq) and potassium iodide (3.25 g, 19.6 mmol, 0.1 eq) in DMF (350 
mL). The resulting mixture was heated to reflux for 5 d, allowed to cool then filtered. 
The filtrate was diluted with Et20  (1250 mL) and washed with water (3 x 700 ml), 
dried (M gS04) and concentrated under reduced pressure to give the crude aldehyde127 
(57.7 g, 92.7 %) as a pale yellow oil that crystallised on standing. Recrystallisation 
from EtOAc/hexane gave the pure aldehyde (37.9 g, 60.8 %) as a light yellow/brown 
solid.
Alternative procedure:
IBX (1.85 g, 6.63 mmol, 3 eq), was added to a solution of alcohol 289 (707.7 mg,
2.21 mmol, 1 eq) in EtO Ac (15 mL) at room temp. The mixture was heated to reflux 
for 6 h then cooled to room temp, and filtered. The filtered solid was washed with 
EtO Ac (30 mL) and the filtrate was concentrated under reduced pressure to give the 
crude aldehyde (475.8 mg, 95.8 %) as an amorphous solid.
ga 1400 MHz: CDCU
5.18 (s, 2H, - 0 O / 2Ph), 5.21 (s, 2H, -OCtf2Ph), 6.99 (d, 1H, J = 8.2 Hz, H -5), 7.27- 
7.47 (m, 12H, Ar-//), 9.77 (s, 1H, -CtfO). 
jL (TOO MHz: CDCU
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70.70 (CH2), 70.85 (CH2), 112.26 (CH), 112.98 (CH), 126.57 (CH), 126.97 (CH),
127.21 (CH), 127.91 (CH), 128.00 (CH), 128.47 (CH), 128.55 (CH), 130.20 (C),
136.14 (C), 136.46 (C), 149.08 (C), 154.15 (C), 190.69 (CH).
MS m /z  (EI+) 318.2 (M+ , 55 %), 227.1 (59), 181.2 (27), 91.1 (100), 65.1 (27); 
C21H180 3 calculated 318.1256, observed 318. 1255.
Microanalysis C21H180 3 requires C 79.23 %, H 5.70 %, found C 79.03 %, H 5.59 %. 
mp = 85 -  86 °C (lit.127 91 °C, EtOH).
IR vmax (golden gate) 2819 (CH2), 1674 (CHO), 1597 (aromatics), 1581 (aromatics), 
1510 (aromatics).
Rf = 0.40 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
l-r3,.4l-bisfBenzvloxv)phenyll-3-r2,,.4f,.6M- 
trisftetrahydropvranvloxvlphenynpropene 143
THPO OTHP
OTHP
Grubbs' 2nd generation catalyst 47 (108.6 mg, 0.13 mmol, 0.057 eq) was added to a 
solution of acetal 312 (1.87 g, 4.47 mmol, 2 eq) and styrene 288 (707.5 mg, 2.24 
mmol, 1 eq) in DCM (22.5 mL) at room temp, under argon. The resulting solution 
was heated to reflux for 5 d then Grubbs' 2nd generation catalyst (108.6 mg, 0.057 eq) 
was added and heating continued for a further 2 d. Grubbs' 2nd generation catalyst 47 
(54.3 mg, 0.029 eq) was added and heating continued for a further 17 h. The reaction 
mixture was allowed to cool and filtered through a pad of deactivated alumina eluting 
Et20/hexane (1:1). The precipitated styrene dimer 313 was filtered and the filtrate was 
concentrated under reduced pressure to give the crude E-alkene (1.71 g) as a dark 
green/brown gum. Purification by column chromatography [alumina deactivated with 
6 % water, eluting with hexane/Et20  (3:1)] gave the title compound (706.0 mg, 44.7 
%) as a pale yellow foam.
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5Hi400JvfflziCDCl1)
1.50-1.60 (m, 9H, -C //2), 1.75-1.78 (m, 6H, -CH2), 1.88-1.99 (m, 3H, -C //2), 3.45 (d, 
2H, J = 6.6 Hz, ArC//2), 3.49-3.53 (m, 2H, -OCH2), 3.77-3.88 (m, 2H, -OCH2), 5.05 
(s, 4H, 2 x -O C //2Ph), 5.30-5.35 (m, 3H, -OCHO), 6.05 (td, 1H, J = 6.6 Hz, 15.7 Hz, 
ArCH=C//), 6.23 (d, 1H, J = 15.7 Hz, ArC//=CH), 6.48 (s, 2H, Ar-//, minor B), 6.50 
(s, 2H, A r-//, major A), 6.53 (s, 2H, Ar-//, minor C), 6.71-6.77 (m, 2H, Ar-//), 6.86 
(s, 1H, Ar-//), 7.19 -7.29 (m, 6H, Ar-//), 7.34-7.37 (m, 4H, Ar-//). 
jL 1100 MHz: CDCl^
18.74 (CH2), 18.75 (CH2), 18.81 (CH2), 25.23 (CH2), 25.28 (CH2), 26.92 (CH2), 30.33 
(CH2), 30.42 (CH2), 30.47 (CH2), 61.74 (CH2), 62.02 (CH2), 71.34 (CH2), 71.41 
(CH2), 96.01 (CH), 96.21 (CH), 96.30 (CH), 96.57 (CH), 96.78 (CH), 97.63 (CH), 
111.49 (C), 112.53 (CH), 115.20 (CH), 119.40 (CH), 127.29 (CH), 127.71 (CH), 
128.29 (CH), 128.41 (CH), 128.87 (CH), 132.22 (C), 137.39 (C), 147.96 (C), 149.02 
(C), 155.78 (C), 155.96 (C), 156.75 (C).
MS m/z (FAB+) 729.6 [(M+Na)+, 5 %], 329.2 (45), 176.1 (100), 85.6 (37), 56.0 (20); 
C^H^OgNa calculated 729.3403, observed 729.3405.
IR v max (neat) 2943 (CH2), 2873 (CH2), 2853 (CH2), 1606 (aromatics), 1510 
(aromatics), 1493 (aromatics), 953 (alkene).
Rf = 0.19 [alumina, hexane:Et20  (2:1)].
2-(2,-IodoethyDphenvl 3” .4” -dibenzvloxvbenzoate 205
.OBn
OBn
Acid 146 (2.39 g, 7.15 mmol, 1.1 eq), was added to a solution of iodide 259 (1.61 g, 
6.50 mmol, 1 eq), EDCI (1.75 g, 9.11 mmol, 1.4 eq) and DMAP (79.4 mg, 0.65 
mmol, 0.1 eq) in DCM (10 mL) at room temp, under nitrogen. The solution was 
stirred at room temp, for 24 h then diluted with DCM (50 mL), washed with saturated 
sodium bicarbonate (3 x 150 mL), water (2 x 150 mL) brine (100 mL), dried (M gS04) 
and concentrated under reduced pressure to give the crude ester (2.15 g, 58.6 %) as a 
yellow/orange oil that crystallised on standing. Recyrstallisation from /-PrOH gave an
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off-white amorphous solid that was filtered and washed with hexane to give the ester 
(937.9 mg, 25.6 %).
gn (400 MHz: CDCM
3.30 (t, 2H, J = 7.7 Hz, ArCtf2), 3.21 (t, 2H, J = 7.7 Hz, -CH2C //2I), 5.15 (s, 2H, - 
OCH2Ph), 5.17 (s, 2H, -OC//2Ph), 6.92 (d, 1H, J = 8.5 Hz, H-3” ), 7.06-7.40 (m, 14H, 
Ar-H), 7.68 (d, 1H, J = 1.9 Hz, H-6” ), 7.72 (dd, 1H, J = 2.0 Hz, 8.4 Hz, H-2").
5 . (100 M HziCDCl,)
3.74 (CH2), 34.93 (CH2), 70.78 (CH2), 71.19 (CH2), 113.26 (CH)115.70 (CH), 121.72 
(C), 122.77 (CH), 124.75 (CH), 126.11 (CH), 127.06 (CH), 127.31 (CH), 127.95 
(CH), 128.02 (CH), 128.15 (CH), 128.52 (CH), 128.59 (CH), 130.24 (CH), 132.51 
(C), 136.31 (C), 136.63 (C), 148.46 (C), 149.06 (C), 153.60 (C), 164.51 (C).
2-r2,.2,-his(Phenylsulfanyl)ethyllphenvl 3M.4,,-dibenzyloxybenzoate 208
OBn
OBn
PhS SPh
3,4-Dibenzyloxybenzoic acid 146 (488 mg, 1.46 mmol, 1.1 eq) was added to a stirring 
solution of thioacetal 237 (450 mg, 1.33 mmol, 1 eq), EDCI (356 mg, 1.86 mmol, 1.4 
eq) and DMAP (16 mg, 0.13 mmol, 0.1 eq) in dry DCM (2.26 mL) under nitrogen. 
The solution was stirred at room temp, for 24 h after which DCM (50 mL) was added 
and the organics washed with saturated bicarbonate (75 mL), water (2 x 75 mL) and 
brine (75 mL). The organics were dried (M gS04) and concentrated under reduced 
pressure to give the title compound (596.6 mg, 68.6 %) as an off white amorphous 
solid. Chromatography on silica eluting petroleum ether (40 - 60 °C):EtOAc (4:1), 
followed by recrystallisation from i-PrOH gave the pure ester (400 mg, 46.0 %) as an 
off white amorphous powder.
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ga f400 MHz: CD CU .
3.14 (d, 2H, J = 7.6 Hz, ArCtf2CH), 4.62 (t, 1H, J = 7.6 Hz, ArCH2Ctf), 5.19 (s, 2H, 
PhCtf2), 5.29 (s, 2H, PhC //2), 6.97 (d, 1H, J = 8.4 Hz, H-5"), 7.70-7.49 (m, 24H, Ar- 
H), 7.69 (dd, 1H, J = 1.9 Hz, 8.4 Hz, H-6"), 7.72 (d, 1H, J = 1.9 Hz, H-2").
5.(4 0 0  MHz: CDCL)
37.54 (CH2), 58.75 (CH), 70.80 (CH2), 71.14 (CH2), 113.29 (CH), 115.73 (CH), 
121.90 (C), 122.54 (CH), 124.80 (CH), 125.81 (CH), 127.06 (CH), 127.42 (CH), 
127.68 (CH), 128.01 (CH), 128.09 (CH), 128.19 (CH), 128.56 (CH), 128.66 (CH), 
128.73 (CH), 130.25 (C), 131.73 (CH), 132.88 (CH), 133.94 (C), 136.43 (C), 136.65 
(C), 148.47 (C), 149.54 (C), 153.43 (C), 164.52 (C).
MS m/z (FAB+) 677.5 [(M+Na)+, 14 %], 427.4 (22), 317.3 (100), 225.1 (12), 176.1 
(23), 154.1 (25), 91.5 (73); C41H34S20 4Na calculated 654.1899, observed 654.1902 
m.p = 81 -8 2  °C.
IR vmax KBr/cm'1 1732 (C=0), 1597 (aromatics), 1508 (aromatics), 1491 (aromatics), 
758 (aromatics).
Rf = 0.76 [silica, petroleum ether (40 - 60 °C):EtOAc (4:1)].
2-r2VTriphenylphosphonium iodidelethvllphenyl 3 ” .4” -dibenzyloxybenzoate 
210
.OBn
OBn
Acid 146 (756.0 mg, 2.26 mmol, 1.1 eq) was added to a stirring solution of salt 262 
(1.00 g, 2.06 mmol, 1 eq), EDCI (552.0 mg, 2.88 mmol, 1.4 eq) and DMAP (25.0 mg, 
0.21 mmol, 0.1 eq) in dry DCM (3.5 mL) at room temp, under argon. The solution 
was stirred for 24 h, diluted with DCM (100 mL), washed with saturated sodium 
bicarbonate (2 x 100 mL), water (2 x 100 mL), brine (2 x 100 mL), dried (M gS04) 
and concentrated under reduced pressure to give the crude ester (1.24 g, 75.0 %) as an 
off white powder. A sample was recrystallised from EtOH for analysis.
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5^ (400 MHz: CDCl^
2.86-2.92 (m, 2H, ArCH2), 3.81-3.88 (m, 2H, -CH2P), 5.21 (s, 2H, -OCH2), 5.36 (s, 
2H, -OCH2), 6.97-6.99 (m, 1H, Ar-//), 7.03 (d, 1H, J = 8.3 Hz, tf-5 ” ), 7.25-7.73 (m, 
23H, Ar-H), 1.61-111  (m, 6H, Ar-H), 7.87-7.88 (m, 1H, Ar-H).
5^ nOO MHz: CDC1A
22.36 (CH2), 23.91 (d, J = 48.2 Hz, CH2), 70.73 (CH2), 71.19 (CH2), 113.36 (CH),
115.78 (CH), 117.32 (d, J = 86.2 Hz, C), 121.14 (C), 122.22 (CH), 124.93 (CH), 
127.13 (CH), 127.36 (CH), 128.04 (CH), 128.20 (CH), 128.56 (CH), 128.70 (CH),
130.06 (CH), 130.22 (CH), 130.38 (d, J = 12.7 Hz, CH), 131.71 (CH), 133.57 (d, J =
10.0 Hz, CH), 135.01 (d, J = 3.1 Hz, CH), 136.27 (C), 136.53 (C), 148.38 (C), 148.52 
(C), 153.61 (C), 164.83 (C).
MS m/z (FAB+) 699.6 [(M-I)+, 100 %), 608.5 (16), 607.5 (15), 489.4 (12), 289.3 (13),
262.2 (41), 183.1 (16), 91.5 (37); C^H^O.P calculated 699.2664, observed 699.2664 
Microanalysis C47H40O4PI requires C 68.29 %, H 4.88 %, I 15.35 %, found C 68.26 
% ,H  4.78% , I 15.44%.
IR vmax (golden gate) 2920 (CH2), 2864 (CH2), 1728 (ester), 1597 (aromatics), 1583 
(aromatics), 1506 (aromatics), 1437 (P-Ph), 739 (aromatics). 
mp = 170 °C (dec.).
2,-r(AllyDphenyllbenzoate 229
Benzoyl chloride (19.1 mL, 164.0 mmol, 1.1 eq) was added slowly to a stirring 
solution of 2-allylphenol 151 (20.0 g, 149.1 mmol, 1 eq) in a 50:50 mixture of 
DCM:pyridine (140 mL) at room temp, under nitrogen. The mixture was stirred at 
room temp, for 5 h then extracted into EtO Ac (400 mL), washed with 1 M HC1 (200 
mL), saturated sodium bicarbonate (200 mL), dried (M gS04) and concentrated under 
reduced pressure to give the crude ester (34.2 g, 96.3 %) as an orange oil.
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^j(400NfflzLCDCl2)
3.36 (d, 2H, J = 6.6 Hz, ArCH2), 4.99 (dd, 1H, J = 1.6 Hz, 10.2 Hz, -CH=C//cisH),
5.03-5.05 (m, 1H, -CH =C//transH), 5.92 (tdd, 1H, J = 6.6 Hz, 10.3 Hz, 16.8 Hz, - 
C//=CH2), 7.17 (dd, 1H, J = 1.7 Hz, 7.8 Hz, H-6), 7.24 (dd, 1H, J = 1.7 Hz, 7.0 Hz, H- 
3), 7.29 (dt, 2H, J = 2.0 Hz, 7.6 Hz, H-4 + H-5), 7.51 (dt, 2H, J = 1.6 Hz, 7.7 Hz, Ar- 
H ), 7.64 (t, 1H, J = 7.4 Hz, H -), 8.20-8.22 (m, 2H, Ar-//).
2-(2,-Trimethylsilyloxybenzy0-1.3-dithiane 235
OTMS
S S
Chlorotrimethylsilane (3.22 mL, 25.4 mmol, 2 eq) was added dropwise to a stirring 
solution of 238 (2.88 g, 12.7 mmol, 1 eq) in dry pyridine (50 mL) at room temp, 
under argon. Stirring was continued for 17 h before extracting into ether (500 mL). 
The organics were washed with water (2 x 400 mL), 0.5 M copper sulfate solution (2 
x 500 mL), water (2 x 400 mL), brine (400 mL), dried (M gSOJ and concentrated 
under reduced pressure to give the title compound (3.35 g, 88.4 %). No further 
purification was required.
ga (400 MHz: CDCU
0.31 (s, 9H, -SiCtf3), 1.83-1.90 (m, 1H, -SCH2C//H), 2.07-2.13 (m, 1H, -SCH2CH//),
2.81-2.83 (m, 4H,-SC//2CH2), 3.00 (d, 2H, J = 7.4 Hz, Ar-CH2), 4.33 (t, 1H, J = 7.4 
Hz, ArCH2C/7), 6.80 (dd, 1H, J = 1.0 Hz, 8.0 Hz, H-3’), 6.90 (dt, 1H, J = 1.1 Hz, 7.4 
Hz, H-5’), 7.14 (dt, 1H, J = 1.8 Hz, 7.7 Hz, H-4 ’), 7.19 (dd, 1H, 1.7 Hz, 7.5 Hz, H-6’). 
5^ (TOO MHz: CDC1T
0.52 (CH3), 25.87 (CH2), 30.36 (CH2), 36.79 (CH2), 47.08 (CH), 118.56 (CH), 120.93 
(CH), 128.06 (CH), 128.13 (C), 131.24 (CH), 154.60 (C).
MS m/z (EI+) 298.1 (M+, 13 %), 119.0 (100), 73.0 (13); C14H 22OS2Si calculated 
298.0881, observed 298.0880.
Microanalysis C14H22OS2Si requires C 56.18 %, H 7.41 %, S 21.69 %, found C 56.31 
%, H 7.41 %, S 21.43%.
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IR vmax (neat) 2954 (CH2), 2898 (CH2), 1601 (aromatics), 1583 (aromatics), 1491 
(aromatics), 1431 (CH2), 1188 [Si(CH3)3], 1101 (Si-O), 756 (aromatics).
2-r2’. 2,-bislPhenylsulfanynethyl1phenol 237
Boron trifluoride diethyletherate (0.22 mL, 1.69 mmol, 1 eq) was added to a stirring 
solution of benzofuran 239 (200 mg, 1.69 mmol, 1 eq), thiophenol (0.36 mL, 3.38 
mmol, 2 eq) and trifluoroacetic acid (0.13 mL, 1.69 mmol, 1 eq) in DCM (1.7 mL) at 
room temp, under nitrogen. The solution was stirred for 26 h then quenched with 
saturated aqueous bicarbonate (4 mL). The mixture was extracted with EtOAc (10 
mL), which was then washed with saturated aqueous bicarbonate (2 x 30 mL), dried 
(M gS04) and concentrated under reduced pressure to give the crude mixture (251.2 
mg) as an orange oil. ]H NMR of the mixture showed essentially no desired product.
Alternative procedure:
Ozone (oxygen flow = 70, voltage = 120) was bubbled through a solution of 2- 
allylphenol 151 (1.00 g, 7.45 mmol, 1 eq) in DCM (37.2 mL) at -78  °C until all of the 
phenol was consumed (tic -  approximately 2.5 h). Oxygen was bubbled through the 
solution for 30 min while being allowed to warm to 0 °C. Triphenylphosphine (2.93 g,
11.2 mmol, 1.5 eq) was added and the solution was stirred at 0 °C for 30 min after 
which a vacuum was applied at 0 °C for 5 min to remove formaldehyde. Thiophenol 
(1.68 mL, 16.4 mmol, 2.2 eq) and freshly prepared MgBr2.OEt2 (2 M in Et20 , 4.81 g,
18.6 mmol, 2.5 eq) were added, the ice-bath was removed and the solution was stirred 
at room temp, for 19 h. The reaction mixture was quenched with saturated bicarbonate 
(75 mL) and extracted into EtOAc (150 mL). The aqueous layer was re-extracted with 
EtOAc (75 mL) and the combined organics were washed with bicarbonate (200 mL), 
dried (M gS04) and concentrated under reduced pressure to give the crude thioacetal 
as a brown oil. Purification by column chromatography [silica, eluting petroleum
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ether (40 -  60 °C):EtOAc (4:1)] gave the pure thioacetal (720 mg, 28.5 %) as a clear 
colourless glass.
8g (400 MHz: CDCU
3.22 (d, 2H, J = 7.0 Hz, ArCH2), 4.74 (t, 1H, J = 7.0 Hz, PhSCHSPh), 5.25 (s, 1H, - 
OH), 6.76 (d, 1H, J = 8.0 Hz, H-6), 6.87 (dt, 1H, J = 1.0 Hz, 7.5 Hz, H-4), 7.09-7.15 
(m, 2H, H-3, tf-5), 7.20-7.29 (m, 6H, Ar-H), 7.36-7.39 (m, 4H, Ar-tf). 
go n o o  MHz: CDCU
38.04 (CH2), 58.52 (CH), 116.13 (CH), 120.96 (CH), 124.61 (C), 127.70 (CH),
128.50 (CH), 128.95 (CH), 132.00 (CH), 132.61 (CH), 134.33 (C), 154.03 (C).
MS m/z (EI+) 229.1 (M+ , 44 %), 228.1 (20), 135.1 (100), 118.1 (52), 110.1 (46), 91.1 
(44), 65.1 (12), 32.0 (11); C20H22S2O calculated 338.0799, observed 338.0796.
2-(2,-HydroxvhenzyP-1.3-dithiane 238
Boron trifluoride diethyletherate (0.22 mL, 1.69 mmol, 1 eq) was added to a stirring 
solution of benzofuran 239 (200 mg, 1.69 mmol, 1 eq), 1,3-propanedithiol (0.17 mL, 
1.69 mmol, 1 eq) and trifluoroacetic acid (0.13 mL, 1.69 mmol, 1 eq) at room temp, 
under nitrogen. The solution was stirred for 24 h then diluted with DCM (10 mL). The 
solution was washed with saturated aqueous bicarbonate (30 mL), dried (M gS04) and 
concentrated under reduced pressure to give the crude mixture (101.4 mg) as a yellow 
oil. ]H NMR of the mixture showed essentially no desired product.
Alternative procedure:
Trifluoroacetic acid (18.8 mL, 247.0 mmol, 6 eq) was added dropwise to a suspension 
of alcohol 249 (10.00 g, 41.2 mmol, 1 eq) in triethylsilane (26.2 mL, 164.6 mmol, 4 
eq) at -10  °C. The reaction was stirred at this temp, for 1 h, diluted with DCM (500 
mL), washed with water (400 mL), brine (2 x 300 mL), dried (M gS04) and
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concentrated under reduced pressure to give the crude title compound  (10.04 g). 
Purification by column chromatography on silica eluting DCM gave the thioacetal 
(2.88 g, 30.8 %) as a white amorphous solid.
ga (400 MHz: CDCU
1.79-1.94 (m, 1H,), 2.03-2.12 (m, 1H,), 2.81-2.84 (m, 4H, ), 3.09 (d, 2H, J = 7.4 Hz, 
Ar-CH2), 4.38 (t, 1H, J = 7.4 Hz, ArCH2CH), 6.76 (d, 1H, J = 8.0 Hz, H-3’), 6.87 (t, 
1H, J = 7.4 Hz, H-5’), 7.10-7.22 (m, 2H, H-4’ + tf-6 ’).
5^ COO MHz: CDCU
25.61 (CH2), 30.03 (CH2), 36.43 (CH2), 46.69 (CH), 115.65 (CH), 120.55 (CH), 
123.92 (C), 128.30 (CH), 131.47 (CH), 153.69 (C).
MS m/z (EI+) 226.0 (M+ , 60 %), 119.0 (100), 91.1 (41), 77.0 (27), 75.0 (17), 45.0 
(22); CnH14OS2 calculated 226.0486, observed 226.0485.
Microanalysis C, jH ^ C ^  requires C 58.37%, H 6.23 %, S 28.33 %, found C 58.49%, 
H 6.24 %, S 28.43 %. 
m p=  1 1 7 - 118 °C.
(a. 2,-dihvdroxyhenzyl)-1.3-dithiane 249
«-Butyllithium (2.5 M in hexanes, 100.0 mL, 250.0 mmol, 2.1 eq), was added 
dropwise to a solution of 1,3-dithiane 247 (30.06 g, 250.0 mmol, 2.1 eq) in THF (300 
mL) at 0 °C under argon. The solution was allowed to warm to room temp, and stirred 
for 1 h then cooled to -78  °C and salicylaldehyde 248 (12.70 mL, 119.05 mmol, 1 eq) 
was added slowly. The resulting yellow solution was allowed to warm to room temp, 
over 2 h, diluted with DCM (500 mL), washed with 10 % sodium bisulfite (2 x 500 
mL) and 2 M KOH (2 x 400 mL). The aqueous layer was extracted with DCM (2 x 
500 mL), acidified with 2 M HC1, extracted into DCM (2 x 500 mL), dried (M gS04) 
and concentrated under reduced pressure to give the thioacetal (26.18 g, 90.8 %) as a
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yellow solid. Recrystallisation from i-PrOH gave the pure thioacetal (24.1 g, 83.5 %) 
as off-white fine needles.
Sp (400 MHz: CDCM
1.98-2.13 (m, 2H, -Ctf2), 2.67-2.73 (m, 2H, -C tf2), 2.96-3.02 (m, 2H, -C //2), 3.80 (br 
s, 1H, ArCH-O//), 4.14 (d, 1H, J = 8.7 Hz, -SCHS), 5.04 (d, 1H, J = 8.7 Hz, ArCH- 
OH), 6.85-6.89 (m, 2H, tf-3 ’ + H -5’), 7.12 (dd, 1H, J = 1.6 Hz, 8.0 Hz, tf-6 ’), 7.22 
(dt, 1H, J = 1.6 Hz, 7.7 Hz, H-4 ’), 7.64 (br s, 1H, A r-0H).
5 . (100 MHz: CDCU
25.00 (CH2), 26.42 (CH2), 27.11 (CH2), 49.87 (CH), 74.97 (CH), 117.40 (CH), 119.59 
(CH), 123.02 (C), 129.52 (CH), 129.73 (CH), 155.35 (C).
MS m/z (EI+) 242.1 (M+ , 0.8 %), 119.0 (100), 77.1 (11); CnH 140 2S2 calculated 
242.0435, observed 242.0434.
Microanalysis CnH 140 2S2 requires C 54.51 %, H 5.82 %, S 26.46 %, found C 54.53 
%, H 5.83 %, S 26.63 %.
IR v™, (golden gate) 3491 (OH), 3182 (OH), 2958 (CH2), 2931 (CH2), 2889 (CH2), 
1597 (aromatics), 1504 (aromatics). 
m p=  139 .8 - 140.1 °C.
Rf = 0.14 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
2-Phenvl-4H-chromene 203a
Ph
Titanocene dichloride (956.1 mg, 3.84 mmol, 4 eq), magnesium turnings (102.6 mg,
4.22 mmol, 1.1 eq), and 4 A molecular sieves (200 mg) were warmed with stirring 
under vacuum. The mixture was allowed to cool under vacuum and flushed with 
argon. Triethylphosphite (1.38 mL, 8.06 mmol, 2.1 eq) and dry THF (5 mL) were 
added and stirring was continued for 3 h. A solution of thioacetal 235 (287.4 mg, 0.96 
mmol, 1 eq) in dry THF (4 mL) was added and the mixture was stirred for a further 15 
min before being syringed into a flask containing the Merrifield resin bound benzoate 
ester 251a (0.311 mequiv/reactor prepared from 170 mg of commercial Merrifield 
resin with a loading of 1.83 mequiv (of benzylic chloride)/g) in 2 porous
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polypropylene reactors in dry THF (6 mL) under argon. The mixture was stirred 
overnight at room temp, and the reactors were washed with THF (x 4), alternate 
MeOH/DCM (x 4), ether and dried under vacuum. A 1 % solution of TFA in DCM (5 
mL) was added to each reactor, followed by shaking for 30 min. Concentration under 
reduced pressure, gave the crude mixture (6.5 mg) as a solid. Spectral data showed no 
product.128
2-Phenylethvl-4H-chromene 203b
Procedure as above gave the crude mixture (13.8 mg) as a brown solid. Spectral data 
indicated at least 4 compounds. Purification was unsuccessful.
2,-(Hydroxy)-2-phenylethyl alcohol 258
Ozone (oxygen flow = 70, voltage = 120) was bubbled through a solution of 151 (3.50 
g, 37.3 mmol, 1 eq) in EtOH (140 mL) at -78 °C until all starting material had been 
consumed (tic, approx. 7 h). Oxygen was bubbled through the solution for 10 min and 
NaBH4 (2.82 g, 74.5 mmol, 2 eq) was added. The solution was stirred at room temp, 
overnight then acidified to pH 3 with 2 M HC1 and extracted into DCM (2 x 250 mL), 
dried (M gS04) and concentrated under reduced pressure to give the alcohol (3.43 g,
95.3 %) as a colourless oil. ]H NMR in agreement with published data.
ga 1400 MHz: CDCU
2.90 (t, 2H, J = 5.3 Hz, ArCH2), 3.99 (t, 2H, J = 5.3 Hz, -CH2C //2OH), 6.86 (dt, 1H, J 
= 1.1 Hz, 7.4 Hz, H A ),  6.91 (dd, 1H, J = 0.9 Hz, 8.0 Hz, H-6), 7.06 (dd, 1H, J = 1.6 
Hz, 7.5Hz, H-3), 7.15 (dt, 1H, J = 1.6 Hz, 7.7 Hz, H-5).
150
2-(2*-Hydroxyphenyl)ethyl iodide 259
Triphenylphosphine (23.46 g, 89.5 mmol, 1.2 eq), imidazole (6.09 g, 89.5 mmol, 1.2 
eq) and iodine (22.71 g, 89.5 mmol, 1.2 eq) were added in that order to a stirring 
solution of alcohol 258 (10.30 g, 74.6 mmol, 1 eq) in dry DCM (340 mL) at room 
temp., under argon. After 18 h, the mixture was washed with water (200 mL), 10 % 
aqueous sodium thiosulfate solution (2 x 150 mL), dried (M gS04) and concentrated 
under reduced pressure to give the crude iodide as a yellow solid. Purification by 
column chromatography [silica, eluting petroleum ether (40 -  60 °C):EtOAc (2:1)] 
gave the pure iodide (14.30 g, 77.3 %) as a white amorphous solid pure enough for 
the next step. A sample was recrystallised from hexane for analysis.
8n 1400 MHz: CDCU
3.21 (t, 2H, J = 7.7 Hz, ArCH2), 3.40 (t, 2H, J = 7.8 Hz, -CH21), 4.75 (s, 1H, -OH),
6.73 (dd, 1H, J = 0.7 Hz, 7.9 Hz, H-3’), 6.89 (dt, 1H, J = 1. 0 Hz, 7.5 Hz, H-5’), 7.11-
7.17 (m, 2 H ,tf-4 ’ + H -6 ’).
5 . Q00 MHz-.CDCM
4.77 (CH2), 35.14 (CH2), 115.47 (CH), 121.03 (CH), 127.09 (C), 128.21 (CH), 130.66 
(CH), 153.29 (C).
MS m/z (EI+) 248.0 (M+ , 22 %), 121.1 (100), 103.1 (22), 91.1 (17), 77.1 (17); C8H9OI 
calculated 247.9698, observed 247.9698.
Microanalysis C8H9OI requires C 38.74 %, H 3.66 %, I 51.16 %, found C 38.73 %, H
3.65 %, I 51.24%.
IR V max (neat) 3512 (OH), 2960 (CH2), 2931 (CH2), 2852 (CH2), 1608 (aromatics), 
1591 (aromatics), 1500 (aromatics), 752 (aromatics). 
mp = 3 9 - 4 0  °C.
Rf = 0.55 [silica, petroleum ether (40 -  60 °C:EtOAc (2:1)].
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2-(2,-Hydroxyphenyl)ethyl triphenylphosphonium iodide 262
Triphenylphosphine (2.36 g, 8.99 mmol, 1 eq) was added to a solution of iodide 259 
(2.23 g, 8.99 mmol, 1 eq) in dry toluene (15.8 mL) at room temp, under nitrogen. The 
resulting mixture was heated to reflux for 16 h. The mixture was cooled to room 
temp, and the toluene was decanted. The remaining oil was washed with toluene and 
dried under vacuum to give the phosphonium salt (3.53 g, 80.8 %) as a white foam. 
No further purification was required.
ga 1400 MHz: CDCU
2.82-2.88 (m, 2H, A tCH2), 3.41-3.48 (m, 2H, -CH2P), 6.57 (dt, 1H, J = 0.8 Hz, 7.4 
Hz, H-5’), 6.91-6.94 (m, 2H, H-3’ + H-4 ’), 7.42 (d, 1H, J = 7.8 Hz, / /-6 ’), 7.69-7.83 
(m, 15H, Ar-H), 8.28 (br s, 1H, OH).
5 . (TOO MHz: CDCU
22.72 (d, J = 47.9 Hz, CH2), 24.78 (CH2), 117.13 (CH), 117.73 (d, J = 85.6 Hz, C),
119.78 (CH), 124.32 (C), 128.70 (CH), 129.50 (CH), 130.60 (CH), 130.73 (CH), 
133.45 (CH), 133.55 (CH), 135.25 (CH), 135.27 (CH), 154.95 (c).
MS m/z (EI+) 382.1 [(M-HI)+, 11 %), 305.1 (19), 262.1 (100), 261.1 (15), 183.0 (51),
108.0 (19), 91.1 (10); C26H23OP calculated 382.1487, observed 382.1485.
IR vmax (neat) 3209 (OH), 2877 (CH2), 1589 (aromatics), 1500 (aromatics), 1437 (P- 
Ph), 733 (aromatics).
1-Allvl -2-ftert-butvldimethvlsilyloxy)benzene 263
tert-Butyldimethylchlorosilane (6.18 g, 41.0 mmol, 1.1 eq) was added to a stirring 
solution of 2-allylphenol 151 (5.00 g, 37.3 mmol, 1 eq), DMAP (0.455 g, 3.73 mmol, 
0.1 eq) and triethylamine (7.79 mL, 55.9 mmol, 1.5 eq) in dry DCM (110 mL). The
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solution was stirred at room  temp., under argon for 18 h and tert- 
butyldimethylchlorosilane (3.04 g, 0.54 eq) was added. The solution was left to stir at 
room temp, for a further 3.5 h at which point the solution was washed with brine (100 
mL), water (100 mL), brine (100 mL), dried (M gS04) and concentrated under reduced 
pressure to give the title compound (10.62 g) as a green runny oil. Purification by 
column chromatography (silica, eluting pentane) gave the pure title compound129 (8.00 
g, 86.4 %) as a colourless runny oil. Spectral data similar to published data.129
gu 1400 MHz: CDCM
0.21 (s, 6H, -S iC /y , 0.99 (s, 9H, -C(CH3)3), 3.35 (d, 2H, J = 6.5 Hz, Ar-CH2), 4.99-
5.03 (m, 2H, -CH=Ctf2), 5.95 (tdd, 1H, J = 6.5 Hz, 9.4 Hz, 16.0 Hz, -Ctf=CH2), 6.77 
(d, 1H, J = 8.0 Hz, H-3), 6.86 (dt, 1H, J = 0.6 Hz, 7.4 Hz, H-5), 7.05 (dt, 1H, J = 1.7 
Hz, 7.7 Hz, H-4), 7.11 (dd, 1H, J = 1.5 Hz, 7.5 Hz, H-6).
5 . (100 MHz: CDCU
-4.15 (CH3), 18.26 (C), 25.81 (CH3), 34.44 (CH2), 115.42 (CH2), 118.41 (CH), 121.08 
(CH), 127.03 (CH), 130.14 (CH), 130.68 (C), 137.05 (CH), 153.35 (C).
MS m/z (EI+) 191.1 (M+ , 100 %), 163.1 (40), 149.0 (22), 147.1 (10), 86.0 (18), 84.0
(26), 73.1 (11); C^H^OSi calculated 248.1596, observed 248.1957.
IR vmax (neat) 3076 (C=CH2), 2958 (CH2), 2931 (CH*), 1599 (aromatics), 1583 
(aromatics), 1491 (aromatics), 1390 [C(CH3)3], 1362 [C(CH3)3], 1255 [Si(CH3)2], 
1007 (Si-O), 839 [Si(CH3)2], 756 (aromatics).
Rf = 0.61 [silica, pentane].
1-Allvl -2-(fert-butyldiphenylsilyloxv)benzene 264
^ ^ .O T B D P SOCX
te/t-Butyldiphenylchlorosilane (2.09 mL, 8.1 mmol, 1.08 eq) was added to a stirring 
solution of 2-allylphenol 151 (1.00 g, 7.5 mmol, 1 eq), DMAP (0.019 g, 0.8 mmol, 
0.1 eq) and imidazole (0.548 g, 8.1 mmol, 1.08 eq) in dry DCM (14.9 mL) at room 
temp, under argon. The solution was stirred at room temp, for 3 d, diluted with DCM 
(50 mL), washed with brine (100 mL), water (100 mL), brine (100 mL), dried
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(M gS04) and concentrated under reduced pressure to give the crude mixture (3.81 g) 
as a colourless oil. Purification by filtration through a plug of silica eluting petroleum 
ether (40 -  60 °C), gave the pure silyl ether (2.04 g, 73.5 %) as a colourless oil.
^  f400 MHz: CDCM
1.09 (s, 9H, -C(Ctf3)3), 3.58 (d, 2H, J = 6.4 Hz, A tC H 2), 5.08-5.13 (m, 2H, - 
CH=Ctf2), 6.11 (tdd, 1H, J = 6.5 Hz, 9.9 Hz, 16.7 Hz, -Ctf=CH2), 6.41 (dd, 1H, J =
1.3 Hz, 7.8 Hz, H-3), 6.77 (dt, 1H, J = 2.0 Hz, 7.6 Hz, H-4), 6.81 (dt, 1H, J = 1.3 Hz,
7.3 Hz, H-5), 7.15 (dd, 1H, J = 1.9 Hz, 7.3 Hz, H-6), 7.34-7.44 (m, 6H, Ar-H), 7.71 
(dd, 4H, J = 1.4 Hz, 7.9 Hz, Ar-H).
5.(1 0 0  MHz: CDCU
19.49 (C), 26.54 (CH3), 34.69 (CH2), 115.48 (CH2), 118.77 (CH), 120.93 (CH),
126.79 (CH), 127.78 (CH), 129.86 (CH), 130.03 (CH), 132.73 (C), 135.41 (CH),
137.12 (CH), 153.13(C).
MS m/z (EI+) 315.1 (M+ , 100 %), 287.1 (22), 237.1 (100), 211.1 (69), 197.0 (31),
165.1 (25), 135.1 (10), 105.0 (26), 91.1 (37), 82.9 (17); C25H 28OSi calculated 
372.1909, observed 372.1910.
IR vmax (neat) 3072 (C=CH2), 2958 (CH2), 2931 (CH2), 1599 (aromatics), 1583 
(aromatics), 1491 (aromatics), 1390 [C(CH3)3], 1362 [C(CH3)3], 1043 (Si-O), 756 
(aromatics), 702 (aromatics).
Rf = 0.16 [silica, petroleum ether (40 -  60 °C)].
1-Allyl -2-(triisopropylsilyloxy)benzene 265
OTIPS
By the published procedure,104 triisopropylchlorosilane (2.39 mL, 11.2 mmol, 1.5 eq) 
was added to a stirring solution of 2-allylphenol 151 (1.00 g, 7.5 mmol, 1 eq), DMAP 
(0.091 g, 0.8 mmol, 0.1 eq) and triethylamine (1.46 mL, 11.2 mmol, 1.5 eq) in dry 
DCM (10 mL) at room temp, under argon. The solution was stirred at room temp, for 
5 d, washed with brine (50 mL), water (50 mL), brine (50mL), dried (M gS04) and 
concentrated under reduced pressure to give the title compound (2.57 g). Purification
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by filtration through a plug of silica eluting petroleum ether (40 -  60 °C) gave the 
silyl ether104 (1.94 g, 89.7 %) as a colourless oil. *H NMR data in agreement with 
published data.104
Sa 1400 MHz: CDCM
1.11 (d, 18H, J = 7.3 Hz, -Ctf3CH), 1.32 (sep, 3H, J = 7.5 Hz, CH3Ctf), 3.41 (d, 2H, J 
= 6.4 Hz, ArCff2), 5.04 (dd, 1H, J = 1.1 Hz, 10.2 Hz, -CH=Ctfcis), 5.05 (dd, 1H, J =
1.5 Hz, 17.0 Hz, -CH=CHtrans), 5.99 (tdd, 1H, J = 6.6 Hz, 10.3 Hz, 16.8 Hz, - 
CH=CH2), 6.79 (d, 1H, J = 8.1 Hz, H-3), 6.87 (t, 1H, J = 7.4 Hz, H-5), 7.06 (t, 1H, J = 
7.7 Hz, H-4), 7.13 (d, 1H, J = 7.4 Hz, H-6).
So (TOO MHz: CDCM
13.08 (CH), 18.08 (CH3), 34.58 (CH2), 115.35 (CH2), 117.89 (CH), 120.71 (CH),
126.97 (CH), 130.03 (CH), 130.25 (C), 137.09 (CH), 153.70 (C).
MS m/z (EI+) 290.2 (M+ , 34 %), 247.1 (62), 205.1 (100), 177.1 (98), 163.1 (40), 149.0 
(49), 135.0 (16), 115.1 (13); C18H30OSi calculated 290. 2066, observed 290.2065.
1581 (aromatics), 1491 (aromatics), 1387 [C(CH3)2],1107 (Si-O), 754 (aromatics). 
Rf = 0.39 [silica, petroleum ether (40 -  60 °C)].
2T2Vfert-ButyIdimethylsilyloxy)phenyriethyI alcohol 266
Ozone (oxygen flow = 70, voltage = 120) was bubbled through a solution of 263 (11.0 
g, 46.3 mmol, 1 eq) in EtOH (230 mL) at -78 °C until all starting material had been 
consumed (tic). Oxygen was bubbled through the solution for 15 min and NaBH4 
(3.45 g, 92.6 mmol, 2 eq) was added. The solution was stirred at room temp, 
overnight then acidified to pH 3 with 2 M HC1 and extracted into DCM (2 x 300 mL), 
dried (M gS04) and concentrated under reduced pressure to give the alcohol130 (11.68 
g, 100 %) as a colourless oil.
IR vmx (neat) 3076 (C=CH2), 2945 (CH2), 2893 (CH), 2868 (CH2), 1599 (aromatics),
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5I1 [400 MHz: CDCU
0.25 (s, 6H, S iC #3), 1.02 [s, 9H, -C(Ctf3)3], 2.88 (t, 2H, J = 6.5 Hz, -ArCH2), 3.83 (t, 
2H, J = 6.5 Hz, -CH2OH), 6.81 (d, 1H, J = 8.0 Hz, H-3’), 6.90 (dt, 1H, J = 0.8 Hz, 7.4 
Hz, H-5’), 7.11 (dt, 1H, J = 1.7 Hz, 7.7 Hz, H-4’), 7.17 (dd, 1H, J = 1.6 Hz, 7.4 Hz, 
t f - 6 ’).
fL aOO MHz: CDCU
-4.15 (CH3), 18.21 (C), 25.76 (CH3), 34.30 (CH2), 62.75 (CH2), 118.52 (CH), 121.20 
(CH), 127.55 (CH), 129.04 (C), 131.06 (CH), 153.86 (C).
MS m/z (CI+) 253.2 [(M+H)+, 100 %], 235.2 (33), 195.1 (18); C14H250 2Si calculated 
253.1624, observed 253.1623.
IR (neat) 3350 (OH), 2956 (CH2), 2931 (CH2), 1601 (aromatics), 1581 
(aromatics), 1493 (aromatics), 1390 [C(CH3)], 1361 [C(CH3)], 1255 [Si(CH3)2], 1009 
(Si-O), 837 [Si(CH3)2], 737 (aromatics).
Rf = 0.38 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
2T2,-(TriisopropylsilyIoxy)phenyllethyl alcohol 267
Ozone (oxygen flow = 70, voltage = 120) was bubbled through a solution of 265 (5.00 
g, 17.2 mmol, 1 eq) in EtOH (80 mL) at -78  °C until all starting material had been 
consumed (tic). Oxygen was bubbled through the solution for 15 min and NaBH4 
(1.30 g, 34.4 mmol, 2 eq) was added. The solution was stirred at room temp, 
overnight then acidified to pH 3 with 2 M HC1 and extracted into DCM (2 x 150 mL), 
dried (M gS04) and concentrated under reduced pressure to give the alcohol (4.96 g,
97.8 %) as a colourless oil.
gn 1400 MHz: CDCU
1.12 (d, 18H, J = 7.4 Hz, -CHCH3), 1.27-1.36 (m, 3H, -CHCH3), 2.92 (t, 2H, J = 6.6 
Hz, A tCH2), 3.85 (t, 2H, J = 6.6 Hz, -C //2OH), 6.82 (d, 1H, J = 8.1 Hz, H-3’), 6.88 
(dt, 1H, J = 1.1 Hz, 7.4 Hz, H-5’), 7.01 (dt, 1H, J = 1.8 Hz, 7.7 Hz, H-4 ’), 7.16 (dd, 
1H, J = 1.7 Hz, 7.4 H z ,//-6 ’).
OTIPS
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5^ aOO MHz: CDCM
13.03 (CH), 18.04 (CH3), 34.32 (CH2), 62.70 (CH2), 118.08 (CH), 120.84 (CH),
127.50 (CH), 128.51 (C), 131.04 (CH), 154.19 (C).
MS m/z (EI+) 294.2 (M+ , 4 %), 251.1 (100), 233.1 (27), 209.1 (100), 181.1 (94), 163.1 
(100), 149.1 (78), 131.1 (42), 103.1 (78), 75.0 (100), 61.0 (68), 59.0 (27); C17H30O2Si 
calculated 294.2015, observed 294.2016.
IR vmax (neat) 3348 (OH), 2945 (CH2), 2891 (CH2), 2868 (CH2), 1601 (aromatics), 
1581 (aromatics), 1491 (aromatics), 1113 (Si-O), 922 (Si-O), 737 (aromatics).
Rf = 0.40 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
2-r2,-(fer^Butyldimethylsily1oxy)phenvllethvl iodide 268
OTBS
Triphenylphosphine (6.10 g, 23.3 mmol, 1.2 eq), imidazole (1.58 g, 23.3 mmol, 1.2 
eq) and iodine (5.90 g, 23.3 mmol, 1.2 eq) were added in order to a stirring solution of 
alcohol 266 (4.89 g, 19.4 mmol, 1 eq) in dry DCM (80 mL) at room temp., under 
argon. After 16.5 h, the mixture was washed with water (200 mL), 10 % aqueous 
sodium thiosulfate solution (2 x 150 mL), dried (M gS04) and concentrated under 
reduced pressure to give the crude iodide (10.80 g) as a colourless oil. Purification by 
column chromatography [silica, eluting petroleum ether (40 - 60 °C)] gave the pure 
iodide (3.35 g, 47.7 %) as a colourless oil.
5^ (400 MHz: CDCh)
0.25 (s, 6H, -SiCH,), 1.03 (s, 9H, -C(CH3)3), 3.14-3.18 (m, 2H, ArCH2), 3.29-3.33 (m, 
2H, CH2CH2I) 6.79 (d, 1H, J = 8.0 Hz, H-3’), 6.89 (dt, 1H, J = 1.1 Hz, 7.4 Hz, H-5’), 
7.12-7.16 (m, 2H, H-4’ + tf-6 ’). 
jL tlOO MHz: CDCU
-4.15 (CH3), 4.45 (CH2), 18.15 (C), 25.77 (CH3), 36.04 (CH2), 118.50 (CH), 121.13 
(CH), 128.02 (CH), 130.36 (CH), 131.29 (C), 153.57 (C).
MS m/z (EI+) 306.0 (M+ , 20 %), 305.0 (100), 177.1 (100), 151.1 (18), 135.0 (15), 73.1
(27); C14H23OISi calculated 362.0563, observed 362.0566.
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Microanalysis C14H23OISi requires C 46.41 %, H 6.40 %, I 35.02 %, found C 46.63 
% ,H  6.49% , I 35.19%.
IR vmax (neat) 2956 (CH2), 2929 (CH2), 1599 (aromatics), 1581 (aromatics), 1491 
(aromatics), 1254 [Si(CH3)2], 1007 (Si-O), 839 [Si(CH3)2], 756 (aromatics).
Rf = 0.29 [silica, petroleum ether (40 -  60 °C)].
2-r2,-(TriisopropylsilvIoxy)phenyllethvl iodide 269
OTIPS
Triphenylphosphine (7.06 g, 26.9 mmol, 1.2 eq), imidazole (1.83 g, 26.9 mmol, 1.2 
eq) and iodine (6.84 g, 26.9 mmol, 1.2 eq) were added in order to a stirring solution of 
alcohol 267 (6.61 g, 22.4 mmol, 1 eq) in dry DCM (50 mL) at room temp., under 
argon. After 16.5 h, the mixture was washed with water (350 mL), 10 % aqueous 
sodium thiosulfate solution (2 x 250 mL), dried (M gS04) and concentrated under 
reduced pressure to give the crude iodide as a colourless oil. Purification by column 
chromatography [silica, eluting petroleum ether (40 - 60 °C)] gave the pure iodide 
(6.71 g, 73.9 %) as a colourless oil.
^  (400 MHz: CDCU
1.13 (d, 18H, J = 7.4 Hz, -CHCtf3), 1.27-1.36 (m, 3H, -CHCH3), 3.18-3.22 (m, 2H, 
Ar-CH2), 3.31-3.35 (m, 2H, -CH2Ctf2I), 6.79 (dd, 1H, J = 0.9 Hz, 8.2 Hz, H-3’), 6.87 
(dt, 1H, J = 0.7 Hz, 7.4 Hz, H-5’), 7.10-7.14 (m, 2H, H-4 ’ + H-6’).
5 . (100 MHz: CDCU
4.63 (CH2), 13.04 (CH), 18.09 (CH3), 36.22 (CH2), 118.14 (CH), 120.81 (CH), 127.99 
(CH), 130.38 (CH), 130.83 (C), 153.90 (C).
MS m/z (EI+) 404.1 (M+ , 14 %), 362.1 (34), 361.0 (100), 319.0 (28), 291.0 (18), 233.1 
(100), 191.1 (88), 163.1 (94), 149.1 (42), 135.0 (25), 84.0 (28), 59.0 (14); C17H29OSiI 
calculated 404.1032, observed 404.1034.
IR vmax (neat) 2943 (CH2), 2866 (CH2), 1599 (aromatics), 1581 (aromatics), 1489 
(aromatics), 1387 [C(CH3)2], 1130 (Si-O), 754 (aromatics), 451 (C-I).
Rf = 0.33 [silica, petroleum ether (40 -60  °C):EtOAc (4:1)].
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S -^ ’-Hydroxyphenyllpropionitrile 271 and dihvdrobenzofuran 260
Potassium cyanide (0.099 g, 1.52 mmol, 1.1 eq) was added to a stirring solution of 
iodide 268 (0.500 g, 1.38 mmol, 1 eq) in dry DMSO (4 mL) at room temp, under 
argon. The solution was stirred at room temp, for 19.5 h then poured into 0.02 M 
ferric chloride solution (25 mL) and extracted into DCM (25 mL). The aqueous layer 
was re-extracted with DCM (25 mL) and the combined organics were washed with 
water (2 x 25 mL), dried (M gS04) and concentrated under reduced pressure to give 
the crude mixture (272.2 mg) as a yellow oil. Purification by column chromatography 
on silica eluting petroleum ether (40 -  60 °C):EtOAc (6:1) gave compounds 260131 
and 271.
Data for 260:
^  1400 MHz: CDCU
3.18 (t, 2H, J = 8.8 Hz, A tCH2), 4.55 (t, 2H, J = 8.8 Hz, -CH2C tf20 ), 6.80-7.20 (m, 
4H, Ar-H).
Data for 271:
^  1400 MHz: CDCU
2.68 (t, 2H, J = 7.4 Hz, -CH2CN), 2.97 (t, 2H, J = 7.4 Hz, ArCH2), 5.48 (s, 1H, -OH),
6.74 (d, 1H, J = 8.0 Hz, H-3), 6.89 (dt, 1H, J = 1.0 Hz, 7.5 Hz, H A), 1.12-1.11 (m, 
2H, H-5 + H-6).
5^ COO MHz: CDCU
17.37 (CH2), 26.76 (CH2), 115.30 (CH), 119.69 (C), 120.93 (CH), 124.54 (C), 128.56 
(CH), 130.58 (CH), 153.64 (C).
MS m/z (EI+) 147 (M+ , 93 %), 146 (47), 107 (100), 91 (17), 77 (54), 63 (10), 51 (17); 
QHjNO calculated 147.0684, observed 147.0684.
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IR Vmax (neat) 3373 (OH), 2931 (CH2), 2854 (CH2), 2254 (CN), 1610 (aromatics), 
1595 (aromatics), 1504 (aromatics), 1458 (CH2), 756 (aromatics).
Rf = 0.19 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
3.4-bis(BenzyloxyM-iodobenzene 282
Benzyl bromide (6.30 mL, 53.5 mmol, 1.5 eq) was added to a solution of phenol 286 
(11.63 g, 35.7 mmol, 1 eq) and potassium carbonate (7.39 g, 53.5 mmol, 1.5 eq) in 
DMF (50 mL) at room temp. The mixture was heated to 80 °C for 2 d then allowed to 
cool. The solution was diluted with E^O (500 mL), washed with water (3 x 300 mL), 
dried (M gS04) and concentrated under reduced pressure to give the crude iodide (15.0 
g) as a brown solid. Recrystallisation from EtOH gave the pure iodide132 (12.36 g,
83.3 %) as a white powder. Melting point in agreement with the published data.
^  (400 MHz: CDCU
5.10 (s, 2H, -O C //2Ph), 5.11 (s, 2H, -OC//2Ph), 6.66 (d, 1H, J = 8.4 Hz, H-5), 7.18 
(dd, 1H, J = 2.0 Hz, 8.4 Hz, H-6), 7.22 (d, 1H, J = 2.0 Hz, H-2), 7.28-7.44 (m, 10H, 
Ar-H).
5 . (TOO MHz: CDCU
71.28 (CH2), 71.44 (CH2), 83.19 (C), 116.97 (CH), 123.89 (CH), 127.22 (CH), 127.36 
(CH), 127.89 (CH), 127.98 (CH), 128.50 (CH), 128.53 (CH), 130.50 (CH), 136.62 
(C), 136.83 (C), 149.03 (C), 149.91 (C).
MS m/z (EI+) 416.1 (M+ , 18 %), 91.1 (100); C20H]7O2I calculated 416.0273, observed 
416.0273.
Microanalysis C20H 17O2I requires C 57.71 %, H 4.12 %, found C 57.86 %, H 3.87 %. 
IR vmax (golden gate) 2935 (CH2), 2866 (CH2), 1574 (aromatics), 1495 (aromatics), 
1454 (aromatics).
mp = 62 - 63 °C [lit.132 65 -  67 °C (MeOH)].
Rf = 0.66 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
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1.2-bis(Benzyloxy)benzene 284
.OBn
OBn
Potassium carbonate (50.34 g, 363.3 mmol, 4 eq) was added to a solution of catechol 
283 (10.00 g, 90.8 mmol, 1 eq) and benzyl bromide (43.3 ml, 363.3 mmol, 4 eq) in 
DMF (100 ml) at room temp. The resulting mixture was heated to 80 °C for 18 h, 
after which the solution was cooled, acidified, extracted into ether (600 ml) and 
washed with 2 M KOH (300 ml). The organics were dried (M gS04) and concentrated 
under reduced pressure to give the crude ether as an orange/brown oil that crystallised 
on standing. Recrystallisation from MeOH gave the pure ether (14.66 g, 55.5 %) as a 
fluffy white solid.
8p f400 MHz: CDCU
5.12 (s, 4H, 2 x PhC//2), 6.83-6.94 (m, 4H, H-3, H-4, H-5, H-6), 7.25-7.43 (m, 10H, 
Ar-//)-
5.  flOO MHz: CDCU
71.18 (CH2), 115.16 (CH), 121.56 (CH), 127.22 (CH), 127.66 (CH), 128.37 (CH), 
137.29 (C), 148.94 (C).
MS m/z (EI+) 290.2 (M+, 15 %), 91.1 (100), 83.0 (14); C20H 18O2 calculated 290.1307, 
observed 290.1308.
Microanalysis C20H ]8O2 requires C 82.73 %, H 6.25 % found C 82.70 %, H 6.25 %. 
mp = 58 - 60 °C [lit.13360 -  61 °C].
IR vmax KBr/cm'1 2941 (CH2), 2882 (CH2), 1589 (aromatics), 1522 (aromatics), 1504 
(aromatics), 741 (aromatics).
Rf = 0.60 [silica, petroleum ether (40 - 60 °C):EtOAc (4:1)].
2-Benzyloxy-4-iodophenol 286
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By the published procedure110 a solution of iodine monochloride (23.2 g, 143 mmol,
1.43 eq) in dry ether (230 mL) was added dropwise to a solution of 2- 
benzyloxyphenol 285 (20.0 g, 99.8 mmol, 1 eq) in dry ether (100 mL) at room temp, 
under argon. The solution was shielded from the light and stirred at room temp 
overnight. The reaction mixture was diluted with ether (300 mL), washed with 10 % 
aqueous thiosulfate (3 x 300 mL), dried (M gS04) and concentrated under reduced 
pressure to give the crude iodide as a brown/red oil. The crude product was passed 
through a plug of silica eluting hexane:DCM (3:2), concentrated and recrystallised 
from ethenhexane to give the pure phenol110 (11.63 g, 36 %) as colourless crystals. ]H 
and 13C NMR agree with the published data.
gu 1400 MHz: CDCU
5.09 (s, 2H, -O C #2Ph), 5.64 (s, 1H, -OH), 6.73 (d, 1H, J = 8.1 Hz, H-6), 7.21-7.24 
(m, 2H, H-3 + H-5), 7.39-7.47 (m, 5H, Ar-H).
5.  (TOO MHz: CDCU
71.42 (CH2), 80.81 (C), 116.68 (CH), 121.08 (CH), 127.99 (CH), 128.66 (CH), 
128.81 (CH), 130.81 (CH), 135.61 (C), 145.94 (C), 146.67 (C).
r3.4-bis(Benzyloxy)benzvlltriphenylphosphonium bromide 287
Triphenylphosphine hydrobromide (404.9 mg, 1.18 mmol, 1 eq) was added to a 
solution of alcohol 289 (378 mg, 1.18 mmol, 1 eq) in acetonitrile (11.8 mL) at room 
temp, under argon. The solution was heated to reflux for 5 h then allowed to cool to 
room temp, and stirred overnight. The precipitate that formed was filtered to give the 
crude phosphonium salt (469 mg, 60.1 %) as a white powder. A sample was 
recrystallised from ethanol for analysis.
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^i400N fflz iC D a2)
4.77 (s, 2H, -O C//2Ph), 5.04 (s, 2H, -O C //2Ph), 5.21 (d, 2H, J = 13.8 Hz, -C tf2P),
6.56-6.60 (m, 1H, Ar-H), 6.65 (d, 1H, J = 8.3 Hz, Ar-H), 6.86-6.87 (m, 1H, Ar-H), 
7.23-7.37 (m, 10H, Ar-H), 7.55-7.74 (m, 15H, Ar-H). 
go 1100 MHz: CDCU
30.10 (d, J = 46.9 Hz, CH2), 70.57 (CH2), 70.82 (CH2), 114.79 (CH), 117.32 (d, J =
4.9 Hz, CH), 117.63 (d, J = 85.5 Hz, C), 124.32 (CH), 124.38 (CH), 127.09 (CH),
127.19 (CH), 127.53 (CH), 127.64 (CH), 128.17 (CH), 128.25 (CH), 129.92 (d, J =
12.5 Hz, CH), 134.22 (d, J = 9.7 Hz, CH), 134.74 (d, J = 2.7 Hz, CH), 136.67 (d, J = 
6.2 Hz, C), 148.48 (C), 148.52 (C), 148.63 (C), 148.67 (C).
IR v™, (golden gate) 2895 (CH2), 2871 (CH2), 2781 (CH2), 1597 (aromatics), 1585 
(aromatics), 1523 (aromatics), 1435 (P-Ph). 
mp = 230 °C (dec.).
3.4-bis(Benzyloxv)styrene 288
BnO 
BnO
rc-Butyllithium (2.5 M in hexanes, 43.2 mL, 108.05 mmol, 2 eq) was added dropwise 
to a suspension of methyltriphenylphosphonium bromide (38.60 g, 108.05 mmol, 2 
eq) in THF (240 mL) at -78 °C under argon. The bright yellow suspension was 
allowed to warm to room temp, and stirred for 2.5 h. The suspension was re-cooled to 
-78 °C and a solution of aldehyde 90 (17.20 g, 54.03 mmol, 1 eq) in THF (85 mL) 
was added slowly. The suspension was allowed to warm to room temp, and stirred for 
19 h. The reaction mixture was diluted with Et20  (1500 mL), washed with water (2 x 
750 mL), dried (M gS04) and concentrated under reduced pressure to give the crude 
styrene134 as an off-white solid. Purification by passing through a plug of silica eluting 
hexane/Et20  (3:1) gave the pure styrene (16.00 g, 93.6 %) as a fluffy white solid.
Sp 1400 MHz: CDCU
5.12 (dd, 1H, J = 0.7 Hz, 10.9 Hz, H cis), 5.16 (s, 2H, -O C//2Ph), 5.17 (s, 2H, - 
O C//2Ph), 5.55 (dd, 1H, J = 0.8 Hz, 17.5 Hz, H ^ J ,  6.60 (dd, 1H, J = 10.9 Hz, 17.5
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Hz, C//=CH2), 6.88 (d, 1H, J = 8.2 Hz, H-5), 6.92 (dd, 1H, J = 1.9 Hz, 8.3 Hz, H-6),
7.04 (d, 1H, J = 1.9 Hz, H-2), 7.26-7.38 (m, 10H, Ar-//).
S^XimMizLCDCla)
71.27 (CH2), 71.41 (CH2), 112.10 (CH2), 112.64 (CH), 114.89 (CH), 120.07 (CH), 
127.25 (CH), 127.35 (CH), 127.77 (CH), 127.80 (CH), 128.47 (CH), 131.44 (C), 
136.32 (CH), 137.23 (C), 137.27 (C), 148.92 (C), 149.02 (C).
MS m/z (EI+) 316.3 (M+, 65 %), 225.2 (21), 181.2 (21), 91.1 (100), 83.0 (16), 65.1
(16); C22H20O2 calculated 316.1463, observed 316.1464.
Microanalysis C22H320 2 requires C 83.52 %, H 6.37 %, found C 83.34 %, H 6.32 %.
IR vmax (golden gate) 3086 (alkene), 2937 (CH2), 2871 (CH2), 1599 (aromatics), 1549 
(aromatics), 1514 (aromatics), 1003 (alkene), 912 (alkene), 746 (aromatics). 
mp = 67 - 69 °C [lit.134 68 -  69 °C, EtOAc].
3.4-bis(Benzyloxy)benzyl alcohol 289
Lithium aluminium hydride (340.8 mg, 8.97 mmol, 1.5 eq) was added slowly to a 
solution of acid 146 (2.0 g, 5.98 mmol, 1 eq) in THF (20 mL) at 0 °C. The solution 
was allowed to warm to room temp, overnight then quenched with water (40 mL), 
extracted into EtOAc (40 mL) and washed with 1 M HC1 (20 ml). The aqueous layer 
was re-extracted with EtOAc (60 ml) and the combined organics were dried (M gS04) 
and concentrated under reduced pressure to give the crude alcohol (1.54 g, 80.2 %) as 
an amorphous solid. 3H NMR data in agreement with published data.135
^  f400 MHz: CDCU
4.49 (s, 2H, ArCH2), 5.11 (s, 4H, 2 x -OC//2Ph), 6.80 (dd, 1H, J = 1.9 Hz, 8.1 Hz, H- 
6), 6.87 (d, 1H, J = 8.2 Hz, H-5), 6.96 (d, 1H, J = 1.8 Hz, H-3), 7.25-7.35 (m, 10H,
Ar-//).
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1.3.5-tris(Acetoxy)benzene 294
OAc
Acetic anhydride (30.0 mL, 317.2 mmol, 4 eq) was added dropwise to a solution of 
phloroglucinol 100 (10.0 g, 79.3 mmol, 1 eq) in a 50:50 mixture of pyridine:DCM 
(100 mL). The resulting solution was stirred at room temp, for 45 mins, diluted with 
EtOAc (600 mL), washed with 1 M HC1 (300 mL), saturated sodium bicarbonate (300 
mL), dried (M gS04) and concentrated under reduced pressure to give the acetate52 
(19.06 g, 95.3 %) as a white solid sufficiently pure for the next step. A sample was 
recrystallised from i-PrOH to give the acetate as fine colourless needles.
5p 1400 MHz: CDCl^
2.28 (s, 9H, 3 x C tf3CO), 6.86 (s, 3H, 3 x Ar-H).
5^ 1100 MHz: CDC121
20.97 (CH3), 112.67 (CH), 151.04 (C), 168.45 (C).
MS m/z  (EI+) 252.1 (M+ , 8 %), 210.1 (20), 168.1 (35), 126.1 (100), 43.0 (42); 
C12H 120 6 calculated 252.0634, observed 252.0635.
Microanalysis C12H 120 6 requires C 57.14 %, H 4.79 % found C 57.12 %, H 4.87 %.
IR vmax (KBr) 1775 (ester), 1602 (aromatics). 
mp = 107 -  108 °C [lit.136 100 -  102 °C].
Rf = 0.76 (silica, EtOAc).
Benzyl 3.5-bislbenzyloxvlbenzoate 296
o
OBn
Benzyl bromide (30.8 mL, 259.5 mmol, 4 eq), was added to a solution of 3,5- 
dihydroxybenzoic acid 295 (10.00 g, 64.9 mmol, 1 eq), potassium carbonate (53.81 g,
389.3 mmol, 6 eq) and potassium iodide (1.08 g, 6.49 mmol, 0.1 eq) in DMF (150
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mL). The resulting mixture was stirred for 27 h before being quenched with EtOAc (2 
x 600 mL), washed with dilute aqueous ammonia (2 x 300 mL), water (3 x 300 mL), 
dried (M gS04) and concentrated under reduced pressure to give the ester111 (21.65 g,
78.6 %) as an oil that crystallised on standing.
ga 1400 MHz: CDCU
5.06 (s, 4H, -O C//2Ph), 5.34 (s, 2H, -C 02C //2Ph), 6.80 (t, 1H, J = 2.4 Hz, H-4), 7.27-
7.44 (m, 17H, H-2, H-6 + Ar-//).
5^ (TOO MHz: CDCU
66.85 (CH2), 70.32 (CH2), 107.21 (CH), 108.57 (CH), 127.58 (CH), 128.12 (CH), 
128.24 (CH), 128.58 (CH), 128.61 (CH), 132.02 (C), 135.93 (C), 136.43 (C), 159.78 
(C), 166.09 (C).
MS m/z  (EI+) 424.1 (M+, 18 %), 227.1 (10), 181.1 (12), 91.1 (100); C28H 240 4 
calculated 424.1675, observed 424.1671.
IR vmax (KBr) 1740 (C=0), 1632 (aromatics), 1599 (aromatics), 1524 (aromatics). 
mp = 57.0 -  57.5 °C (lit.111 63 -  66 °C benzene/hexane).
Rf = 0.91 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
3.5-bis(Benzyloxy)benzyl alcohol 297
OBn
Lithium aluminium hydride (671.0 mg, 17.7 mmol, 1.5 eq) was added slowly to a 
solution of ester 296 (5.00 g, 11.8 mmol, 1 eq) in dry THF (30 mL) at 0 °C under 
argon. The mixture was stirred for 2 h before being quenched with water (60 mL) and 
extracted into EtOAc (2 x 100 mL). The combined organics were washed with 2 M 
HC1 (40 mL), dried (M gS04) and concentrated under reduced pressure to give the 
crude alcohol111 (4.39 g) as a white solid. Recrystallisation from hexane/Et20  gave the 
pure alcohol (3.72 g, 98.7 %) as an amorphous solid.
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Sp (400 MHz: CDCU
4.60 (s, 2H, -C //2OH), 5.02 (s, 4H, PhCH2), 6.54 (t, 1H, J = 2.2 Hz, H-4), 6.61 (d, 2H, 
J = 2.1 Hz, H-2 + H-5), 7.29-7.41 (m, 10H, Ar-//). 
jL g o o  MHz: CDCU
65.22 (CH2), 70.03 (CH2), 101.27 (CH), 105.71 (CH), 127.48 (CH), 127.96 (CH), 
128.55 (CH), 136.79 (C), 143.40 (C), 160.12 (C).
MS m/z (CI+) 321.2 [(M + H)+, 38 %], 303.2 (24), 57.1 (100); C21H 210 3 calculated 
321.1491, observed 321.1493.
Microanalysis C2]H20O3 requires C 78.73 %, H 6.29 %, found C 78.42 %, 6.36 %.
IR vmax (golden gate) 3315 (OH), 2902 (CH2), 2866 (CH2), 1591 (aromatics), 1496 
(aromatics).
mp = 11 -  77.5 °C (lit.111 8 1 .5 -8 2  °C, benzene/hexane).
Rf = 0.20 [silica, petroleum ether (40 -  60 °C):EtOAc (2:1)]
3.5-bis(Benzyloxy)benzaldehyde 298
OBn
Manganese dioxide (5.24 g, 62.4 mmol, 40 eq) was added to a solution of alcohol 297 
(500.0 mg, 1.56 mmol, 1 eq) in DCM (10 mL). The mixture was stirred at room temp, 
for 30 h. The mixture was filtered through a short plug of celite, which was then 
washed with DCM (100 mL). The organics were concentrated to give the aldehyde111 
(404.0 mg, 81.3 %) as a white solid. No further purification was required.
Alternative procedure:
IBX (1.31 g, 4.68 mmol, 3 eq) was added to a solution of alcohol 297 (500.0 mg, 1.56 
mmol, 1 eq) in EtOAc (10 mL). The mixture was then heated to reflux for 4.5 h 
before being allowed to cool to room temperature. The mixture was filtered and the 
solid was washed with EtOAc (30 mL). The organics were concentrated under
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reduced pressure to give the aldehyde111 (475.8 mg, 95.8 %) as a white solid. No 
further purification was required.
Sp 1400 MHz: CDCU
5.08 (s, 4H, -OCZ/2Ph), 6.86 (t, 1H, J = 2.3 Hz, H-4), 7.10 (d, 2H, J = 2.3 Hz, H-2 + 
H-6), 7.31-7.43 (m, 10H, Ar-//), 9.88 (s, 1H, -C //0).
5 . (TOO MHz: CDCU
70.34 (CH2), 108.28 (CH), 108.65 (CH), 127.52 (CH), 128.19 (CH), 128.64 (CH),
136.19 (C), 138.39 (C), 160.35 (C), 191.77 (CH).
MS m/z (EI+) 318.1 (M+, 87 %), 181.1 (21) 91.1 (100), 65.0 (30); C ^H jA i calculated 
318.1256, observed 318.1257.
mp = 79.7 -  80.2 °C (lit.111 76.5 -  77 °C benzene/hexane).
Rf = 0.87 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
IR vmax (KBr) 1682 (CHO), 1623 (aromatics), 1581 (aromatics), 1498 (aromatics).
4.6-bis(BenzyIoxy)-2-hydroxybenzaIdehvde 300
OH O
Benzyl bromide (3.50 mL, 29.25 mmol, 3 eq) was added to a stirring solution of 
Phloroglucinaldehyde 299 (1.50 g, 9.75 mmol) and potassium carbonate (2.70 g, 19.5 
mmol, 2 eq) in DMF (25 mL) at room temp, under nitrogen. The resulting mixture 
was stirred at room temp, for 18 h then diluted with water (100 mL) and extracted 
with ether (100 mL). The combined organics were dried (M gS04) and concentrated 
under reduced pressure to give a dark red oil. Recrystallisation from MeOH (x 2) 
yielded the pure aldehyde (720 mg, 22 %) as fine red/orange crystals.
^  (400 MHz: CDCU
5.07 (s, 2H, -OC//2Ph), 5.08 (s, 2H, -OC//2Ph), 6.08 (d, 1H, J = 2.1 Hz, H-5), 6.11 (d, 
1H, J = 2.1 Hz, Z/-3), 1.33-1.40 (m, 10H, Ar-//), 10.18 (s, 1H, CZ/O), 12.50 (s, 1H, 
OH).
5 . tlOO MHz: CDCU
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70.46 (CH2), 70.52 (CH), 92.35 (CH), 94.13 (CH), 106.32 (C), 127.38 (CH), 127.63 
(CH), 128.38 (CH), 128.44 (CH), 128.74 (CH), 135.60 (C), 135.67 (C), 162.61 (C), 
166.31 (C), 167.09 (C), 191.93 (CH).
MS m/z (EI+) 334.1 (M+ , 12 %), 91.0 (100); C21H180 4 calculated 334.1205, observed 
334.1203.
Microanalysis C21H 180 4 requires C 75.43 %, H 5.43 %, found C 75.45 %, H 5.50 %.
IR vmax (KBr) 3433 (OH), 1644 (CHO), 1621 (aromatics), 1579 (aromatics), 1497
(aromatics).
mp = 9 1 - 9 2  °C.
Rf = 0.69 (silica, Et20).
2-Nitrophloroglucinol 307
OH
A mixture of concentrated nitric acid (0.8 mL) in 50 % sulphuric acid (5 mL) was 
added dropwise over 15 min to a suspension of phloroglucinol 100 (1.00 g) in 50 % 
sulphuric acid (15 mL) at 0 °C. The suspension was stirred for 6 h then diluted with 
water (50 mL). The solution was extracted with ether (2 x 100 mL) and the combined 
organics were washed with water (2 x 100 mL), dried (M gSOJ and concentrated 
under reduced pressure to give the crude title compound (616.5 mg, 45.3 %) as a red 
powder. lH  NMR spectrum identical to commercially available material apart from a 
small amount of starting material as impurity.
8a 1400 MHz: dr Acetonel
6.10 (s, 3H, Ar-H), 10.25 (br s, 1H, -OH), 11.14 (br s, 2H, -OH).
2.4.6-tris(Benzyloxy)-nitrobenzene 308
OBn
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Benzyl bromide (20.43 mL, 172.2 mmol, 6 eq) was added to a solution of 2- 
nitrophloroglucinol 307 (4.91 g, 28.7 mmol, 1 eq), potassium carbonate (23.8 g, 172.2 
mmol, 6 eq) and potassium iodide (476.3 mg, 2.87 mmol, 0.1 eq) in DMF (100 mL). 
The mixture was then heated to 80 °C for 11 d before being allowed to cool to room 
temp, and diluted with water (200 mL). The solution was extracted into Et20  (2 x 500 
mL) and the combined organics were washed with water (2 x 500 mL), dried 
(M gS04), and concentrated under reduced pressure to give the crude ether (14.23 g) 
as a brown/yellow oil that crystallised on standing. Recrystallisation from EtOH gave 
the pure title compound (10.02 g, 79.1 %) as fine yellow needles.
gp 1400 MHz: CDCU
4.98 (s, 2H, -O C//2Ph), 5.10 (s, 4H, -OC//2Ph), 6.23 (s, 2H, H-3 + H-5), 7.31-.7.41 
(m, 15H, Ar-H).
6 . (TOO MHz: CDCU
70.47 (CH2), 70.95 (CH2), 93.50 (CH), 126.96 (CH), 127.43 (CH), 128.15 (CH), 
128.35 (CH), 128.62 (CH), 128.71 (CH), 135.47 (C), 135.72 (C), 152.19 (C), 160.87 
(C).
MS m/z  (EI+) 441.3 (M+ , 15 %), 91.1 (100), 65.1 (10); C27H 23N 0 5 calculated 
441.1576, observed 441. 1577.
Microanalysis C27H23N 0 5 requires C 73.46 %, H 5.25 %, N 3.17 % found C 73.43 %, 
H 5.15 % ,N  3.15%.
IR vmax (golden gate) 1595 (aromatics), 1516 (aromatics), 1498 (aromatics), 1338 
(N 02).
m p=  119 .5 -120  °C.
Rf = 0.51 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
2.4.6-tris(BenzvIoxy)aniline 309
OBn
A suspension of iron powder (3.00 g, 53.71 mmol, 3 eq), ammonium chloride (4.79 g, 
89.51 mmol, 5 eq) and benzyl ether 308 (7.90 g, 17.90 mmol, 1 eq) in EtOH/H20
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(4:1, 500 mL) was heated to reflux for 44 h. The mixture was allowed to cool to room 
temp, and filtered through a plug of celite eluting EtOAc (300 mL). The filtrate was 
concentrated under reduced pressure and the residue was extracted into EtOAc (700 
mL), washed with water (400 mL), brine (2 x 400 mL), dried (M gS04) and 
concentrated under reduced pressure to give the crude aniline (7.00 g, 95.1 %) as a 
black powder. No further purification was required.
Sp 1400 MHz: CDCU
3.61 (br s, 2H, N tf2), 4.93 (s, 2H, -OC//2Ph), 5.04 (s, 4H, -OCtf2Ph), 6.38 (s, 2H, H-3 
+ H-5), 7.29-7.43 (m, 15H, Ai-H). 
fL OOP MHz: CDCU
70.65 (CH2), 70.85 (CH2), 94.47 (CH), 120.17 (C), 127.44 (CH), 127.50 (CH), 127.78 
(CH), 127.87 (CH), 128.44 (CH), 128.45 (CH), 137.00 (C), 137.23 (C), 146.97 (C), 
151.18(C).
MS m/z (EI+) 411.2 (M+, 45 %), 320.2 (45), 181.1 (10), 91.1 (100); C27H 25N 0 3 
calculated 411.1834, observed 411.1834.
Microanalysis C27H25N 0 3 requires C 78.81 %, H 6.12 %, N 3.40 % found C 78.65 %, 
H 6.04 % ,N  3.53 %.
IR vmax (golden gate) 3408 (NH2), 3332 (NH2), 1600 (aromatics), 1504 (aromatics). 
mp = 80 -  81 °C.
Rf = 0.53 [silica, petroleum ether (40 -  60 °C):EtOAc (2:1)].
1.3.5-tris(Tetrahydropvranyloxy)benzene 311
OTHP
Concentrated hydrochloric acid (2 drops) was added to a suspension of anhydrous 
phloroglucinol 100 (10.0 g, 79.3 mmol, 1 eq) in 2,3-dihydropyran (25.3 mL, 277.5 
mmol, 3 eq). The solution was stirred at room temp, for 67 h then diluted with Et20  
(800 mL). The combined organics were washed with 10 % KOH (500 mL) and brine 
(2 x 500 mL) then dried (M gS04) and concentrated under reduced pressure to gave
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the crude ether (30.68 g) as a yellow/orange viscous oil that crystallised slowly on 
standing. Recrystallisation from EtOH gave the pure ether (2:1 mixture of 
diastereomers, 13.53 g, 45.1 %) as a white amorphous solid.
gu 1400 MHz: CDCU
1.54-1.71 (m, 9H, -CH2), 1.80-1.86 (m, 6H, -CH2), 1.93-2.04 (m, 3H, -CH2), 3.58-
3.62 (m, 3H, -OCH2), 3.89-3.94 (m, 3H, -OCH2), 5.35-5.40 (m, 3H, -OCHO), 6.43 (s, 
3H, A t-H, minor), 6.44 (s, 3H, Ar-H, major).
(100 MHz: CDCU
18.68 (CH2), 18.73 (CH2), 18.78 (CH2), 25.19 (CH2), 30.30 (CH2), 61.92 (CH2), 61.98 
(CH2), 62.03 (CH2), 96.18 (CH), 96.35 (CH), 96.51 (CH), 98.47 (CH), 98.61 (CH),
98.73 (CH), 158.53 (C), 158.63 (C), 158.66 (C).
MS m/z (EI+) 378.3 (M+ , 5 %), 294.3 (15), 210.2 (71), 126.1 (100), 85.1 (100), 84.1 
(54), 57.1 (26); C21H30O6 calculated 378.2042, observed 378.2042.
Microanalysis C21H30O6 requires C 66.65 %, H 7.99 %, found C 66.76 %, H 8.01 %.
IR vmax (golden gate) 2937 (CH2), 2871 (CH2), 1599 (aromatics), 1549 (aromatics), 
1514 (aromatics). 
mp = 100 -  101 °C.
Rf = 0.74 [silica, Et2Oj.
l-Allyl-2.4.6-tris(tetrahydropyranyloxv)benzene 312
THPO V V 'O T H P
y C ,
OTHP
terf-Butyllithium (1.5 M in pentane, 1.76 mL, 2.64 mmol, 2 eq) was added dropwise 
to a solution of freshly dried acetal 311 (500 mg, 1.32 mmol, 1 eq) in THF (5 mL) at - 
78 °C under argon. The resulting yellow solution was allowed to slowly warm over 70 
min. then cooled in an ice-bath and distilled allyl bromide (0.69 mL, 7.93 mmol, 6 eq) 
was added. The solution was allowed to warm to room temp, over 1 h then diluted 
with EtOAc (100 mL), washed with dilute ammonia (2 x 80 mL), water (2 x 80 mL), 
dried (M gSOJ and concentrated under reduced pressure to give the crude acetal
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(471.5 mg, 85.3 %) as a cloudy colourless gum as a 10:1 ratio of products:starting 
material. The material was used without further purification. Recrystallisation of a 
sample from Et20 / hexane gave pure acetal as a 10:1:1 ratio of diastereomers A:B:C 
as colourless cubes.
ga ("400 MHz: CDCU
1.56-1.67 (m, 9H, -CH2), 1.79-1.85 (m, 6 H, CH2), 1.93-2.07 (m, 3H, CH2), 3.41 (d, 
2H, J = 6.3 Hz, A rC//2), 3.57-3.61 (m, 2H, -OC//2), 3.85-3.95 (m, 2H, -OCH2), 4.91 
(d, 1H, J = 9.9 H z ,), 5.02 (dd, 1H, J = 1.7 Hz, 17.1 Hz,), 5.36-5.41 (m, 3H, -OCHO), 
5.94 (tdd, 1H, J = 6.4 Hz, 10.1 Hz, 16.6 Hz, CH2=C//), 6.55 (s, 2H, Ar-//, minor B), 
6.57 (s, 2H, Ar-//, major A), 6.59 (s, 2H, Ar-//, minor C).
5^ HOP MHz: CDCl^
18.70 (CH2), 18.77 (CH2), 25.19 (CH2), 25.28 (CH2), 27.80 (CH2), 30.23 (CH2), 30.29 
(CH2), 30.38 (CH2), 30.43 (CH2), 61.68 (CH2), 61.71 (CH2), 61.76 (CH2), 61.84 
(CH2), 61.93 (CH2), 95.98 (CH), 96.03 (CH), 96.26 (CH), 96.38 (CH), 96.52 (CH), 
96.76 (CH), 96.96 (CH), 97.02 (CH), 97.59 (CH), 97.62 (CH), 98.71 (CH), 111.44 
(CH), 113.69 (CH), 137.67 (CH), 155.68 (C), 155.86 (C), 156.66 (C).
MS m/z (EI+) 418.3 (M+ , 1 %), 250.1 (12), 166.1 (100), 85.1 (55), 84.0 (40); C ^ O ,  
calculated 418.2355, observed 418.2354.
Microanalysis requires C 6 6 . 8 8  %, H 8.19 %, found C 66.89 %, H 8.19 %.
IR (golden gate) 2945 (CH2), 2877 (CH2), 1593 (aromatics), 1493 (aromatics), 
1016 (alkene), 904 (alkene). 
mp = 100 - 101 °C.
Rf = 0.74 [silica, Et20].
n/?.^.2/?.^-l-r3,.4,-bislBenzvloxvlphenvll-3-r2?,.4,?.6»- 
tris(tetrahydropyranyloxy)phenyll-propan-1.2-diol 315
THPO OTHP
OTHP
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Osmium tetroxide (0.02 M in water, 0.80 mL, 0.014 mmol, 0.1 eq) was added over 5 
min to a solution of alkene 143 (100 mg, 0.14 mmol, 1 eq) and NMO (60 wt % in 
water, 0.08 mL, 3 eq) in THF:water (3:1, 2 mL) at room temp. The dark 
yellow/brown solution was stirred for 16 h then quenched with 1 0  % aqueous sodium 
thiosulfate (2 mL) and stirred for a further 30 min. The solution was filtered through a 
plug of celite eluting with EtOAc (5 mL). The aqueous layer was extracted with 
EtOAc (2 x 20 mL), dried (M gS04) and concentrated under reduced pressure to give 
the crude d io l (98.3 mg, 93.8 %) as a brown gum. Purification by column 
chromatography [alumina deactivated with 10 % water, eluting with Et20:hexane 
(2:1)] gave the pure diol (47.6 mg, 45.4 %) as a yellow gum as a mixture of six 
diastereomers.
f400 MHz: CDCU
1.55-1.64 (m, 9H, -Ctf2), 1.67-1.70 (m, 6 H, -CH2), 1.78-1.80 (m, 3H, -CH2), 2.66-
3.14 ( 6  x d, 1H, J = 5.6 Hz, C (l)-0 //), 2.76-2.85 (m, 2H, C(3)H2), 3.45-3.47 (m, 1H, 
C(2)-OH), 3.57-3.60 (m, 3H, -OCH2), 3.75-3.94 (m, 4H, -OCH2 + H -1), 4.40-4.45 (m, 
1H, H-2), 5.13 (s, 2H, -OCtf2Ph), 5.14 (s, 2H, -OC//2Ph), 5.29-5.40 (m, 3H, -OCHO),
6.54-6.60 (m, 2H, H -5’ + H-6 ’), 6.89 (s, 2H, H -3”  + H-5” minor B + B ’), 6.91 (s, 
2H, //-3 ”  + H-5”  major A + A’), 6.94 (s, 2H, H-3” + H-5”  minor C + C’), 7.09 (s, 
1H, H -T), 7.27-7.46 (m, 10H, Ar-H).
5.  (100 MHz: CDCU
18.63 (CH2), 18.71 (CH2), 18.89 (CH2), 18.95 (CH2), 25.02 (CH2), 25.07 (CH2), 25.17 
(CH2), 27.24 ((CH2), 27.42 (CH2), 27.58 (CH2), 30.22 (CH2), 30.32 (CH2), 30.43 
(CH2), 61.99 (CH2), 62.21 (CH2), 62.30 (CH2), 62.42 (CH2), 71. 29 (CH2), 71.38 
(CH2), 75.95 (CH), 76.45 (CH), 77.58 (CH), 77.66 (CH), 96.13 (CH), 96.51 (CH),
96.66 (CH), 96.88 (CH), 96.95 (CH), 97.20 (CH), 97.29 (CH), 97.37 (CH), 97.43 
(CH), 97.78 (CH), 97.95 (CH), 98.29 (CH), 113.77 (CH), 114.95 (CH), 119.86 (CH),
119.98 (CH), 120.08 (CH), 127.22 (CH), 127.43 (CH), 127.71 (CH), 127.75 (CH),
128.42 (CH), 134.65 (C), 137.29 (C), 137.43 (C), 148.39 (C), 148.98 (C), 156.07 (C),
156.13 (C), 156.27 (C).
MS m/z (FAB+) 763.7 [(M+Na)+, 96 %], 471.4 (10), 319.3 (19), 229.2 (10), 139.1 
(32), 85.6 (100), 58.0 (12); C ^ O ^ N a  calculated 763.3458, observed 763.3442.
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IR vmax (neat) 3467 (OH), 2943 (CH2), 2871 (CH2), 1608 (aromatics), 1591 
(aromatics), 1510 (aromatics), 1261 (OH), 1151 (C-OH).
2-r2’-(2” -Triisopropylsilyloxyphenyl)ethyIsulfanyHbenzothiazole 338
OTIPS
A solution of iodide 269 (8.03 g, 18.1 mmol, 1.1 eq) in acetone (25 mL) was added to 
a solution of 2-mercaptobenzothiazole 339 (2.75 g, 16.5 mmol, 1 eq) and potassium 
carbonate (2.50 g, 18.1 mmol, 1.1 eq) in acetone (25 mL). The mixture was heated to 
reflux and stirred for 5 h. The mixture was diluted with water (30 mL) and extracted 
into ether (3 x 30 mL). The combined organics were washed with water (2 x 30 mL) 
and brine (2 x 30 mL), dried (M gS04) and concentrated under reduced pressure to 
give the crude sulfide  (1.15 g, 86.4 %) as a brown oil. Purification by filtration 
through a plug of silica eluting petroleum ether (40 -  60 °C) followed by ether gave 
the pure sulfide (4.76 g, 65.2 %) as a colourless oil.
ga 1400 MHz: CDC1A
1.11 (d, 18H, J = 7.4 Hz, -CHC//3), 1.26-1.36 (m, 3H, -CHCH3), 3.15 (t, 2H, 7.6 Hz, 
ArCH2), 3.59 (t, 2H, J = 7.6 Hz, -SCH2), 6.81 (d, 1H, J = 8.1 Hz, H-3” ), 6.89 (t, 1H, J 
= 7.4 Hz, H-5” ), 7.10 (dt, 1H, J = 1.7 Hz, 7.7 Hz, H-4 ” ), 7.21 (dd, 1H, J = 1.6 Hz,
7.4 Hz, H -6 ” ), 7.28 (t, 1H, J = 7.6 Hz, H-6 ), 7.41 (t, 1H, J = 7.6 Hz, H -5), 7.75 (d,
1H, J = 7.9 Hz, H -l), 7.87 (d, 1H, J = 8.1 Hz, H A). 
go (TOO MHz: CDCl^
13.05 (CH), 18.08 (CH3), 30.78 (CH2), 33.48 (CH2), 118.04 (CH), 120.77 (CH), 
120.87 (CH), 121.49 (CH), 124.06 (CH), 125.93 (CH), 127.76 (CH), 129.59 (C),
130.66 (CH), 135.25 (C), 153.40 (C), 154.07 (C), 167.09 (C).
MS m/z (EI+) 443.2 (M+ , 4 %), 400.1 (53), 276.2 (100), 233.1 (100), 191.1 (80), 163.1
(72), 149.0 (30), 135.0 (23), 59.0 (24); C ^ N O S .S i  calculated 443.1773, observed 
443.1774.
IR vmax (neat) 2944 (CH2), 2866 (CH2), 1599 (aromatics), 1581 (aromatics), 1491 
(aromatics), 1387 [C(CH3)2], 1099 (Si-O), 754 (aromatics).
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Rf = 0.71 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)]. 
2-r2,-(2” -Triisopropvlsilyloxyphenvl)ethylsulfonyHbenzothiazole 340
OTIPS
A solution of ammonium molybdate (490.3 mg, 0.40 mmol, 0.039 eq) in 30 % 
hydrogen peroxide (3.52 mL, 31.1 mmol, 2.9 eq) was added to a stirring solution of 
sulfide 338 (4.76 g, 10.7 mmol, 1 eq) in EtOH (38 mL) at 0 °C and the resulting 
solution was stirred for 18 h. Most of the solvent was removed under reduced pressure 
and the residue was dissolved in DCM (200 mL), washed with 0.5 M H 2S 0 4 (100 
mL), brine (2 x 100 mL), dried (M gS04) and concentrated under reduced pressure to 
give the title compound (4.20 g, 82.3 %) as a brown solid. Recrystallisation from 
EtOH gave the pure sulfone (3.37 g, 66.0 %) as off-white needles.
gu (400 MHz: CDCh)
1.03 (d, 18H, J = 7.4 Hz, -CH Ctf3), 1.18-1.27 (m, 3H, -C//CH3), 3.22 (m, 2H, 
ArCH2), 3.78 (m, 2H, -SO2CH2), 6.74 (d, 1H, J = 8.1 Hz, tf-3 ” ), 6.81 (dt, 1H, J = 0.8 
Hz, 7.4 Hz, H-5” ), 7.04 (dt, 1H, J = 1.7 Hz, 7.8 Hz, H-4” ), 7.11 (dd, 1H, J = 1.6 Hz,
7.5 Hz, H-6 ” ), 7.59 (dt, 1H, J = 1.4 Hz, 7.6 Hz, H-6), 7.63 (dt, 1H, J = 1.4 Hz, 7.6 Hz, 
H-5), 8.01 (dd, 1H, J = 1.2 Hz, 7.6 Hz, H -l), 8.20 (dd, 1H, J = 1.1 Hz, 8 . 6  Hz, H A). 
go HOP MHz: CDCU
13.04 (CH), 17.94 (CH3), 24.52 (CH2), 54.60 (CH2), 118.01 (CH), 121.02 (CH), 
122.23 (CH), 125.49 (CH), 126.86 (C), 127.51 (CH), 127.92 (CH), 128.23 (CH), 
130.34 (CH), 136.86 (C), 152.78 (C), 154.02 (C), 165.75 (C).
MS m/z (FAB+) 476.1 [(M +H)\ 80 %], 432.1 (100), 312.1 (15), 277.2 (26), 163.1 
(24), 115.3 (21), 73.8 (26), 60.0 (43); C24H 34N 0 3S2Si calculated 476.1749, observed 
476.1749.
Microanalysis C24H33N 0 3S2Si requires C 60.59 %, H 6.99, N 2.94 %, S 13.48 % found 
C 60.51 %, H 6.91 %, N 3.08 %, S 13.54 %.
IR vmax (golden gate) 2918 (CH2), 1591 (aromatics), 1491 (aromatics), 1327 (S 0 2), 
1130 (S 02), 1061 (Si-O), 775 (aromatics).
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mp = 135.5 -  136.0 °C.
Rf = 0.57 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
2-(3,.4,-Dimethoxyphenyl)-3-(2” -triisopropylsilyl-phenyD-propene 338
OTIPS OMe
OMe
LDA (2 M in THF/heptane/ethylbenzene, 0.23 mL, 0.46 mmol, 1.1 eq) was added 
dropwise to a solution of sulfone 340 (200.0 mg, 0.42 mmol, leq) and veratraldehyde 
341 (76.9 mg, 0.46 mmol, 1.1 eq) in dry THF (2 mL) at -78  °C under argon. The 
solution was allowed to slowly warm to room temperature over 24 h, then diluted 
with DCM (10 mL) and washed with 1 M HC1 (10 mL). The aqueous layer was then 
extracted with DCM (2 x 10 mL) and the combined organics were washed with 1 M 
NaOH (15 mL), dried (M gS04) and concentrated under reduced pressure to give the 
crude E-alkene (199.3 mg) as a brown oil. 'H  NMR showed a 5:1 mixture of product 
to starting material. Purification of the mixture was unsuccessful.
gu (400 MHz: CDCU
1.13 (d, 18H, J = 7.4 Hz, -CHCtf3), 1.30-1.37 (m, 3H, -CtfCH3), 3.55 (d, 2H, J = 6.4 
Hz, ArCH2), 3.87 (s, 6 H, -OCH3), 6.25 (dt, 1H, J = 15.8 Hz, 6.5 Hz, ArCH=CH), 6.36 
(d, 1H, J = 15.8 Hz, ArCH=CH), 6.78-6.88 (m, 5H, Ar-H), 7.08 (dt, 1H, J = 1.7 Hz,
7.7 Hz, Ar-H), 7.18 (dd, 1H, J = 1.7 Hz, 7.4 Hz, Ar-H).
2.4-bisfMethoxymethoxyl-6-hydroxybenzaldehyde 345
Diisopropylethylamine (11.8 mL, 58.2 mmol, 5.25 eq) was added dropwise over 10 
min to a suspension of chloromethyl methyl ether (4.93 mL, 64.9 mmol, 5 eq) and 
aldehyde 299 (2.00 g, 13.0 mmol, 1 eq) in dry DCM (20 mL) at 0 °C under argon. 
The mixture was stirred for 4 h and the reaction mixture was concentrated under
OH O
MOMO' OMOM
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reduced pressure. The residue was taken up in EtOAc (100 mL) and washed with 
water (100 mL). The aqueous layer was extracted with EtOAc (4 x 30 mL) and the 
combined organics were washed with cold 0.5 M HC1 (30 mL), 2 M KOH (2 x 50 
mL), brine (50 mL), dried (M gS04) and concentrated under reduced pressure to give 
the crude aldehyde3 (1.40 g, 44.6 %) as a brown oil. The base layer was carefully 
acidified and extracted into DCM (100 mL) which was then dried (M gSOJ and 
concentrated under reduced pressure to give crude aldehyde121 (1.27 g, 40.5 %) as a 
brown oil to give a combined yield of 85.1 %. The combined aldehyde was purified 
by column chromatography on silica, eluting DCM to give the pure aldehyde (1.03 g,
32.8 %) as a white solid, 
gn (400 MHz: CDCU
3.40 (s, 3H, -O C//3), 3.44 (s, 3H, -OCH3), 5.11 (s, 2H, -OCH20 ), 5.14 (s, 2H, - 
OCH20 ), 6.15 (d, 1H, J = 2.0 Hz, H-5), 6.18 (d, 1H, J = 2.1 Hz, H-3), 10.09 (s, 1H, - 
C //0 ), 12.21 (s, 1H, -OH).
5^ (100 MHz: CDC121
56.46 (CH3), 56.60 (CH3), 94.03 (CH2), 94.08 (CH), 94.58 (CH2), 96.54 (CH), 106.86 
(C), 161.22 (C), 165.44 (C), 165.60 (C), 192.10 (CH).
MS mJz (EI+) 242.1 (M+ , 100 %), 214.1 (20), 197.1 (78), 182.1 (18), 181.1 (15), 167.1 
(14), 83.0 (17), 69.0 (18); CnH 140 6 calculated 242.0790, observed 242.0793. 
Microanalysis CnH ]40 6requires C 54.55 %, H 5.83 % found C 54.54 %, H 5.86 %.
IR vmax (golden gate) 2908 (CH2), 1614 (C H O ). 
mp = 6 8  -  69 °C.
Rf = 0.18 (silica, DCM).
2-(Methylthio)benzothiazole 346
Methyl iodide (8.20 mL, 131.5 mmol, 1.1 eq) was added to a solution of 2- 
mercaptobenzothiazole 339 (20.00 g, 119.6 mmol, 1 eq) and potassium carbonate 
(18.20 g, 131.5 mmol, 1.1 eq) in acetone (200 mL). The mixture was then heated to 
reflux for 7.5 h before being quenched with EtOAc (2 x 400 mL), washed with 
approx. 2 M ammonia (400 mL), water (400 mL), dried (M gS04) and concentrated
178
under reduced pressure to give the sulfide122 (20.01 g, 92.3 %) as a brown/yellow 
solid.
ga (400 MHz: CDCU
2.78 (s, 3H, -SCH3), 7.27 (dt, 1H, J = 1.1 Hz, 7.7 Hz, H-6 ), 7.40 (dt, 1H, J = 1.2 Hz,
7.7 Hz, H-5), 7.74 (dd, 1H, J = 1.1 Hz, 8.5 Hz, H -l), 7.87 (dd, 1H, J = 0.9 Hz, 8.7 Hz, 
H- 4).
5.(1 0 0  MHz: CDCU
15.86 (CH3), 120.89 (CH), 121.32 (CH), 124.02 (CH), 125.99 (CH), 135.09 (C), 
153.31 (C), 167.99 (C).
MS m/z (EI+) 181.0 (M+ , 100 %), 180.0 (22), 148.1 (70), 136.1 (17), 108.0 (33), 69.0 
(17), 45.0 (13); C8H7NS2 calculated 181.0020, observed 181.0021.
Microanalysis C8H7NS2requires C 53.01 %, H 3.89 %, N 7.73 %, S 35.38 %, found C
53.03 %, H 3.80 %, N 7.62 %, S 35.52 %. 
mp = 46 -  47 °C.
2-r2,-(Benzothiazol-2,,-ylsulfanyn-l,-hvdroxyethvll-3.5- 
his(methoxymethoxy)phenol 347
N OH OH
sVs^ VS
M O M O ^ ^ O M O M
LDA (2 M in THF/heptane/ethylbenzene, 2.27 mL, 4.54 mmol, 2.2 eq), was added 
over 15 min to a solution of sulfide 346 (748.4 mg, 4.13 mmol, 2.0 eq) in dry THF (7 
mL) at -78 °C under an atmosphere of argon. The mixture was stirred at -78 °C for 1 
h then a solution of aldehyde 345 (500.0 mg, 2.06 mmol, 1 eq) in dry THF (5 mL) 
was added over 5 min and the solution was allowed to slowly warm to room temp, 
over 20 h. The reaction mixture was quenched with water (50 mL) and the aqueous 
layer was extracted with Et20  (3 x 50 mL). The combined organics were washed with 
water (100 mL), dried (M gS04) and concentrated under reduced pressure to give the 
crude sulfide (853.3 mg, 97.6 %) as a viscous brown oil. Filtration through a plug of 
silica eluting petroleum ether (40 -  60 °C):EtOAc (6:1) then MeOH, gave cleaner 
sulfide (434.7 mg, 50.1 %) as a viscous yellow oil.
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8 p f400 MHz: CDCU
3.47 (s, 3H, -O C//3), 3.48 (s, 3H, -OCH3), 3.56 (dd, 1H, J = 2.1 Hz, 14.9 Hz, -CHaHb), 
3.73 (dd, 1H, J = 7.2 Hz, 14.9 Hz, -CHaHb), 5.13 (s, 2H, -0C H 20 ), 5.16 (d, 1H, J =
6.5 Hz, -OCHHO), 5.19 (d, 1H, J = 6.5 Hz, -OCHHO), 5.70 (dd, 1H, J = 2.1 Hz, 7.2 
Hz, -C//OH), 6.30 (d, 1H, J = 2.3 Hz, H-6), 6.32 (d, 1H, J = 2.3 Hz, H-4), 7.36 (dt, 
1H, J = 1.0 Hz, 7.7 Hz, H-6 ” ), 7.47 (dt, 1H, J = 1.1 Hz, 8.3 Hz, H-5” ), 7.77 (d, 1H, J 
= 7.9 Hz, H-7” ), 7.88 (d, 1H, J = 8.1 Hz, H-4” ), 9.97 (br s, 1H, -OH).
5.  HOP MHz: CDCU
41.36 (CH2), 56.08 (CH3), 56.39 (CH3), 72.52 (CH), 94.37 (CH2), 94.53 (CH2), 94.67 
(CH), 98.64 (CH), 107.45 (C), 121.07 (CH), 121.19 (CH), 124.97 (CH), 126.53 (CH),
135.39 (C), 151.70 (C), 154.84 (C), 158.40 (C), 158.50 (C), 169.10 (C).
MS m/z (FAB+) 446.0 [(M+Na)+, 10 %], 406.0 (54), 281.0 (15), 207.0 (21), 180.9
(24), 147.0 (19), 73.7 (59), 46.1 (100); C 19H 21N 0 6S2Na calculated 446.0708, observed 
446.0709.
2-r2,-fBenzothiazol-2” -ylsulfanyD-vinyll-3.5-bis(niethoxyinethoxy)phenol 348
MOMO'
LDA (2 M in THF/heptane/ethylbenzene, 2.20 mL, 4.33 mmol, 2.1 eq), was added 
dropwise over 10 min to a solution of sulfide 351 (1.10 g, 4.33 mmol, 2.1 eq) in dry 
THF (20 mL) under argon at -78 °C. The solution was stirred for 1 h before a solution 
of aldehyde 345 (500.0 mg, 2.06 mmol, 1 eq) in dry THF (10 mL) was added over 10 
min. The mixture was removed from the dry ice bath and allowed to warm slowly to 
room temp, over 17 h. The reaction was quenched with water (50 mL) and extracted 
into Et20  (3 x 50 mL). The combined organics were washed with water (100 mL), 
dried (M gS04) and concentrated under reduced pressure to give the vinyl sulfide 
(786.0 mg, 81 %) as a yellow solid. The solid was washed with hexane and dried 
under high vacuum to give the pure vinyl sulfide (274.4 mg, 32.8 %) as an off-white 
solid [E:Z 10:1 from ]H NMR]. Recrystallisation from z-PrOH gave the pure E-vinyl 
sulfide as an amorphous solid.
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gu (400 MHz: CDCL)
3.43 (s, 3H, -OC//3), 3.49 (s, 3H, -OCH3), 5.08 (s, 2H, -0 C tf20 ), 5.16 (s, 2H, - 
0C H 20 ), 6.27 (d, 1H, J = 2.2 Hz, H-6 ), 6.32 (d, 1H, J = 2.2 Hz, H-4), 7.29 (dt, 1H, J 
= 1.1 Hz, 8.1 Hz, H-6 ” ), 7.32 (d, 1H, J = 15.5 Hz, -C //2.=CH), 7.40 (dt, 1H, J = 1.1 
Hz, 7.7 Hz, H-5” ), 7.48 (d, 1H, J = 15.5 Hz, -CH=C//r ), 7.75 (d, 1H, J = 7.7 Hz, H- 
7” ), 7.90 (d, 1H, J = 8.1 Hz, H-4” ), 7.99 (br s, 1H, -O//).
<5L aOO MHz: CDCU
56.08 (CH3), 56.33 (CH3), 94.35 (CH2), 94.77 (CH2), 95.32 (CH), 97.75 (CH), 107.16 
(C), 116.73 (CH), 120.97 (CH), 121.35 (CH), 124.31 (CH), 126.24 (CH), 132.29 
(CH), 135.03 (C), 153.04 (C), 156.84 (C), 157.06 (C), 158.46 (C), 169.63 (C).
MS m/z (EI+) 405.2 (M+, 36 %), 238.2 (31), 194.1 (10), 167.1 (18), 162.1 (15); 
C 19H 19N 0 5S2 calculated 405.0705, observed 405.0704.
Microanalysis C 19H]9N 0 5S2 requires C 56.28 %, H 4.72 %, N 3.45 %, S 15.82 %, 
found C 56.32 %, H 4.73 %, N 3.68 %, S 15.98 %.
Rf = 0.62 [silica, ether].
2-(Trimethylsilylmethylthiolbenzothiazole 351
Chloromethyltrimethylsilane (0.62 mL, 4.48 mmol, 1.5 eq) was added to a solution of 
2-mercaptobenzothiazole 339 (500.0 mg, 2.99 mmol, 1.5 eq) and potassium carbonate 
(619.8 mg, 4.48 mmol, 1.5 eq) in acetone (10 mL) and the resulting mixture was 
heated to reflux for 75 min. After cooling, the mixture was diluted with Et20  (150 
mL), washed with dilute aqueous ammonia (2 x 50 mL), water (2 x 50 mL), dried 
(M gS04) and concentrated under reduced pressure to give the crude TMS sulfide123 
(680.7 mg, 89.8 %) as a yellow oil.
^  (400 MHz: CD CM
0.21 (s, 9H, -SiCtf3), 2.62 (s, 2H, -SCtf2Si), 7.20 (dt, 1H, J = 1.2 Hz, 7.7 Hz, H-6),
7.28 (dt, 1H, J = 1.2 Hz, 7.6 Hz, H-5), 7.55 (dd, 1H, J = 0.5 Hz, 8.0 Hz, H -l), 7.66 (d, 
1H, J = 8.1 Hz, H A).
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5.(1 0 0  MHz: CDCU
-1.78 (CH3), 18.94 (CH2), 120.82 (CH), 121.19 (CH), 123.80 (CH), 126.88 (CH),
135.18 (C), 153.47 (C), 170.52 (C).
MS m/z (EI+) 253.1 (M+, 27 %), 238.0 (100) 206.1 (13), 192.0 (12), 149.0 (10), 83.0
(42), 73.1 (47); CuH 15NS2Si calculated 253.0415, observed 253.0417.
Rf = 0.60 [silica, petroleum ether (40 -  60 °C):EtOAc (4:1)].
2-r2,-(2” .4” .6” -tris(Tetrahydropyranyloxy)phenyl)ethylsulfanyllhenzothiazole
355
THPO .OTHP
OTHP
Potassium carbonate (117.0 mg, 0.85 mmol, 1.1 eq) was added to a solution of iodide 
366 (410.0 mg, 0.77 mmol, 1 eq) and 2-mercaptobenzothiazole 339 (142.0 mg, 0.85 
mmol, 1.1 eq) in acetone (8.2 mL) at room temp. The mixture was heated to reflux 
and left for 23 h. After cooling, the mixture was diluted with Et20  (60 mL) and 
washed with 1 M KOH (30 mL). The aqueous layer was re-extracted with Et20  (20 
mL) and the combined organics were washed with water (30 mL), brine (30 mL), 
dried (M gS04) and concentrated under reduced pressure to give the crude sulfide 
(400.0 mg, 90.9 %) as a yellow gum. Purification by column chromatography 
[alumina 6  % water, hexane:Et20  (20:1-5:1)] gave the pure sulfide (140.0 mg, 31.8 %) 
as a viscous oil as a 1:2:1 mixture of diastereomers A:B:C.
^  1400 MHz: CDCL)
1.44-1.92 (m, 18H, -CH2), 3.05-3.22 (m, 2H, ArCH2), 3.46-3.55 (m, 5H, -CH2 and - 
CH2S), 3.76-3.89 (m, 3H, -C //2), 5.29-5.36 (m, 3H, -OCHO), 6.48 (s, 2H, A r-//, 
minor B), 6.50 (s, 2H, Ar-//, major A), 6.53 (s, 2H, Ar-//, minor C), 7.19 (dt, 1H, J =
1.1 Hz, 8.1 Hz, H-6), 7.32 (dt, 1H, J = 1.1 Hz, 7.7 Hz, H-5), 7.66 (d, 1H, J = 7.7 Hz, 
H -l), 7.76 (d, 1H, J = 8.1 Hz, H A).
182
2-12’>- \2 '' .4 '' .6'' - tris(Tetrahydropy ranvloxv Iphenvllethanesulfonvl Ihenzothiazole 
356
A solution of ammonium molybdate (11 mg, 0.009 mmol, 0.037 eq) in 30 % 
hydrogen peroxide (0.08 mL) was added to a solution of sulfide 355 (140 mg, 0.25 
mmol, 1 eq) in EtOH (1 mL) at 0 °C. The solution was allowed to warm to room 
temp, and left overnight. Most of the EtOH was removed and the residue was 
dissolved in DCM (30 mL) and washed with water (20 mL), brine (20 mL), dried 
(M gS04) and concentrated under reduced pressure to give the crude sulfone (7 mg) as 
a brown gum. ]H NMR showed a complex mixture of many compounds.
Alternative procedure:
Oxone (3.67 g, 5.97 mmol, 3 eq) was added to a solution of sulfide 355 (853 mg, 1.49 
mmol, 1 eq) in DMF (10 mL) at room temp. The resulting solution was stirred at 
room temp for 2.5 h, diluted with EtOAc (70 mL) washed with water (4 x 30 mL), 
dried (M gSOJ and concentrated under reduced pressure to give the crude sulfone 
(800.0 mg, 90.1 %) as a dark red glass. ]H NMR showed no desired product.
Alternative procedure:
te/T-Butyllithium (1.5 M in pentane, 0.59 mL, 0.89 mmol, 2 eq) was added dropwise 
to a solution of acetal 311 (337.5 mg, 0.89 mmol, 2 eq) in THF (1 mL) at -78  °C 
under argon. The yellow solution was allowed to warm slowly over 70 min. then 
placed in an ice-bath and freshly dried and ground copper iodide (178.3 mg, 0.94 
mmol, 2.1 eq) was added. The resulting dark brown/yellow solution was stirred in the 
ice-bath for 15 min. then re-cooled to -78  °C and a solution of freshly dried vinyl 
sulfone 359 (100.0 mg, 0.45 mmol, 1 eq) in THF (0.5 mL) was added dropwise. The 
resulting solution was allowed to warm slowly over 70 min. then diluted with EtOAc
THPO OTHP
f ^ H iOTHP O S
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(15 mL). The organics were washed with NH4C1 (3 x 30 mL), water (2 x 30 mL), 
dried (M gS04) and concentrated under reduced pressure to give the crude sulfone 
(313.9 mg) as an off-white foam. Recrystallisation from EtOH gave the pure sulfone 
(46.6 mg, 17.3 %) as a 1:1:1 mixture of three diastereomers A:B:C as a clear cube.
^  (400 MHz: CDCM
1.46-1.97 (m, 18H, -C //2), 3.17-3.23 (m, 2H, -C //2), 3.54-3.58 (m, 3H, -CH2), 3.58- 
3.91 (m, 5H, -CH2 + -SO2C //2), 5.30-5.39 (m, 3H, -O C //0), 6.48 (s, 2H, Ar-//, minor
B), 6.49 (s, 2H, Ar-//, major A), 6.52 (s, 2H, Ar-//, minor C), 7.59 (dt, 1H, J = 1.5 Hz, 
7.6 Hz, Ar-//), 7.63 (dt, 1H, J = 1.3 Hz, 7.4 Hz, Ar-//) 8.02 (dd, 1H, J = 0.9 Hz, 7.9 
Hz, Ar-//), 8.20 (dd, 1H, J = 1.0 Hz, 7.3 Hz, Ar-/7).
2-r(Benzothiazol-2’-vlisulfanvllethanol 357
A mixture of 2-mercaptobenzothiazole 339 (40.00 g, 239.16 mmol, 1 eq), potassium 
carbonate (39.66 g, 286.99 mmol, 1.2 eq) potassium iodide (3.97 g, 23.92 mmol, 0.1 
eq) and 2-chloroethanol (19.22 mL, 286.99 mmol, 1.2 eq) in acetone (400 mL) was 
heated to reflux for 3 d. The mixture was allowed to cool to room temp., filtered and 
the filtrate concentrated under reduced pressure. The residue was dissolved in EtOAc 
(500 mL), washed with 1 M KOH (300 mL), dilute aqueous ammonia (300 mL), 
water (300 mL), dried (M gS04), filtered and concentrated under reduced pressure to 
give the crude sulfide124 (48.86 g, 96.7 %) as a yellow solid. A small quantity was 
recrystallised from Et20/hexane to give yellow needles.
^ i4 0 0 M H ziC D C l2)
3.51 (t, 2H, J = 5.2 Hz, -S 0 2C //2), 4.08 (m, 3H, -CH2CH2 and -OH), 7.30 (dt, 1H, J = 
1.0 Hz, 8.1 Hz, Ar-//), 7.41 (dt, 1H, J = 1.1 Hz, 8.2 Hz, Ar-//), 7.74 (dd, 1H, J = 0.4 
Hz, 8.0 Hz, Ar-//), 7.84 (d, 1H, J = 8.2 Hz, Ar-//).
5 . (TOO MHz: CDCM
36.55 (CH2), 62.56 (CH2), 120.99 (CH), 121.29 (CH), 124.52 (CH), 126.18 (CH),
135.39 (C), 152.51 (C), 167.30 (C).
184
MS m/z (EI+) 211.1 (M+ , 22% ), 181.1 (17), 167.0(100), 148.1 (10), 136.1 (11), 108.1
(14); C9H9NOS2 calculated 211.0126, observed 211.0126.
Microanalysis C9H9NOS2requires C 51.16 %, H 4.29 %, N 6.63 %, found C 51.17 %,
H 4.24 % ,N  6.60% .
mp = 51 - 52 °C [lit. 124 53 -  55 °C].
2-r(Benzothiazol-2,-yl)sulfonyllethanol 358
A solution of ammonium molybdate (5.49 g, 4.44 mmol, 0.037 eq) in 30 % hydrogen 
peroxide (39.2 mL, 348.32 mmol, 2.9 eq) was added slowly to a solution of sulfide 
357 (25.38 g, 120.11 mmol, 1 eq) in EtOH (210 mL) at 0 °C. The solution was 
allowed to warm to room temp, and stirred for a further 40 h. The mixture was diluted 
with DCM (600 mL), washed with 0.5 M H2S 0 4 (250 mL), brine (250 mL), dried 
(M gS04), filtered and concentrated under reduced pressure to give the crude sulfone137 
(26.35 g, 90.2 %) as a fluffy white solid.
ga 1400 MHz: CDCU
2.97 (t, 1H, J = 6.7 Hz, -OH), 3.77 (t, 2H, J = 5.2 Hz, -S 0 2C //2), 4.21 (m, 2H, - 
CH2CH2), 7.62 (dt, 1H, J = 1.4 Hz, 7.6 Hz, Ar-H), 7.67 (dt, 1H, J = 1.5 Hz, 7.6 Hz, 
Ar-H), 8.04 (dd, 1H, J = 1.4 Hz, 7.4 Hz, Ar-//), 8.22 (dd, 1H, J = 1.3 Hz, 7.4 Hz, Ar- 
H).
jL (TOO MHz: CDCU
56.38 (CH2), 57.66 (CH2), 122.38 (CH), 125.36 (CH), 127.84 (CH), 128.26 (CH), 
136.52 (C), 152.32 (C), 166.16 (C).
MS m /z (EI+) 243.1 (M+, 8  %), 151.1 (17), 135.1 (100), 108.0 (20); C ^ N C ^ S , 
calculated 243.0024, observed 243.0022.
Microanalysis C9H9N 0 3S2requires C 44.43 %, H 3.73 %, N 5.76 %, S 26.36 %, found 
C 44.24 %, H 3.62 %, N 5.71 %, S 26.26 %.
185
IR vm  (golden gate) 3386 (OH), 2964 (CH2), 2927 (CH2), 2881 (CH2), 1612 
(aromatics), 1512 (aromatics), 1471 (aromatics), 1321 (S 0 2), 1126 (S 0 2), 754 
(aromatics).
mp = 114 -  114.5 °C [lit. 137 101 -  102 °C].
2-(Vinylsulfonyl)-benzothiazole 359
Methanesulfonyl chloride (0.64 mL, 8.22 mmol, 2 eq) was added slowly to a solution 
of sulfone 358 (1.00 g, 4.11 mmol, 1 eq) in a 50:50 mixture of DCM/Et3N at 0 °C 
under argon. The solution allowed to warm to room temp, and stirred for 8  h. The 
solution was diluted with DCM (50 mL), washed with 2 M HC1 (30 mL), N aHC03 (2 
x 30 mL), water (3 x 30 mL), brine (30 mL), dried (M gS04), filtered and concentrated 
under reduced pressure to give the crude vinyl sulfone137 (604.7 mg, 65.6 %) as a 
brown solid. Purification by column chromatography (silica eluting DCM) gave the 
pure vinyl sulfone (420.3 mg, 45.6 %) as an amorphous off-white solid. A small 
quantity was recrystallised from EtOH, to give pure vinyl sulfone as an amorphous 
white solid.
ga (400 MHz: CDCU
6.44 (dd, 1H, J = 0.7 Hz, 9.8 Hz, CH=C77cisH ^ J ,  6.74 (dd, 1H, J = 0.7 Hz, 16.6 Hz, 
CH=CHcis/ / trans), 6.99 dd, 1H, 9.8 Hz, 16.6 Hz, Hc), 7.58 (dt, 1H, J = 1.4 Hz, 7.6 Hz, 
H-6 ), 7.64 (dt, 1H, J = 1.5 Hz, 7.6 Hz, H-5), 8.01 (dd, 1H, J = 1.1 Hz, 7.1 Hz, H-7), 
8.22 (dd, 1H, J = 1.1 Hz, 7.2 Hz, H-4). 
jL (TOO MHz: CDCU
122.28 (CH), 125.48 (CH), 127.66 (CH), 128.06 (CH), 132.23 (CH2), 135.89 (C), 
136.89 (CH), 152.80 (C), 165.98 (C).
MS m/z (EI+) 225.1 (M+, 100 %), 160.1 (91), 135.1 (81), 134.1 (43), 108.0 (42), 90.1
(32), 69.0 (24), 63.0 (22); C9H7N 0 2S2 calculated 224.9918, observed 224.9919. 
Microanalysis C9H7N 0 2S2 requires C 48.20 %, H 3.15 %, N 6.25 %, S 28.59 %, found 
C 47.98 %, H 2.95 %, N 6.18 %, S 28.61 %.
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IR vmax (golden gate) 1604 (aromatics), 1550 (aromatics), 1469 (aromatics), 1319 
(S 0 2), 1142 (S 02), 984 (CH=CH2), 945 (CH=CH2), 764 (aromatics). 
mp = 87 -  89 °C [lit. 137 8 6  -  8 8  °C (n-PrOH)].
Rf = 0.26 (silica, DCM).
l-Deuterio-2.4.6-tris(tetrahydropyranyl)benzene 360
terr-Butyllithium (1.5 M in pentane, 0.35 mL, 0.53 mmol, 1 eq), was added to a 
solution of freshly dried acetal 311 (200 mg, 0.53 mmol, 1 eq) in THF (2 mL) at -78 
°C under argon. The solution was allowed to warm 0 °C over 1 h then MeOD (0.5 
mL) was added and the solution was allowed to warm to room temp, over 2 h. The 
mixture was concentrated under reduced pressure, the residue was dissolved in DCM 
(10 mL) and washed with water (10 mL), brine (10 mL), dried (M gSO J and 
concentrated under reduced pressure to give the crude acetal (200 mg, 99.8 %) as a 
white amorphous solid as a 2:1 mixture of diastereomers A:B.
^  1400 MHz: CDCU
1.54-1.71 (m, 9H, -C //2), 1.80-1.86 (m, 6 H, -CH2), 1.93-2.04 (m, 3H, -CH 2), 3.58- 
3.62 (m, 3H, -OCH2), 3.89-3.94 (m, 3H, -OCH2), 5.35-5.40 (m, 3H, -OCHO), 6.43 (s, 
2H, Ar-H, minor), 6.44 (s, 2H, Ar-H, major).
2-(Hexane-l '-sulfonyDhenzothiazole 361
rc-Butyllithium (1.6 M in hexanes, 0.56 mL, 0.89 mmol, 1 eq) was added to a solution 
of freshly dried sulfone 359 (200 mg, 0.89 mmol, 1 eq) in THF (2 mL) at 0 °C under 
argon. The bright yellow/orange solution was allowed to warm to room temp, over 15 
h. The dark red solution was quenched with 0.5 M HC1 (10 mL) and extracted into
THPO .OTHP
OTHP
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DCM (30 mL). The organics were washed with water (10 mL), brine (10 mL), dried 
(M gS04) and concentrated under reduced pressure to give the crude sulfone118 (170.5 
mg, 81.9 %) as a bright orange oil. Purification by column chromatography on silica 
eluting DCM gave purer sulfone (26 mg, 12.5 %) as a bright yellow oil. The JH NMR 
spectrum showed an inseparable mixture of 360 and 364.
Alternative procedure:
tt-Butyllithium (1.6 M in hexanes, 1.12 mL, 1.78 mmol, 2 eq) was added to a 
suspension of freshly dried copper iodide (169.8 mg, 0.89 mmol, 1 eq) in THF (2 mL) 
at 0 °C under argon. The mixture was stirred at 0 °C for 1 h then cooled to -78 °C and 
a solution of freshly dried sulfone 359 (200 mg, 0.89 mmol, 1 eq) in THF (1 mL) was 
added slowly. The resulting mixture was allowed to warm slowly to room temp, over
5.5 h, then worked-up as above to give the crude sulfone118 (35.4 mg, 17 %) as a 
yellow oil. Analysis of the JH NMR spectrum showed the presence of the alkyl chain, 
but the integrations did not match the product.
2-(2,-PhenylethanesuIfonyDhenzothiazole 362
Phenyllithium (0.58 M in cyclohexane/ether, 1.51 mL, 0.89 mmol, 1 eq) was added to 
a solution of freshly dried sulfone 359 (200 mg, 0.89 mmol, 1 eq) in THF (1 mL) at - 
78 °C under argon. The resulting orange solution was allowed to warm to room temp, 
over 17 h then worked-up as above to give the crude sulfone123 (190.5 mg, 70.6 %) as 
a yellow oil. The ]H NMR spectrum showed no product, but what looked like 
benzothiazole 362.
Alternative procedure:
Phenyllithium (0.58 M in cyclohexane/ether, 1.51 mL, 0.89 mmol, 1 eq) was added to 
a suspension of copper bromide dimethyl sulfide complex (183.3 mg, 0.89 mmol, 1 
eq) in Et20  (1 mL) at 0 °C under argon. The resulting mixture was stirred at 0 °C for 1
188
h then cooled to -78 °C and a solution of freshly dried sulfone 359 (200 mg, 0.89 
mmol, 1 eq) in Et20  (1 mL) was added slowly. The resulting mixture was allowed to
(156.4 mg, 58.0 %) as a yellow oil. The 'H  NMR spectrum was similar to that above. 
2-r2,.4’.6’-tris(Tetrahydropyranyloxy)phenyllethyl alcohol 366
Ozone (oxygen flow = 70, voltage = 120) was bubbled through a solution of 312  
[(5.19 g, 5.97 mmol, 1 eq), as a 1:1 mixture of 311:312] in a 50:50 mix of 
EtOH:DCM (60 mL) at -78 °C for 3 h. Oxygen was bubbled through the solution for 
15 min then EtOH (50 mL) and NaBH4 (500 mg, 11.94 mmol, 2 eq) were added. The 
solution was stirred at room temp overnight then diluted with DCM (200 mL), 
washed with water (100 mL), brine (100 mL), dried (M gS04) and concentrated under 
reduced pressure to give the crude alcohol (4.75 g) as a pale yellow viscous gum. 
Purification by column chromatography [alumina deactivated with 6  % water, eluting 
with Et20:hexane (3:2)] gave the pure alcohol (1.66 g, 6 6  %) as a 1:2:1 mixture of 
diastereomers A:B:C and recovered 311 (2.2 g , 85% ).
gu [400 MHz: CDCM
1.54-1.69 (m, 9H, -CH2), 1.80-2.02 (m, 9H, -CH2), 2.98 (t, 2H, J = 6.3 Hz, ArCH2), 
3.59-3.63 (m, 3H, -CH2), 3.78-3.94 (m, 5H, -CH2 + -C tf2OH), 5.37-5.41 (m, 3H, - 
OCHO), 6.57 (s, 2H, Ar-H, minor B), 6.59 (s, 2H, Ar-H, major A), 6.61 (s, 2H, Ar-H, 
minor C).
jL (TOO MHz: CDCM
18.60 (CH2), 18.68 (CH2), 18.74 (CH2), 18.95 (CH2), 19.01 (CH2), 25.13 (CH2), 25.16 
(CH2), 26.85 (CH2), 30.19 (CH2), 30.24 (CH2), 30.32 (CH2), 30.44 (CH2), 30.49 
(CH2), 61.83 (CH2), 61.91 (CH2), 61.95 (CH2), 62.17 (CH2), 62.23 (CH2), 63.02 
(CH2), 96.07 (CH), 96.45 (CH), 96.58 (CH), 96.64 (CH), 96.79 (CH), 96.90 (CH), 
96.93 (CH), 97.04 (CH), 97.26 (CH), 97.83 (CH), 110.14 (C), 110.26 (C), 110.44 (C),
156.19 (C), 156.34 (C), 156.77 (C), 156.93 (C), 157.11 (C).
warm to room temp, over 17 h the worked-up as above to give the crude sulfone123
THPO .OTHP
OTHP
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MS m/z (CI+) 423.3 (M+ , 13 %), 339.3 (39), 311.3 (13), 255.2 (63), 227.2 (11), 171.1
(27), 170.1 (11), 85.1 (100), 84.1 (18); C23H 340 7 calculated 423.2383, observed 
423.2382.
IR (neat) 3430 (OH), 2941 (CH2), 2871 (CH2), 1606 (aromatics), 1593 
(aromatics), 1508 (aromatics), 1259 (OH), 1151 (C-OH).
2-r2*. 4 ’. 6’-tris(Tetrahydropyranyloxv)phenvllethyl iodide 367
Triphenylphosphine (1.24 g, 4.71 mmol, 1.2 eq), imidazole (320.0 mg, 4.71 mmol,
1.2 eq) and iodine (1.20 g, 4.71 mmol, 1.2 eq) were added in order to a solution of 
alcohol 366 (1.66 g, 3.93 mmol, 1 eq) in DCM (16.6 mL) at room temp, under argon 
and shielded from the light. The resulting solution was stirred at room temp, for 6.5 h, 
diluted with DCM (150 mL) washed with 10 % aqueous sodium thiosulfate (2 x 100 
mL), brine (100 mL), dried (M gS04) and concentrated under reduced pressure to give 
the crude iodide (1.60 g) as a pale yellow viscous gum. The crude iodide was passed 
through a plug of alumina ( 6  % water) eluting hexane:Et20  (5:1) and then columned 
[alumina eluting hexane:EtOAc (10:1)] to give cleaner iodide (410.0 mg, 20.5 %) as a 
viscous oil as a 2:1:1 mixture of diastereomers A:B:C. The iodide was found to be 
unstable and used immediately. Selected signals from the !H NMR spectrum are 
shown below.
gu (400 MHz: CDCU
5.28-5.35 (m, 3H, -O C //0), 6.46 (s, 2H, Ar-H, minor B), 6.47 (s, 2H, Ar-//, major A), 
6.50 (s, 2H, A t-H, minor C).
1 -Iodo-2.4.6-tris(tetrahydropyranyloxy)benzene 368
THPO .OTHP
OTHP
THPO .OTHP
OTHP
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tert-Butyllithium (1.76 mL, 2.64 mmol, 2 eq) was added to a solution of acetal 311 
(500 mg, 1.32 mmol, 1 eq) in THF (5 mL) at -78  °C under argon. The resulting 
yellow solution was allowed to warm over 70 min. then placed in an ice-bath. A 
solution of iodine (2.01 g, 2.64 mmol, 6  eq) in THF (10 mL) was added dropwise and 
the resulting solution was stirred for 75 min. then diluted with EtOAc (100 mL), 
washed with 10 % sodium thiosulfate (2 x 150 mL), water (2 x 100 mL), dried 
(M gS04) and concentrated under reduced pressure to give the crude iodide (641.2 mg,
96.2 %) as an off white sticky gum as a 5.5:1 mixture of products: starting material 
and as 2:1:1 mixture of diastereomers A:B:C. Purification by recrystallisation was 
unsuccessful and decomposed the product. Selected signals from the ]H NMR 
spectrum are shown below.
5^ (400 MHz: CDCU
6.48 (s, 2H, A r-//, minor B), 6.50 (s, 2H, Ar-//, major A), 6.57 (s, 2H, Ar-//, minor
C).
2-(2'•-PhenvlethenesulfonvBbenzothiazole 369
Palladium acetate (4.9 mg, 0.02 mmol, 0.05 eq) was added to a solution of 
iodobenzene (0.05 mL, 0.43 mmol, 1 eq), triethylamine (0.08 mL, 0.54 mmol, 1.25 
eq) and sulfone 359 (121.2 mg, 0.54 mmol, 1.25 eq) in acetonitrile (2 mL) at room 
temp, under argon. The resulting mixture was heated to reflux for 69 h, allowed to 
cool to room temp, then diluted with DCM (10 mL). The organics were washed with 
water (3 x 10 mL), dried (M gS04) and concentrated under reduced pressure to give 
the crude mixture (161.6 mg, 99.6 %) as a pale green oil. Purification by column 
chromatography on silica eluting DCM gave purer 369 (28.5 mg, 17.6 %) as a pale 
yellow oil. The !H NMR spectrum showed the presence of product as only the trans 
double bond, but only a small amount was present. Selected signals from the *H NMR 
spectrum are shown below.
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^ i4 00Jv fflz iC D C I2)
7.15 (d, 1H, J = 15.4 Hz, -CH=CH), 7.89 (d, 1H, J = 15.4 Hz, -Ctf=CH).
Alternative procedure A:
A mixture of sulfone 359 (44.9 mg, 0.2 mmol, 1 eq), palladium acetate (2.2 mg, 0.01 
mmol, 0.05 eq) diisopropylethylamine (0.14 mL, 0.8 mmol, 4 eq) and bromobenzene 
(0.08 mL, 0.8 mmol, 4 eq) in 15 % aqueous DMF (1.38 mL) was placed in a 
microwave tube and degassed under an argon flow for 5 min. The tube was sealed and 
microwaved (50 W) for 10 min at 150 °C. The mixture was diluted with EtOAc (5 
mL), washed with water (3 x 10 mL), dried (M gS04) and concentrated under reduced 
pressure to give the crude mixture (19.8 mg, 32.7 %) as a brown oil. The *H NMR 
spectrum showed what looked like saturated sulfone 361 and bromobenzene.
Alternative procedure B:
A mixture of sulfone 359 (44.9 mg, 0.2 mmol, 1 eq), palladium acetate (2.2 mg, 0.01 
mmol, 0.05 eq) diisopropylethylamine (0.14 mL, 0.8 mmol, 4 eq), triphenylphosphine 
(6.3 mg, 0.024 mmol, 0.12 eq) and bromobenzene (0.08 mL, 0.8 mmol, 4 eq) in 15 % 
aqueous DMF (1.38 mL) was placed in a microwave tube and degassed under an 
argon flow for 5 min. The tube was sealed and microwaved (50 W) for 10 min at 150 
°C. The mixture was diluted with EtOAc (5 mL), washed with water (3 x 10 mL), 
dried (M gS04) and concentrated under reduced pressure to give the crude mixture 
(19.8 mg, 32.7 %) as a brown oil. The lH NMR spectrum showed what looked like 
saturated sulfone 361 and bromobenzene. Selected signals from the ]H NMR 
spectrum are shown below.
^  (400 MHz: CDCU
3.64 (app. t, 2H, PhCtf2), 4.03 (app. t, 2H, -SO2CH2).
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